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The regulation of the ubiquitin-proteasome system (UPS) has been the subject of a 
vast body of work because of its implication in normal development and a wide range of 
diseases. The UPS controls the degradation of a large number of cellular proteins and 
thereby regulates essential cellular processes critical for cellular adaptation and more. 
Amongst the main processes are removal of mis-folded and potentially toxic proteins, cell’s 
loss of protein quality control is often associated with muscle atrophy and 
neurodegenerative diseases. The proteasome is subject to tight regulation, as many 
different proteins govern its transcription, assembly, stability and activity. Consequently, 
its regulation is extremely complex and even further complicated by the fact that all the 
above events are responsive to changing cellular environment and different 
pathophysiological conditions. Although the proteasome has been studied extensively, 
much still remains unknown, especially missing is a detailed mechanism as to how its 
complexed and multi-phased assembly adapts to proteotoxic stress. 
In this thesis I used a proteasome impaired genetic background to screen for 
suppressors of proteotoxic stress which modify proteasomes adaptive tress response. To 
my surprise I identified a core 20S subunit of the proteasome, a1 subunit. This finding 
uncovered its functional interaction with a yet un-characterized regulator of proteasome 
stability in Drosophila, Ecm29 (CG8858). Whereas much is known of proteasome stress 
response at the level of its expression, very little is known of adaptive responses through 
alternative assembly. The results of this thesis suggest a new mechanism for proteasome 
stress adaption through modified assembly. To date most studies of proteasome regulation 
focused on the regulatory particle as master regulator and overlooked participation of the 
proteasome core particle in regulatory function. This thesis exemplifies the significance of 
the core particle, specifically its a ring, as an integral entity in the regulation of protein 
degradation by the proteasome. The overall findings demonstrate vitality of the 
proteasomes as active players in the response to proteotoxic stress. Furthermore, they 
define regulation of proteasome assembly as a mechanism to control suitable protein 
turnover and healthy cellular function.  
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1. Introduction
1.1 The Ubiquitin Proteasome System 
The cellular protein pool is under continuous change and its regulation is crucial 
for normal cellular function. Loss of protein homeostasis has been implicated in many 
pathological conditions, most noted cancer, aging, muscle atrophy and a plethora of 
neurodegenerative diseases. The UPS is the primary degradation system that mediates the 
degradation of short-lived regulatory proteins and the removal of damaged soluble 
proteins. The UPS is involved in a diverse array of biological processes, including cell-
cycle progression, DNA repair, apoptosis, immune response, signal transduction, 
transcription, metabolism, protein quality control and developmental programs. 
As proteasome-mediated degradation plays a key role in essentially all cellular 
processes, its own regulation is primal for preserving cellular homeostasis. Proteasome 
activity is regulated at several levels: from its expression levels to the rate of assembly and 
stability, further fine-tuned by its localization and conformation changes due to post-
translational modifications and binding of different accessory proteins and activators. 
Given the diversity and complexity of proteasome regulation, marked by a growing number 
of proteasome associated proteins being identified, it is becoming clear that the proteasome 
is more than just a static funnel for degradation as once imagined but rather a dynamic 
player in shaping the cellular proteomic profile.   
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1.1.2 Proteasomes and the ubiquitin pathway 
Proteins are targeted for degradation by the proteasomes with a ubiquitin tag, 
covalently attached to lysine residues in substrate proteins. Ubiquitin (Ub) conjugation is 
ATP dependent and is achieved via an enzymatic cascade involving three distinct classes 
of enzymes: E1 (Ub-activating enzyme) hydrolases ATP and forms a thioester-linked 
conjugate between itself and ubiquitin; E2 (Ub-conjugating enzyme) receives ubiquitin 
from E1 and forms a similar thioester bond; and E3 (Ub ligase) binds both E2 and the 
substrate, mediating ubiquitin transfer to the substrate (Glickman and Ciechanover, 2002). 
Sub sequential reactions link additional ubiquitin molecules to the primary ubiquitin via 
internal ubiquitin lysines, thus creating a ubiquitin chain. A chain of at least four ubiquitins 
linked via lysine 48 is the classical recognition motif for proteasomal degradation (Thrower 
et al., 2000). Though other linkage types exist they are mostly used for signal propagation 
at different pathways rather than as a degradation signal. De-ubiquitinating enzymes 
(DUBs) remove polyubiquitin from proteasome substrates before substrates are 
translocated into the proteasome to rejoin the free ubiquitin pool. Substrate specificity is 
mostly achieved through the E3 enzyme (Finley, 2009). The most common and best 
understood E3 ligases are the Cullin-RING Ub ligases, they form a complex with F-box 
proteins which mediate substrate binding. The versatility of the Cullin proteins and their 
binding partners facilitates the recognition and ubiquitination of a large number of diverse 
proteins (Glickman and Ciechanover, 2002). Additionally, tissue specific expression of the 
Ub ligases contributes to substrate specificity, for example the muscle specific E3 ligases: 
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Muscle RING Finger 1 (MuRF1) and the Muscle atrophy F-box (MAFbx) (Bodine et al., 
2001). 
1.1.3 Proteasome Structure 
Protein degradation is a vital process of life but when left un-checked it presents a 
major threat. Cells have developed several mechanisms to ensure specific activity of their 
proteases. The proteasome is a multi-subunit protease, uniquely controlled by its structure 
and composition. Protein degradation is contained in a hollow cylinder with sequestered 
active sites. The 26S eukaryotic proteasome is composed of the catalytic particle (CP,20S) 
capped by either one or two regulatory particles (RP,19S). (Kunjappu and Hochstrasser, 
2014) (Figure 1.1). The CP is composed of four stacked hepta-heteromeric rings, forming 
a barrel shape structure. All proteasomes are composed of two related types of subunits, a 
subunits which form the two outer rings and b subunits which form the two inner rings. 
The b rings enclose an inner chamber in which the proteolytic activity is contained and 
carried by three dedicated b subunits:  b1, b2 and b5. Each of these subunits convey site 
specificity to a broad range of peptide sequences, but are different from each other in their 
preferred site. Each of these subunits has a specific activity and are classified as caspase-
like (b1), trypsin-like (b2) and chymotrypsin-like (b5) proteases (Arendt and Hochstrasser, 
1997). The protein is sequentially degraded into small peptides, which upon exit into the 
cytoplasm are rapidly removed by amino-proteases. 
Substrates gain entry to the core particle's interior through a gated axial channel 
formed by the N-termini of the a subunits (Rabl et al., 2008). For proteolysis to take place 
the proteasome must assume an open gate conformation. The a subunit tail is evolutionary 
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conserved between species however its sequence differs between the seven subtypes. 
Mutant analysis revealed that not all a subunits N-termini contribute to this gate in the 
same level of importance (Groll et al., 2000; Tian et al., 2011). For example, α3 mutants in 
comparison to α7 mutants are more deleterious to gate closure and functioning proteasome 
activity. Interestingly, the importance of the tails in the gate function correlates with their 
evolutionary conservation, as is exemplified by a3 and a7 subunits. 
Even in the open gate conformation, the pore is still too narrow. For proteins to 
enter the catalytic chamber, they must first unfold and be freed of their ubiquitin tag, both 
events are highly regulated involving the RP as well as additional accessory proteins. The 
α subunits interact with the regulatory complex to control the opening and closing of the 
gated pore. The RP is divided into two sub-particles, the base and the lid (Figure 1.1). The 
base is made of 6 ATPases (Rpt1-6) forming a ring that sits on top of the CP, and three 
proteins, Rpn1, Rpn2 and Rpn13. The lid is composed of Rpn3,5-9,11,12 and 15 with 
Rpn10 sitting at the interface between the lid and base (Murata et al., 2009). Some of the 
base subunits capture ubiquitylated proteins either directly or through proteins that contain 
both UBL (ubiquitin-like) domains and UBA (ubiquitin-associated) domains. The one 
known function of the lid involves Rpn11 in de-ubiquitinating the substrates prior to entry 
into the channel. The function of other lid subunits is still un-known. The ATPase ring 
provides energy and assist in substrate unfolding and mechanical opening of the CP gate. 
The pockets formed between two adjacent a subunits serve as docking site for the C-
termini tails of the Rpt proteins, hence playing an important regulatory and structural role 
in the gate configuration and the holo-complex stability (Tian et al., 2011). Some of the 
Rpt subunits contain a unique motif at their C-terminus, termed HbYX (hydrophobic-
5 
tyrosine-X) motif, which mediates binding to the alpha pocket and subsequent gate 
conformational changes (Smith et al., 2007). Later studies have shown that multiple 
regulators and interacting proteins of the 20S proteasome also possess an HbYX motif that 
inserts into these same surface pockets between the α subunits and can induce gate opening 
(Dange et al., 2011; Kusmierczyk et al., 2011; Yu et al., 2010). 
Figure 1.1. Subunit composition and structure of the proteasome. The 26S proteasome consists 
of two particles, the 20S core particle with catalytic function and the 19S regulatory particle. The 
20S particle is built of four hepta-oligomeric rings, two outer a subunits ring (blue) and two inner 
b subunits ring (orange). The RP is made of two sub-complexes, the lid (purple) and base (green). 
The base is composed of both RPT and RPN subunits whereas the lid from RPN only. RPN10 
(yellow) is found at the base–lid interface. Not depicted in this diagram are the various proteasome 
associating proteins as they are not proteasome stoichiometric subunits. Picture adapted from 
(Murata et al., 2009). 
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1.1.4 26S Proteasome assembly 
The 20S proteasome assembly proceeds through an ordered series of intermediates 
with step-wise addition of subunits (Figure 1.2). Assembly initiates with the progressive 
assembly of the a ring on top of which the b ring is later formed, together they make a half 
CP. In the final step two half CP attach through the b subunits and form the complete core 
particle (Zwickl et al., 1994). In mammalian cells, systematic knockdowns of individual 
subunits suggested that β2 and b7 are the first and last β subunit added to the α ring 
respectively (Hirano et al., 2008). Free b subunits are synthesized with a C-terminal pro-
peptide, rendering them inactive as proteases. This appendage is not found inside the 
mature proteasome so b subunits can be active in proteolysis. This mechanism prevents 
dis-regulated proteolysis by immature proteasomes. β7 incorporation stimulates the 
autocatalytic processing of the b-propeptides marking the final step in proteasome 
maturation (Li et al., 2007; Ramos, 2004).  
An important gap in our current knowledge is whether RP assembly depends on 
the CP as template or whether it occurs independently of the CP. There are conflicting 
reports on this question, but it is possible that both mechanisms contribute to RP assembly. 
Previous studies in yeast suggested that Rpt ring assembly is guided in part by a pre-
existing CP (Kusmierczyk et al., 2008; Park et al., 2009; Roelofs et al., 2009).  This model 
supports RP assembly in a modular way. One subset of Rpt subunits assembles directly 
on the CP, including Rpt4 and Rpt6, and the corresponding mutants show the strongest 
assembly phenotype (Hendil et al., 2009; Park et al., 2009). Another group of Rpt subunits, 
including Rpt1, Rpt2 and Rpt5, is thought to initially assemble freely of the CP into a base 
intermediate called BP1, which later incorporates onto the existing RP-CP intermediate. 
7 
Of particular importance to this model is that both a subunit mutants and Rpt mutants 
show the accumulation of Rpt ring assembly intermediates. Further support is provided 
by the alternative proteasome lacking a3 which resulted in alternative RP intermediates 
(Kusmierczyk et al., 2011). Cells lacking a3 still form intact proteasomes however they 
also display many more types of different 19S intermediates. Interestingly, the tail of Rpt6, 
key subunit in promoting 19S assembly, was found to specifically cross-link with a3. 
In contrast Kim and DeMartino showed that Rpt subunits with a 26S assembly 
defect (C-terminal truncation) were still found in intact 19S. Intact 19S was also found 
when 20S content was reduced by b5 RNAi; the RNAi reduced β5 content by more than 
90% and proteasome activity in cell extracts by ∼75% (Kim and DeMartino, 2011). These 
results support a model in which 20S is not an obligatory template for 19S assembly. 
However, the Rpts in question were Rpt3 and Rpt5, which belong to the subset of proteins 
that assembles into BP intermediates freely of 20S. Additionally, it is possible that the lid 
spontaneously attaches to the base when the base is in access due to assembly disruption. 
Order and timing of Rpt assembly is regulated by a set of four RP chaperones (Roelofs et 
al., 2009). A detailed mechanism of how the RP chaperones interact with the CP is still 
missing and additional studies are needed to shed light on this intricate assembly program. 
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Figure 1.2. Core particle assembly is a multi-step process. a ring (blue) assembly starts with a5 
with the aid of Pba3-Pba4 (red) chaperone dimer, followed by integration of a4 and a3 also guided 
by Pba3-Pba4. Pba1-Pba2 (green) provides scaffold for ring formation and prevent off-pathway 
interactions of two a subunit rings. b ring (orange) assembly is orchestrated on top of the formed 
a ring with the aid of Ump1 (yellow), starting with the addition of β2, β3 and β4. The last one to 
be incorporated is b7. Ump1 presides over this check point to prevent premature association of two 
half core particles. The dimerization of the half-proteasomes forms the pre-holoproteasome that is 
still immature. CP maturation is achieved by the autocatalytic processing of the β subunit 
propeptides and the degradation of the Ump1 chaperone. The Pba1-Pba2 chaperone also manages 
the maturation step and is supposedly degraded by the mature 20S. This process yields a functional 
CP competent for protein degradation. Picture adapted from (Kunjappu and Hochstrasser, 2014). 
9 
1.1.5 20S assembly chaperones 
a subunits possess the intrinsic ability to self-assemble, but for efficient and correct 
assembly dedicated chaperones are recruited (Gerards et al., 1997; 1998; YAO et al., 1999). 
These chaperones interact with intermediates to guide assembly in an organized and timely 
fashioned manner but are not found on the mature proteasome. Dedicated 20S chaperones 
have been identified and studied in archaea, yeasts and mammals; although functionally 
related they are not orthologues (Hirano et al., 2005; Kusmierczyk et al., 2008; 2011). The 
first 20S assembly chaperone to be identified was Ump1 in yeast (called hUMP1 or 
POMP1 in humans), continuing with the identification of the heterodimeric chaperones 
Pba1-Pba2 (human PAC1-PAC2, PbaA-PbaB the only chaperone to be found in archaea) 
and Pba3-Pba4 (human PAC3/PAC4). Two additional factors, Blm10 and Ecm29, have 
been proposed to have roles in 20S proteasome assembly, but they are also thought to have 
other functions. The assembly chaperones can act slightly differently in different species: 
for instance in mammals, it has been shown that Ump1 can inhibit dimerization of two half 
particles but not in yeasts (Ramos et al., 1998; Witt et al., 2000). These differences are 
evident in their mutant phenotypes, which exhibit stronger phenotypes in mammals than in 
yeasts. Under normal conditions, their absence only has minimal effects on organismal 
growth despite slower and aberrant proteasome assembly, suggesting compensatory 
pathways and adaptation mechanisms. But when proteasome function is compromised by 
other mutants or environmental conditions, their absence is strongly deleterious or even 
lethal (Kusmierczyk et al., 2008; 2011; Ramos et al., 1998). Many mechanistic details of 
assembly factors function remain unknown and even less is known in Drosophila, where 
no 20S chaperones have been identified yet. 
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Ump1 was first identified as a chaperone needed to orchestrate β-subunit 
processing and 20S proteasome maturation (Ramos et al., 1998). β5 propeptide is normally 
thought essential for proteasome assembly and cell viability with the exception of when 
Ump1 is also deleted. Based on these data, β5 propeptide interacts with Ump1 to facilitate 
its auto-cleavage thus Ump1 is no longer needed in its absence. Years later an added 
function was described by Li et al., showing that high levels of β7 can suppress defects 
associated with loss of the β5 propeptide and that this suppression requires the β7 C-tail to 
enhance 20S half-mer dimerization (Li et al., 2007). Overall Ump1 presides an assembly 
checkpoint; by inhibiting half CP dimerization and 20S maturation until all β subunits are 
properly incorporated. 
PAC1–PAC2 heterodimer was first identified by its interaction with a-ring 
intermediates in human cells (Hirano et al., 2005). Knockdown led to compromised 
proteasome assembly and the accumulation of aberrant α-ring dimers indicating it was 
needed to prevent the off-pathway interaction of two α-subunit rings. Loss of Pba2 also led 
to the accumulation of poly-ubiquitinated proteins pointing to a proteotoxic stress (Le 
Tallec et al., 2007). PAC1 knockout mice are embryonic lethal, however yeast deleted for 
either one or both Pba1 and Pba2 show no growth defects. Though their absence does 
aggravate the phenotypic defects of other UPS genes mutants such as a3 and Rpn4, 
remarkably deletion of either one of them suppresses the growth defect of DUmp1 (Li et 
al., 2007). Interestingly, these chaperones possess C-terminal HbYX motifs like Rpt 
proteins and the recently identified proteasome activator, PI31 (Bader et al., 2011). The 
Pba1 and Pba2 HbYX motifs both contribute to chaperone function and proteasome 
precursor binding (Kusmierczyk et al., 2011).  
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Pba3-Pba4 serves as a scaffold on which α ring assembly is guided in a specific 
order, especially ensuring that the α3 subunit is positioned between the α2 and α4 subunits 
in the ring (Kusmierczyk et al., 2008). Knockdown of the mammalian PAC3 or deletion of 
either Pba3 or Pba4 resulted in retarded growth and proteasome assembly defects 
(Kusmierczyk et al., 2008; Le Tallec et al., 2007). Velichutina and colleagues showed in 
yeasts that in the absence of the chaperone dimer Pba3-Pba4 or a3 subunit, alternative 
proteasomes can be created with a4 as a substitute for a3 subunit (Velichutina et al., 2004). 
Recently, such proteasomes were also found in human cells (Padmanabhan et al., 2016). 
These alternative proteasomes can be formed naturally, albeit at a slower pace than the 
canonical proteasomes, suggesting that proteasome-dedicated chaperones provide 
structural flexibility of the proteasome depending on cellular environment. Interestingly, it 
has been shown that they have an advantage under specific stresses such as high metal and 
oxidative stress (Kusmierczyk et al., 2011). Moreover, chronic oxidative stress may alter 
proteasome assembly such that assembly of α4-α4 proteasomes is favored. Such 
proteasomes are expected to have a constitutively open α ring (Osmulski et al., 2009) and 
are thus better equipped to deal with high influx of damaged proteins. Additionally, the 
a4-a4 surface may interact differently with proteasome regulatory factors such as the RP 
and others. 
1.1.6 Regulation of CP-RP interaction 
The 20S is normally found in a latent form with a closed gate. A closed gate 
prevents the majority of proteins from entering the catalytic chamber to be degraded. 
Evading this mechanism are small peptides and partially un-folded proteins. The binding 
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of the regulatory particle is primary for gate opening. In the past year a cohort of high 
resolution structural analyses of the human proteasome reported the surprising observation 
that despite engagement of the RP ATPase with the CP outer ring, the CP gate remained 
closed (Chen et al., 2016; Huang et al., 2016; Schweitzer et al., 2016). The 26S can assume 
4 different confirmations of which only one has an open gate. In the three closed 
confirmations only Rpt 3 and Rpt2 (Rpt5 in yeast) insert their tails into CP surface pockets. 
In the last active confirmation, all Rpt tails are inserted except Rpt4. Together with 
previous functional data (Kim and DeMartino, 2011; Lee et al., 2012b; Tian et al., 2011), 
it is now clear that not all subunits contribute to proteasome function symmetrically and 
some interactions might even contribute negatively. Since the capacity of the proteasome 
to degrade proteins depends crucially on RP-CP interaction and with so many factors 
affecting this interaction, it seems highly likely that this interface is subjected to complex 
regulation. 
Though still not completely understood, there are some data supporting a model in 
which dynamic changes at distal points within the CP might regulate interactions occurring 
on the surface of the proteasome. Kusmierczyk and colleagues suggested that the archaeal 
chaperones PbaA-PbaB recognize immature 20S particles due to the presence of b subunits 
pro-peptides, implying that their binding is regulated allosterically by changes that are 
initiated at distant sites (Kusmierczyk et al., 2011). This model is supported by the 
observation that the chaperones bind stably to a 20S whose active sites are bound to 
inhibitors, mimicking an active proteolytic state of the propeptides (Kleijnen et al., 2007). 
Inhibition of proteasome active sites also stabilized 26S proteasomes, suggesting that the 
interface between the RP and the 20S proteasome dynamically changes depending on the 
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activities of the 20S proteasome. Interestingly, in yeast despite a lid assembly mutant of 
Rpn5, the base and 20S still assembled normally; however, they could not form a stable 
complex. It was proposed that the association of the lid with the base induces some 
conformational change in the base that strengthen and stabilize its association with the 20S 
proteasome (Isono et al., 2007).  
Proteasome interacting proteins have been shown to regulate RP association with 
the 20S proteasome, most notably the Extracellular matrix 29 (Ecm29). Intact 26S 
proteasomes can be purified without ATP when Ecm29 is present, but ATP is required for 
maintaining a stable RP–CP interaction in the absence of this factor. This suggests that 
Ecm29 can stabilize the 26S proteasome complex (Kleijnen et al., 2007; Leggett et al., 
2002). Ecm29 is a large protein of approximately 200 kDa with HEAT repeat motifs, 
repeats of a helices linked by a short loop, making it also a flexible one. Since it can bind 
to both the RP and the 20S proteasome in yeast it is likely that Ecm29 stabilizes 26S 
proteasomes by tethering the 20S proteasome to the RP. Ecm29 has a broader function and 
can act through several pathways (further details are outlined in Chapter 3). Another 
example of proteasome-stabilizer is a complex of p27, RPT4 and RPT5 which was found 
to enhance the proteolytic activity of the proteasome in mammalian cells by promoting the 
association of the RP and CP (Adams et al., 1997). However, the details of the mechanism 
in action remain unknown. Regulation of the RP-CP interface under stress adaptation has 
been mostly overlooked so far. But the increasing number of proteasome-interacting 
proteins suggests that 26S proteasomes are more diverse in their composition in response 
to various stimuli than previously assumed. The study of these proteins will lead to new 
perspectives on the dynamics of this uniquely complex machine. 
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1.1.7 Proteasome interacting proteins 
In addition to the proteasome core subunits, many different proteins associate with 
the proteasome and influence its activity; some have been studied, but many more remain 
a mystery (Schmidt et al., 2005b). Interacting proteins are defined by their salt liability and 
sub-stoichiometric levels. Numerous well-documented examples illustrate how such 
proteins are changing views of proteasome function and regulation. 
Several E3 ubiquitin ligases are found on proteasome, and in some cases this 
interaction was found to be important for their ligase activity (Chuang and Madura, 2005; 
Sakata et al., 2003; Seeger et al., 2003; Xie and Varshavsky, 2002). Ufd4 is an E3 ligase, 
which binds to the 26S proteasome through its N-terminal domain, presumably to Rpt4 and 
Rpt6. A truncated Ufd4, devoid of his N-terminal domain, can still catalyze ubiquitination 
of its substrates but does not promote their degradation (Xie and Varshavsky, 2002), 
indicating that for this E3 ligase both ubiquitination and proteasome association are crucial 
for degradation of its substrates. Parkin is a Ring ubiquitin ligase implicated in Parkinson 
disease. Although the pathogenesis of Parkinson is still not completely resolved, one of the 
disease associated mutations is in Parkin’s binding domain to Rpn10 (Sakata et al., 2003). 
Detailed mechanism of the functional coupling between ubiquitination and degradation can 
provide better understanding of this disease.   
Furthermore, some proteasome interacting proteins have similar roles to those of 
intrinsic subunits, like ubiquitin-binding, de-ubiquitination and unfolding. For example, in 
yeast, deletion of Rpn10, the only core subunit to be well-characterized as a receptor for 
ubiquitinated substrates, barely diminished cellular protein degradation. However, when 
coupled with a Rad23 deletion, global protein degradation was significantly impaired, 
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meaning that for some functions, associating proteins can complement core subunits. Rad 
23 is part of a larger group of “shuttle” proteins, including Dsk2, Ddi1, the 
p97/cdc48Ufp1/Npl4 complex, and p62 (Madura, 2004). These proteins contain one or 
more of the domains capable of binding polyubiquitin (e.g., UBA domains) and N-terminal 
Ubl (ubiquitin-like) domains that reversibly bind to the RP. Such proteins likely serve as 
“shuttles” for delivery of poly-ubiquitinated proteins to the proteasome. Mutations in 
Ubiquilin2 (the human homologue of Dsk2), diminish proteasome activity and associate 
with the pathogenesis of ALS and dementia (Deng et al., 2011). Although the complexity 
of such regulation is not well understood, it might represent an important element in 
determining rate of degradation.  
De-ubiquitination is a second important proteasome function supplemented by 
reversibly interacting proteins. Removal of polyubiquitin chains from substrates is a pre-
requisite for proteasome-dependent degradation, however in some cases it can spare 
substrates from proteolysis. Premature substrate deubiquitination by Uch37, an intrinsic 
subunit of mammalian RP, actually prevented degradation (Guterman and Glickman, 
2004). This mechanism further highlights the general notion that the proteasome actively 
participates in determining the fate of substrates that reach it. Uch37 does not remove 
ubiquitin chains in one group but rather shortens them (Lam et al., 1997). Simple truncation 
in ubiquitin chains might reduce their affinity to the proteasome, or alternatively edit 
molecules in a way that prevents degradation of lightly ubiquitinated substrates. Similarly 
yeast Ubp6 (and its mammalian orthologue Usp14) also cleave ubiquitin chains 
progressively (Guterman and Glickman, 2004). Ubp6 activity is greatly enhanced upon 
proteasome binding and deletion of its Ubl domain effectively neutralizes it completely. 
Remarkably, Ubp6 also appears to regulate general aspects of both proteasome and 
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ubiquitin homeostasis. Inactivation of Ubp6 resulted in a decrease of free ubiquitin which 
in turn up-regulated Ubp6 expression and its proteasome-associated fraction (Hanna et al., 
2007) and additionally higher proteasome levels were marked. This observation suggests 
a transcription mediated response to ubiquitin stress (more on transcription regulation of 
the proteasome in section 1.1.9).  
1.1.8 Alternative activators of the proteasome 
20S proteasomes are known to associate with three, or even four, different families 
of activators that provide access to the central proteolytic chamber. 19S is the most 
common and conserved activator. The 19S activator requires ATP hydrolysis to promote 
the degradation of protein substrates and it mostly mediates degradation of ubiquitin-
tagged proteins. The other two activator families are the 11S complexes (aka PA28, REGg, 
PA26) and PA200/Blm10. These factors are less broadly conserved. While their substrates 
and biological functions are not as clear; the mechanisms they use to activate proteasomes 
have been characterized. Presumably, they have relatively specialized functions and enable 
largely unstructured proteins or peptides to pass through the degradation channel 
(Stadtmueller and Hill, 2011). Not too long ago, it was discovered that another form of the 
proteasome might exist in cells in which the AAA+ protein CDC48 (also known as p97 or 
VCP) serves as an additional ATPase cap (Barthelme and Sauer, 2012). Hybrid 
proteasomes that comprise a 19S regulatory particle on one end of the core particle and a 
different activator at the opposite end also exist, but it is not yet understood how the 
different caps act together (Cascio et al., 2002; Shibatani et al., 2006; Tanahashi et al., 
2000). 
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After the RP the most intensively studied activator of the CP is proteasome activator 
PA28 (11S cap) (Förster et al., 2005). In contrast to the RP, PA28 lacks ATPase activity 
and the ability to bind ubiquitin conjugates. PA28 has been studied primarily in mammals. 
It is encoded within the MHC locus and is induced by interferon-γ. It is believed that PA28 
optimizes efficient cell surface presentation of antigens by MHC class I molecules. It 
presumably does so by enhancing the cleavage specificity of certain antigens so they are 
more suited for MHC presentation (Cascio et al., 2002; Goldberg et al., 2002; Groettrup et 
al., 1996; Strehl et al., 2005), or/and by facilitating rapid exit of the peptide so it is not 
over-digested (Whitby et al., 2000). Regg is similar in size to PA28, but is present in more 
organisms. Unlike PA28 it is not inducible. Since it has no ATPase activity to support 
unfolding, nor does it contain ubiquitin sensing receptors, it probably mediates the 
digestion of non-ubiquitinated targets (Masson et al., 2001). Although it is generally 
reported that 11S activators stimulate the hydrolysis of model peptide substrates but not 
full length proteins, REGγ  has been implicated in the degradation of some naturally 
occurring unfolded proteins (Nie et al., 2010; Suzuki et al., 2009). 
 PA200, and its yeast orthologue Blm10 (no orthologue reported in Drosophila) are 
large and flexible owing to their HEAT-repeat motifs. These proteins assume a dome-
shaped spiral atop the CP (Schmidt et al., 2005a). They differ from the 11S caps in that 
they bind the CP as a monomer, as opposed to the heptameric assemblies of the other two 
(Iwanczyk et al., 2006). Like 11S caps PA200 does not hydrolyze ATP, but its interaction 
with the CP disorders the α-ring gate and promotes entry of peptide substrates (Dange et 
al., 2011). Blm10/PA200 seems to be multi-functional as several reports describe its role 
as a proteasome assembly factor, activator, or quality-control factor (Dange et al., 2011; 
18 
Khor et al., 2006; Lopez et al., 2011; Ustrell et al., 2002). Blm10 has also been proposed 
to bind preferentially to 20S proteasomes with an open or disordered gate. CP mutants 
harboring a subunits with a truncated N-termini were found enriched with Blm10 – the 
same was observed a Ump1Δ mutant (Lehmann et al., 2008). These findings suggest a role 
for Blm10 in sequestering 20S proteasomes with a non-functional gates, thereby preventing 
uncontrolled substrate access to the catalytic chamber. 
1.1.9 Transcription mediated regulation of the proteasome 
Proteasome subunits are found in stoichiometric levels in the holocomplex, 
suggesting their biogenesis is transcriptionally regulated. Current knowledge regarding the 
basal rate of proteasome subunit biosynthesis is limited. It is believed that all core subunits 
are found in cells only in the context of their respective complex, the 20S or 19S. An 
exception is the 19S subunit Rpn10/S5a, which is also present in a free state in some cell 
types (Hendil et al., 2002; Piterman et al., 2014). Though information on physiological 
synthesis rate is lacking, numerous studies demonstrated a concerted upregulation of 
proteasome subunits in response to stress, uncovering a common signaling pathway 
regulating proteasome gene expression. The best studied transcriptional regulators of the 
proteasome are yeast Rpn4 and its mammalian counterpart Nrf1/Nrf2. Metazoan genomes 
apparently lack an Rpn4 orthologue, and neither a transcription factor nor a DNA 
regulatory element that regulates proteasome levels has been identified in higher 
eukaryotes. However, a concerted upregulation of UPS genes was observed in S2 
Drosophila cell line upon RNAi-mediated knockdown of Rpn10/S5a or MG132 
(proteasome inhibitor) treatment (Lundgren et al., 2005).  
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Rpn4 acts as a transcription factor, binding a unique sequence upstream to 
proteasomal genes termed PACE (proteasome associated control element), which 
stimulates their up-regulation (Mannhaupt et al., 1999). Rpn4 is a short-lived protein, 
whose degradation is ubiquitin dependent and regulated by the proteasome. Being a 
proteasomal substrate Rpn4 levels correlate with proteasome activity, making it part of a 
negative feedback loop which senses reduction in proteasome activity and in response 
elevates proteasomal genes expression (Xie and Varshavsky, 2001). Rpn4 by itself is 
regulated by stress factors. It was found that many stress-induced TFs recognize motifs 
upstream to the RPN4 gene, including factors related to oxidative stress, drug resistance, 
and heat shock. These findings suggest a possible role for proteasome upregulation under 
different stress conditions (Ma and Liu, 2010).  
Besides common regulatory pathways, an intriguing study suggested that 
overexpression of a proteasome subunits, β5 or b1, may upregulate the level of other 
subunits, as well as proteasome assembly and activity (Chondrogianni et al., 2003; 2005). 
Increased amount of assembled proteasomse conferred enhanced survival following 
treatment with oxidants, primarily through a higher rate of degradation (Chondrogianni et 
al., 2005). Additional support regarding auto-regulation of proteasome subunits comes 
from the work of Wojcik and DeMartino in S2 Drosophila cell line (Wójcik and 
DeMartino, 2002). RNAi silencing of different proteasomal genes (β5, Rpt1, Rpt2, Rpt5, 
Rpn2, and Rpn12) resulted in mRNA induction of non-targeted proteasome subunits. 
These results and others (Meiners et al., 2003) show a concerted regulation of proteasome 
genes in response to proteasome inhibition, however not all subunits respond equally, 
suggesting a different regulation between different proteasome subunits. 
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1.1.10 Tissue specific proteasomes 
The proteasome has specialized itself in some tissues by adapting tissue-specific 
subunits. Vertebrates encode four additional catalytic b-subunits: three interferon 
(IFN)gamma-inducible b1i, b2i, b5i defining the immunoproteasome (Kloetzel, 2004; 
Tanaka and Kasahara, 1998) and one thymus-specific b5t subunit defining the 
thymoproteasome (Murata et al., 2007). These alternative proteasomes have key roles in 
acquired immunity by altering antigen processing. The immunoproteasome preferable 
catalytic activities are chymotrypsin-like and trypsin-like activities, generating peptides 
which are suited for optimal  presentation by MHC class I molecules (Kloetzel, 2004; Rock 
et al., 2004). The reduced chymotrypsin-like activity of the thymoproteasome favorably 
contributes to production of a unique peptide repertoire in the thymus (Murata et al., 2007; 
2008). 
Duplication of 20S subunits is also observed in the Drosophila testis. In Drosophila 
melanogaster, 13 of the 28 CP proteasome subunits are found to have testis-specific 
isoforms and in some cases they even have distinct functions (Belote et al., 1998; Ma et 
al., 2002; Zhong and Belote, 2007). For example, proteasome subunit alpha6 testis-specific 
(a6T), is required for spermatogenesis (Zhong and Belote, 2007). The canonical a6 can 
compensate for a6t deletion, but it still does not exclude the need for a specialized 
proteasome and the idea that the testis specific proteasome is somewhat different from the 
constitutive one.  
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1.1.11 Proteasome sub-cellular localization 
Yeast proteasomes are mainly nuclear (Wilkinson et al., 1998), while mammalian 
proteasomes can be distributed both in the nucleus and cytoplasm, but are often 
concentrated in the nucleus as well (Reits et al., 1997). The 26S proteasome is synthesized 
within the cytoplasm and partly imported into the nucleus through the nuclear pore 
complex (Nederlof et al., 1995; Wendler et al., 2004), whereas the active transport of 
proteasomes from the nucleus to the cytoplasm has not been observed. Indication as to 
where assembly steps occur can be asserted from sub-cellular localization of the assembly 
chaperones. Early assembly chaperones, Pba1-Pba2 and Pba3-Pba4 are primarily 
cytoplasmic, whereas the late assembly chaperone, Ump1, is predominantly nuclear (Huh 
et al., 2003). This pattern supports a model in which CP assembly is initiated in the 
cytoplasm with final maturation steps occurring in the nucleus (Lehmann et al., 2002). 
Several proteasome subunits have nuclear localization sequences (NLSs), and a possible 
way to regulate localization of either mature proteasomes or assembly intermediates may 
be by modifying accessibility of these sequences (Nederlof et al., 1995; Tanaka et al., 
1990). The fact that only a fraction of proteasome subunits bear an NLS suggests that for 
most of the subunits, transport into the nucleus requires prior formation of either mature 
proteasomes or proteasomal sub-particles.  
Proteasome localization can also be modified by both extrinsic and intrinsic signals. 
A gradual shift of proteasome localization from the nucleus to the cytoplasm has been 
previously reported in both yeast and human cell lines under conditions of overgrowth or 
nutritional depletion (Laporte et al., 2008; Machiels et al., 1995).  DNA damage response 
illustrates local recruitment of proteasomes to double-stranded DNA break sites and DNA 
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damage proteins (Krogan et al., 2004). Nerve synapses and testis exemplify how 
proteasome localization serves an active role in cellular function. During neuronal 
excitation, GFP-tagged proteasomes translocate on actin networks to synaptic spines, 
actively altering the synaptic proteomic profile (Bingol and Schuman, 2006). Furthermore 
it appears that proteasome localization can be regulated by post translational modification, 
as is the case for CaMKIIa phosphorylation of the proteasome in synaptic translocation 
(Bingol and Schuman, 2006) or Rpt2 myristoylation in determining cytoplasmic versus 
nuclear localization in yeast (Kimura et al., 2012). Such level of regulation distinguishes 
proteasome localization, highlighting its importance and specificity as opposed to a random 
diffusion process. Testis spermatogenesis involves massive cellular remodeling mediated 
by the proteasome (Zhong and Belote, 2007). Proteasome movement is critical for 
spermatogenesis, so much so that disrupted localization can yield sterile males (Ma et al., 
2002). 
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1.2 Muscle atrophy: roles and regulation 
Maintaining protein homeostasis (proteostasis) is a critical factor in preventing 
cellular dysfunction and propagating many disease states. Functional proteostasis is 
achieved by a balance between protein synthesis and degradation, although the latter is 
more often associated with pathological states than with normal cellular functioning. 
Atrophy is defined as a decrease in the size of a tissue or organ due to cellular shrinkage; 
this decrease in cell size is caused by the loss of organelles, cytoplasm and proteins. Un-
controlled excessive protein degradation can be detrimental for skeletal muscle, and is the 
principle machinery behind muscle atrophy and weakness. This view is supported by the 
fact that activation of proteolysis is a feature of a number of pathologies, including cancer 
(cachexia), sepsis, renal failure (uremia), acquired immune deficiency syndrome, diabetes 
mellitus, aging (sarcopenia), disuse and denervation (Kandarian and Jackman, 2006; 
Lecker et al., 2006; Mitch and Goldberg, 1996). While aberrant chronic activation of 
proteolysis is damaging in disease states, long-term viability and maintenance of any organ 
system requires regular protein turnover and in muscle, when regulated, can even be 
beneficial.  
Skeletal muscle is of unique importance when considering the necessity for 
properly functioning proteolytic systems. The maintenance of healthy muscles is crucial 
for preventing metabolic disorders, maintaining healthy aging and providing energy to vital 
organs during stress conditions. Skeletal muscle serves two essential functions, a 
contractile function for locomotion/maintenance of posture and a metabolic function as the 
protein reservoir of the body. The myofibers that make up the muscle consist primarily of 
myofibrillar proteins. These proteins assume a precise organization of contractile units 
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called the sarcomere, which are the force units behind locomotion (Hwang and Sykes, 
2015; Knöll and Marston, 2012). The sarcomere consists of thick myosin filaments that 
can slide over thin actin filaments. Both types of filaments contain additional regulatory 
proteins and together they also serve as the major protein reservoir of the body. Upon 
fasting, once hepatic glycogen stores are depleted, muscle protein degradation releases 
amino acids which serve as building blocks for new protein synthesis in the body and are 
oxidized for energy production (Bell et al., 2016). Skeletal muscles are continuously 
challenged by mechanical, heat, and oxidative stress. These events increase protein damage 
and require efficient protein turnover to maintain optimal functioning. Furthermore, 
skeletal muscle repair and regeneration requires extensive remodeling through cycles of 
protein degradation and synthesis (Chen and Goldhamer, 2003; Dey et al., 2015).  These 
examples illustrate the necessity of proteolysis in skeletal muscle.  
Muscle proteostasis is a transcriptionally regulated process with a common 
transcriptional program carried by ‘atrogenes’ in various catabolic conditions (Lecker et 
al., 2004). ‘Atrogenes’ are genes identified as regulators of muscle mass whose expression 
is modified in different atrophy conditions, regardless of whether they promote protein 
degradation or prevent synthesis. Two major signaling pathways instruct muscle atrophy 
and growth. One is mediated by the forkhead box O (FoxO) transcription factors which are 
inactivated by Akt when the IGF-1/PI3K signaling pathway is active (Sandri et al., 2004; 
Stitt et al., 2004). The second regulatory pathway involves the transcription factor NF-kB, 
which is known to mediate signaling by TNF-a in the inflammatory response, this pathway 
activates the cachexia response to cancer (Cai et al., 2004). Intriguingly, these different 
pathways crosstalk and modulate one another at different levels to coordinate homeostatic 
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balance between protein synthesis and degradation simultaneously. Eventually, muscle 
proteolysis proceeds through either of these proteolytic systems: caspase mediated 
proteolysis, autophagy and the ubiquitin proteasome system (UPS), the latter considered 
the main driving force behind muscle atrophy. 
1.2.1 Proteasome-mediated proteolysis in muscle 
The UPS is responsible for degrading the majority of cellular proteins (Rock et al., 1994). 
A hallmark feature of the UPS is its ability to target specific proteins for degradation in a 
temporally highly regulated manner, through the coordinated activity of ubiquitin ligase 
and deubiquitinating enzymes. The significant dependence of muscle atrophy on the UPS 
became clear as a remarkable number of these enzymes have been implicated in muscle 
atrophy and identified as ‘atrogenes’ (see table 1.1 for UPS genes identified as ‘atrogenes’). 
Among the strongly induced genes were also polyubiquitins and various subunits of the 
proteasome. 
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Table 1.1 UPS identified as ‘atrogenes’ by their loss of function phenotype. 
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Adapted from (Bilodeau et al., 2016). 
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UPS genes have been implicated as ‘atrogenes’ in a multitude of muscle wasting 
conditions, including cancer (Baracos et al., 1995), fasting (Medina et al., 1995; 1991; 
Wing and Goldberg, 1993), denervation (Furuno et al., 1990; Medina et al., 1991; 1995), 
acidosis (Mitch et al., 1994), and sepsis (Tiao et al., 1994; Voisin et al., 1996). Initial 
studies to suggest a role for proteasome dependent degradation in the muscle were carried 
in incubated muscles where proteolysis, as measured by tyrosine release, was not reduced 
by lysosomal inhibition or by calpain inhibitors (calcium dependent proteases). However, 
ATP depletion greatly reduced proteolytic rates. Furthermore, in many of these conditions 
there was a concomitant increase of mRNA levels of ubiquitin and proteaosomal subunits, 
as well as ubiquitin-conjugated proteins (Baracos et al., 1995; Medina et al., 1991; 1995). 
The advent of the proteasome inhibitors, MG132 and LLN, provided a more direct assay 
of proteasome dependent proteolysis (Tawa et al., 1997). Proteolysis was reduced by 50% 
in incubated rat muscles upon treatment with these inhibitors, with no change in protein 
synthesis. Proteasome inhibition was further confirmed by accumulation of poly-
ubiquitinated proteins. Their efficacy in inhibiting proteolysis was even more evident in 
muscles under catabolic conditions including denervation, hyperthyroidism, and sepsis. 
Enhanced proteolysis was blocked by 70%-100% when rats were treated with inhibitors. 
A key finding in establishing the role UPS plays in muscle atrophy was the 
identification of muscle specific E3 ubiquitin ligases (Bodine et al., 2001; Gomes et al., 
2001). Bodine et al., performed transcript profiling (mRNA comparison) to identify genes 
regulated upon immobilization. Although many genes were up regulated in immobilization 
model, only a small subset was regulated in additional models of denervation and 
unweighting, indicating their universality as markers of atrophy. These genes were MuRF1 
(Muscle RING Finger 1) and MAFbx (Muscle atrophy F-box). Atrophy upon denervation 
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was attenuated by 56% and 36% at 14 days in MAFbx knockout mice and MuRF1 
knockout mice respectively. Myosin heavy chains (MYH) were also significantly spared 
in MuRF1-/- mice treated with glucocorticoids and fasting MuRF1 mutant mice (Baehr et 
al., 2011; Clarke et al., 2007; Cohen et al., 2009). Moreover, MuRF1 was found in physical 
association with MYH and functioned as its E3-ligase in vitro. MuRF1 was also reported 
in the degradation of other muscle structural proteins, including troponin I, actin, myosin 
binding protein C and myosin light chains 1 and 2 (Cohen et al., 2009; Kedar et al., 2004; 
Polge et al., 2011). Gomes and colleagues used cDNA microarrays to identify MAFbx, 
named atrogin-1. Atrogin 1 expression was induced by more than 9-fold in fasting muscle, 
its mRNA was also markedly increased in atrophy related to diabetes, cancer and renal 
failure. Cloning and structure of MAFbx characterized it as an F-box protein found in the 
SCF complex. It was strongly induced even before muscle weight loss was detected and 
maintained at high levels as proteolysis accelerated, suggesting a role in both initiation and 
maintenance of the proteolysis. Remarkably, in age-related atrophy (sarcopenia),  inducing 
these UPS genes delayed aging symptoms by maintaining protein quality control 
(Demontis and Perrimon, 2010; Edström et al., 2006). These findings further underline the 
importance of balanced proteasome activity, of which too high or too low can be 
detrimental. 
Though far less established some UPS genes have been linked to atrophy through 
regulation of protein synthesis. MAFbx was found to bind and ubiquitinate eIF3-f 
(eukaryotic translation initiation factor 3 subunit F ), as well as MyoD both in vivo and in 
vitro (Lagirand-Cantaloube et al., 2008; Tintignac et al., 2005). MyoD is a transcription 
factor required for myogenic stem cell and expression of eIF3-f, an important activator of 
protein synthesis. Genetic activation of eIF3-f was sufficient to cause hypertrophy and to 
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block atrophy in myotubes, reversed by ectopic expression of MAFbx. Conversely, 
MAFbx knock down prevented eIF3-f degradation sparing myotubes atrophy. Silencing 
USP19, a de-ubiquitinating enzyme, increased expression of myofibrillar protein due to 
up-regulation of the myogenic transcription factor Myogenin, though how it does so is still 
unclear (Sundaram et al., 2009). In agreement, USP19 knockout mice showed reduced 
atrophy in response to glucocorticoid or denervation; however muscle protein synthesis 
was similar to control mice (Bédard et al., 2015). MuRF1 and MAFbx expression was 
reduced in USP19 knockout, suggesting reduced proteolysis could account for muscle 
sparing. 
1.2.2 Autophagy/lysosome mediated proteolysis in muscle 
Autophagy is one of the major protein degradative pathways within virtually all 
cells of the body. Autophagy is a highly conserved homeostatic mechanism that is used for 
the degradation and recycling of long-lived proteins and organelles. It involves formation 
of membrane bound vesicles (termed autophagosomes) followed by their fusion with 
lysosomes where degradation takes place (Mizushima and Komatsu, 2011). Several studies 
over the past decade have indicated that excessive autophagy aggravates muscle wasting 
and contributes to muscle weakness (Dobrowolny et al., 2008; Mammucari et al., 2007; 
Wang et al., 2005; Zhao et al., 2007). Autophagosome accumulation has been observed in 
various myopathies (Malicdan et al., 2008). However, it could be activated as part of a 
stress response as basal autophagy is also necessary to maintain muscle mass and actually 
prevent atrophy.  
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During aging, muscle stem-cell regenerative function declines, mainly due to 
irreversible senescence of muscle satellite cells (Tang and Rando, 2014). Muscle stem cells 
preserve their regenerative capacity through autophagy-mediated proteostasis as a cellular 
quality control mechanism. Physiological decline of autophagy in old satellite cells or its 
genetic impairment in young cells, resulted in toxic cellular waste accumulation, 
mitochondrial dysfunction and oxidative stress together resulting in entry into senescence 
(García-Prat et al., 2016). Moreover, mice deficient of Atg7 or Atg5, autophagy related 
gene, showed a 20–40% age-dependent reduction in muscle fiber cross-sectional area and 
formation of protein aggregates (Masiero et al., 2009; Raben et al., 2010). Loss of muscle 
mass in Atg7-/- mice was also accompanied by corresponding decrease in force generation. 
An interesting link between autophagy and aging was recently described in Drosophila, 
where the maintenance of a normal autophagic flux in aged muscles was found to induce a 
beneficial extension of lifespan (Demontis and Perrimon, 2010). Loss of muscle 
proteostasis evident by protein aggregation and muscle weakness precedes aging of other 
tissues and contributes to life span decrease. Remarkably, increased activity of the 
transcription factor FOXO and its target 4E-BP in skeletal muscle was sufficient to prevent 
accumulation of protein aggregates and extend life span at least in part by promoting the 
basal autophagy. Taken together, these studies highlight the necessity for basal autophagy 
in muscle mass maintenance.  
In addition, there is some evidence for an essential role for autophagy in exercise-
induced muscle growth. However, the effects of acute and chronic exercise on the 
autophagic response in skeletal muscle cells appear to be inconclusive. Mechanical stress 
and the simultaneous production of ROS during physical exercise culminate in damaged 
cellular components and the need for their removal (Moylan and Reid, 2007). Ultra-
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endurance runners show signs of increased autophagic activity evident by elevated 
expression and formation of autophagy complexes (Jamart et al., 2012a; 2012b). Studies 
in mice complemented these data, showing that not only was autophagy induced during 
short-term exercise but lack thereof hindered muscle performance (Grumati et al., 2011; 
He et al., 2012; Møller et al., 2015).  On the other hand Kim and colleagues observed 
reduced expression of autophagy related genes, whereas MURF-1 which is involved in 
proteasome-mediated degradation was significantly increased (Kim et al., 2012). 
Conflicting reports were also observed after chronic exercise, with some studies depicting 
rise in autophagy markers (Lira et al., 2010) and some a decline (Grumati et al., 2011). It 
is possible that exercise intensity level, muscle type and metabolic state of the muscle 
(AMP/ATP reservoir) determine which degradation pathway will be induced (Schwalm et 
al., 2015). 
1.2.3 Caspase-mediated proteolysis in muscle 
Caspases (cysteine-aspartic proteases) are a family of proteolytic enzymes that are 
most commonly known for their role in initiating apoptosis. Despite their common 
association with cell death, caspase-mediated signaling events have been linked to a diverse 
array of vital cell tasks, which are independent of inducing apoptosis (Fuchs and Steller, 
2011). Though caspases have been linked to muscle growth and maintenance by 
modulating stem cell commitment and differentiation (Dick et al., 2015; Fernando et al., 
2002; Murray et al., 2008), their role in promoting muscle atrophy is limited. One possible 
mechanism of caspase involvement in muscle stress adaptation is through regulation of 
autophagy and proteasome-mediated protein degradation. In Drosophila oogenesis, death 
32 
caspase-1 (DCP-1), has been shown to promote autophagy by cleaving and inhibiting the 
key autophagy suppressing protein SesB (DeVorkin et al., 2014). In catabolic conditions, 
such as sepsis, cancer and uremia, initial breakdown of actomyosin by caspase-3 triggered 
sequential degradation by the UPS (Du et al., 2004). Coordinated regulation of proteasome 
activity by caspase-3 was observed in myoblast differentiation to myotubes (Wang et al., 
2010a). In myoblast Rpt5 (19S proteasome subunits) cleavage decreased proteasome 
activity, whereas cleavage of Rpt2 and Rpt6 in myotubes increased activity. Mutation of 
the respective caspase-3 cleavage sites resulted in the expected corresponding change in 
proteasome activity with a profound block in the differentiation program. Moreover, they 
found that in mice with a chronic kidney disease, a muscle wasting condition, there was 
cleavage of subunits Rpt2 and Rpt6 and stimulation of proteasome activity.  
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2. A screen for proteasome modifiers in muscle atrophy model
2.1 Summary 
UPS function is important for muscle cell function at several levels. Muscle growth 
and contractile function require a high level of proteasome activity, evident by its 
importance to both maintenance of muscle architecture and mobility. When proteasome 
function is impaired, muscle atrophy occurs, accompanied by loss of striated sarcomeric 
architecture and patterned spacing of nuclei, erosion of neuromuscular junctions and 
cytoplasmic aggregates, but does not result in cell death. DTS5 and DTS7 are b subunit 
proteasome mutants which impair proteasome function. From a collection of 327 RNAi 
lines previously shown to cause rough eye when DTS5+DTS7 are expressed in the eye, I 
conducted a screen for genes that when knocked down rescue muscle atrophy. This screen 
resulted in the identification of 10 candidate genes of which 4 were further characterized 
for their impact on muscle architecture and proteasome activity. The screen culminated in 
the surprising revelation that a1 knockdown, a proteasome core subunit, restores 
proteasome activity in the background of the DTS5 mutant. This chapter summarizes key 
steps of the screen and initial characterization of candidate genes. 
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2.2 Introduction 
Drosophila’s genetic pliability and well-characterized musculature provide an 
excellent in vivo system to study the targeted effects of muscle proteasome inhibition. The 
larval body wall musculature is composed of a reiterated set of 30 defined muscles in each 
abdominal hemisegment (Bate, 1990; Beckett and Baylies, 2006). The development of 
these muscles is highly stereotyped, with each muscle cell achieving a specific orientation, 
a standard number of nuclei and innervation at NMJs of exacting size and placement. One 
way to investigate the in vivo regulation of the ubiquitin–proteasome pathway is to use a 
mutational approach to disrupt proteasome function. However, since this pathway is so 
vital for many critical cellular functions, the majority of proteasome null mutants are lethal. 
Thus, temperature-dependent conditional mutants have proven themselves very useful in 
studying the UPS. In Drosophila, two such mutants are DTS5 and DTS7, which carry a 
single-amino-acid substitution in the β6 and β2 subunits, respectively (Saville and Belote, 
1993; Smyth and Belote, 1999). Their DTS nomenclature originates in their identification 
in a screen for dominant temperature-sensitive (DTS) lethal mutants, when expressed in 
whole organism (Holden and Suzuki, 1973). Though their mechanism of action is still 
unclear they have been widely used to specifically inhibit the Drosophila proteasome (Haas 
et al., 2007; Henchoz et al., 1996; Hériché et al., 2003; Huang et al., 2016; Zirin et al., 
2015) These mutant proteasome subunits can be spatially targeted only to muscles using 
the GAL4-UAS system (Brand and Perrimon, 1993), and temporally targeted using the 
conditional GS (GeneSwitch) system (Osterwalder et al., 2001). This provides a 
methodology to investigate the temporal requirement of proteasome function specifically 
within the developing musculature. 
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2.3 Results 
2.3.1 Targeted expression of proteasome mutants causes larval 
paralysis 
The DTS mutations DTS5 and DTS7 result from single amino acid substitutions in 
the β6 and β2 subunits of the 20S proteasome respectively (Saville and Belote, 1993; Smyth 
and Belote, 1999). These mutant subunits have been shown to inhibit UPS-mediated 
protein degradation of known proteasome substrates (Neuburger et al., 2006; Schweisguth, 
1999; Speese et al., 2003). Previous studies corroborated by work carried in the Steller lab 
by Dolors Ferres Marco showed that transgenic co-expression of both proteasome subunit 
mutants in the Drosophila eye using the GAL4-UAS system had a synergistic effect in 
blocking proteasome function (Belote and Fortier, 2002), evident by a rough eye 
phenotype. To target DTS-mediated proteasome inhibition spatially in muscle and 
temporally under experimental control, the Gene-Switch (GS) inducible expression system 
was used with the muscle-specific MHC (myosin heavy chain) driver (Osterwalder et al., 
2001). The GS system ensures expression of mutants only when food is supplemented with 
the RU-486 inducer and only in tissues in which the driver is active. Since this system is 
highly sensitive to developmental variability, for comparable measurements of age-
matched larvae I devised the experimental design presented in Figure 2.1. Initially, both 
mutant subunits were co-expressed in the musculature in the present study.  
DTS expression was temporally targeted during the early third instar stage of larval 
development by transferring age-matched larvae to RU486-containing food (RU) or 
RU486-free food (control) for 24 h incubation at the DTS permissive temperature 28.3°C. 
To assess muscle function two parameters were measured: 1. Number of larvae crawling 
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on the vial wall out of total larvae placed in vial. 2. Motility on apple plates of those larvae 
remaining in yeast food. Expression of both DTS mutants resulted in roughly 50% 
reduction of larvae exiting the food compared to larvae grown on control food (Figure 
2.2A). Furthermore, DTS expressing larvae looked wasted and did not pupate. When larvae 
were transferred onto apple plates, DTS larvae demonstrated near complete loss in their 
ability to crawl compared to the random crawling of control larvae. Only 1% of DTS 
expressing larvae showed movement. Given genetic constraints of expressing both DTS5 
and DTS7, I tested whether expression of only DTS5 yields a comparable phenotype to co-
expression of both DTS mutants. DTS5 expression alone was comparable in both 
parameters and sufficient to cause paralysis, hence from here on all experiments were 
carried with DTS5 alone. As a control for induction of the GS-UAS system and to 
categorize paralysis as specific to DTS induction I expressed GFP as an inherent gene. As 
expected when driving GFP expression using this system, no paralysis was observed 
compared to control. Independent of conditions or genetic background roughly 50% of 
larvae always remained inside the food. Some of these remaining larvae represent random 
crawling in and out of food. However, some were dead probably due to some toxicity issues 
with the inducer. I used RU-486 at concentration of 15µg/ml, which was the minimal dose 
to produce a robust activation of the system (GFP expression in majority of larvae) at 
minimal toxicity. A lower dose of 10 µg/ml did not activate system in high numbers and a 
higher dose of 20 µg/ml increased toxicity-induced death. 
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Figure 2.1 Scheme of experimental design and assays of larval paralysis. For age matching 
indicated crosses were carried in fly cages (50 females over 20 males) for the duration of 6 hours, 
followed by incubation of the egg laid plates at 25°C for additional 72 hours allowing eggs to 
mature into early third stage larvae. Larvae were collected into yeast food vials supplemented with 
RU-486 inducer versus mock supplementation as control. End point assay was analyzed by number 
of larvae crawling on vial wall and their movement on apple plates. 
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Figure 2.2 DTS expression results in larval paralysis. In both assays DTS expressing lines 
showed reduced movement compared to control, ranging from ~50% reduction in climbing to 
almost complete loss of motility on plates. A. Quantification of number of larvae exiting food 
as percentage of total larvae transferred into test tubes after 24 hours of growth in permissive 
temperature. Results collected of 5 independent trials over 200 larvae. B.  Motility assay of 
larvae on apple plates. 20 larvae found in the yeast food of each test tube were placed on apple 
plates at experiment end point and monitored for their dispersion from start site (bottom of 
plate). C. Quantification of motility assayed in panel B. Results collected of 5 independent 
trials over 100 larvae. **P<0.001, Statistical analysis was performed with a two-tailed, paired, 
t test. 
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2.3.2. Proteasome function is required for muscle maintenance 
The Drosophila larval musculature is formed during embryonic development by 
myoblast fusion, leading to formation of 30 unique multinucleated muscles per abdominal 
hemisegment (Bate, 1990; Beckett and Baylies, 2006). A subset of internal ventral 
longitudinal muscles, have been particularly well characterized. Each of these muscles, 
individually identifiable by position and size, contain a muscle-specific number of nuclei 
that are evenly distributed along the length of the syncitial cell. To directly assay the impact 
on the musculature, phalloidin (actin) and DAPI (4′,6-diamidino-2- phenylindole) 
(nuclear) staining was used to examine muscle architecture (Figure 2.3). Phalloidin 
labelling revealed striking muscle atrophy after 24 h induction of the DTS proteasome 
mutants (Figure 2.3C). Although muscle cell integrity and attachments were maintained, 
all muscles showed a dramatic reduction in cellular volume with a loss of the regular actin 
filaments cyto-architecture. Due to its large size muscle number 6 (VL3) was used for size 
measurements. On average width of muscle number 6 from wild-type larvae was 80 µm, 
whereas muscles of DTS5 expressing larvae demonstrated a 2.7-fold reduction on average 
(Figure 2.3D).  In control muscle nuclei are often distributed in an organized manner along 
the length of the myotube, however DAPI staining revealed that in atrophied muscle nuclei 
were dramatically shifted and found in a disarrayed pattern, mostly clustering at muscle 
ends, near tendon insertion sites (see insets in figure 2.3C).  Nonetheless there was no 
significant difference in nuclei number (Figure 2.3E), averaging 14 nuclei per wild-type 
muscle-6 and 13 per mutant muscle-6. Interestingly, this nuclear clustering phenotype 
recapitulates a pattern seen early in embryonic muscle development (Bate, 1990). Despite 
the prominent muscle atrophy and loss of nuclear spacing/localization, there was no sign 
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of apoptosis as evident by lack of staining for active caspase-3 (Figure 2.4). Thus, 
conditional inhibition of the proteasome disrupted muscle architecture within 24 h, but did 
not cause cellular degeneration. Preliminary results (more data on the matter in chapter 3) 
suggested activation of autophagy as muscle atrophy progressed. These results were 
obtained with an ATG8-dsRed transgene introduced to either wild-type or DTS5 strains. 
Atrophy induction in the DTS5 strain was accompanied by an average 2.7-fold increase in 
number of ATG8-dsRed cytoplasmic puncta. No statistical analysis was carried out since 
experiment was performed only once with 4 larvae.  It is possible that autophagy underlines 
the mechanistic basis of distraught architecture caused by loss of proteasome function, yet 
this experiment was carried out only once. 
To examine the time-course of the effects of proteasome inhibition, muscle 
structures were examined at timed intervals following induction of DTS5 proteasome 
mutant expression (Figure 2.3). Control muscles maintained a normal architecture with a 
clear striated sarcomeric pattern and organized nuclei along the myotube length at all time 
points: 6,12 and 24-hours post induction. At 6 hours after induction DTS5-expressing 
muscles were still comparable to control muscles with no gross morphological changes 
(Figure 2.3A). It is possible that not enough DTS5 mutant proteasomes have accumulated 
at this time point or that it takes much longer till perturbed proteasome function results in 
evident muscle atrophy. However, by 12 hours, muscles clearly began to reduce in width 
and loose nuclear pattern (Figure 2.3B). This coincided with a loss of the muscle striation 
pattern and sarcomeric boundaries were no longer clearly defined despite intense actin 
staining along the length of the muscle. At 24 hours after induction of DTS5 expression, 
there was a complete loss of the normal striated sarcomeric pattern.  
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To assess the specific effect of DTS expression on UPS function in muscle, larvae 
were stained with an antibody against poly-ubiquitinated proteins (FK-2 antibody; Figure 
2.3). Accumulation of poly-ubiquitinated proteins is indicative of reduced protein 
degradation due to proteasome function impairment and elevation of proteotoxic stress. A 
marked accumulation of poly-ubiquitinated proteins was observed at the 24-hour time point 
in RU486-fed larvae compared with control (Figure 2.3C). As expected, poly-ubiquitinated 
proteins accumulated only in the targeted-muscles, but not in surrounding soma or other 
tissues. Poly-ubiquitinated proteins accumulated throughout the muscle cell, but the 
accumulation was most evident in perinuclear regions and punctate distribution (see inset 
figure 2.3C). It is important to note that RU-486 fed flies present mild increase in poly-
ubiquitinated levels already at the 12-hour time point, preceding morphological changes of 
atrophy. This result alludes to the progress of events, most likely proteotoxic stress 
precedes atrophy induction and plays a role in its progression. These results demonstrate 
the ability to interfere with proteasome function in vivo, only in muscle cells and in a 
temporally controlled manner. 
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Figure 2.3 Time-course of muscle atrophy following DTS5 induction. A-C. Muscles were 
dissected and stained for phalloidin (actin), DAPI and poly-ubiquitinated proteins (FK-2) at the 
following time points respectively: 6, 12 and 24 hours after RU486 or control supplementation. 
No apparent morphological changes were seen after 6 hours, but progressive muscle atrophy 
and overt accumulation of poly-ubiquitinated proteins was observed onward. Scale bar 50µm. 
D-E. Quantification of muscle number 6 width and nuclei number respectively, at 24-hour time 
point. Statistical analysis was carried out on 3 independent experiments by taking measures of 
the muscle from 4 larvae per experiment, in total 12 muscles were quantified. **P<0.001, 
Statistical analysis was performed with a two-tailed, paired, t test. 
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Figure 2.4 Muscle atrophy does not involve apoptotic program but trigger autophagy. A-B. 
Muscles were dissected at experiment end point and stained for active caspase-3. Negative staining 
in both wild-type and DTS5 expressing larvae indicate that observed atrophy does not proceed 
through induction of apoptosis. Note that muscles are marked by GFP. C-D. Transgenic flies 
expressing ATG8-dsRed in either WT or DTS5 background were dissected for muscles at 
experiment end point. Increased puncta in DTS5 strain mark autophagy induction. 
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2.3.3. Screen for modifiers of DTS5 induced muscle atrophy 
To learn more about proteasome regulation in the muscle, I devised a screen to 
identify enhancers of proteasome activity which rescue larval paralysis when proteasome 
function is disturbed by the expression of the DTS5 proteasome mutant. I carried out this 
screen on 327 RNAi expressing lines, which were already identified as modifiers of the 
rough eye phenotype. The rough eye phenotype is the manifestation of DTS5 targeted 
expression in the eye. To score the rough eye phenotype females expressing DTS5 under a 
GMR (glass multiple reporter) driver were crossed with males expressing the respective 
RNAi (UAS-TRiP). The GMR-GAL4  driver is believed to be expressed from mid-third- 
instar stage through pupal development exclusively in all cells posterior to the 
morphogenetic furrow (MF) in differentiating eye discs (Freeman, 1996). Crosses were 
carried and propagated in 25°C and were subsequently transferred to the DTS5 permissive 
temperature 6 days after egg laying (AEL), 4 days before eclosing. Adults were collected 
during the first two days after hatching. Since gender may produce mild effects due to 
hormonal differences only males were compared (un-published observations). 
Additionally, only those with a Tm6B balancer on their third chromosomes were 
compared, since the Stubble marker can affect Notch signaling and thus enhance the rough 
eye phenotype independent of proteasome-related interaction. DTS5 expressing flies 
grown at 25°C for their entire life cycle developed normal looking eyes just like wild-type 
flies (Oregon-R) as expected from the temperature dependent nature of the DTS5 mutation 
(Figure 2.5A). However, flies transferred to 28.3°C at day 6 AEL developed a rough eye 
due to retinal cells degeneration, accompanied by reduced width of the eye and some 
necrotic tissue at its periphery. 
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To confirm that the rough eye phenotype was specific to retinal degeneration due 
to proteasome specific stress, I continued with the analysis of head sections. Heads were 
fixed and prepared by sucrose gradient prior to OCT embedding and cryostat sectioning. 
To establish retinal degeneration and deformed morphology, I stained sections with 
Chaoptin antibody (24B10). Chaoptin is a cell surface glycoprotein required for 
Drosophila photoreceptors (Reinke et al., 1988). Analysis of photoreceptor morphology 
was supplemented with counterstaining for ELAV to demarcate brain tissue. ELAV is an 
RNA-binding protein exclusively expressed in neurons and is important for the formation 
and maintenance of the nervous system (Koushika et al., 1996). DTS5 induction was 
damaging for photoreceptors which revealed a shorter, stacked morphology when stained 
for Chaoptin. ELAV staining was deformed and aggregated instead of running along the 
length of the photoreceptor. Additionally, nuclear DAPI staining moved distally, indicative 
of cell degeneration (Figure 2.1B). In vertical sections, there were gaps amidst the Chaoptin 
staining which might be accounted for by dead photoreceptors. However, ELAV 
expression and distribution was unaffected as GMR is not expressed in neurons. 
I followed the same approach to validate proteasome de-regulation as the cause for 
observed degeneration. Proteasome inhibition should lead to impaired protein degradation 
and thus accumulation of poly-ubiquitinated proteins. Mono-ubiquitinated proteins are not 
specific targets for degradation and therefore can be disregarded. Prevalence of poly-
ubiquitinated proteins was analyzed with FK2 antibody (Figure 2.5C). Enhanced FK2 
staining in DTS5 strains confirmed that DTS5-expressing strains indeed experienced 
proteotoxic stress as expected from proteasome inhibition. 
Finally, I analyzed the distribution of Rpt3 protein, subunit of the proteasome 
regulatory particle (Figure 2.5D). In DTS5 flies, Rpt3 staining was weaker with the 
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appearance of some aggregates. This observation may correlate with proteasome 
interference; however, it could also result from cellular degeneration. In the coming 
sections I address the distinction between disruption of proteasome activity and/or 
assembly. Overall DTS5 promoted retinal degeneration due to specific proreasome related 
proteotoxic stress.   
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Figure 2.5. DTS5 expression produces proteotoxic stress followed by retinal degeneration. A. 
DTS5 is a temperature sensitive mutant. GMR driven expression in permissive temperature 
manifests itself as a rough eye. B-D. Heads were fixed, dehydrated and embedded in 
OCT.cryosections were immunostained with the indicated antibodies and imaged by confocal 
microscopy. B. Staining with 24B10 (green) and ELAV (red) depict photoreceptors and neuronal 
tissues. To assess tissue architecture heads were cross-sectioned as well as vertically sectioned. C. 




Impaired proteasome function is lethal at early developmental stages, therefore 
DTS5 expression was targeted at the early third instar larvae stage by the combination of 
RU486 supplementation and transfer to permissive temperature at that specific 
developmental stage. However, DTS5 expression was still leaky, despite inducer absence, 
when combined with the MHC-GS driver. This resulted in a sick line with low eclosion 
rates, thus obstructing proper progression of the screen. This issue was resolved with an 
added preceding cross to the screen design. The DTS5 strain was first crossed with an 
RNAi target strain; followed by a subsequent cross between the suitable progenies and the 
MHC-GS driver to be screened for larval paralysis (see screen design in Figure 2.6). To 
follow DTS5 expression I recombined it with a UAS-GFP. 
Figure 2.6. Crossing scheme to screen for modifiers of muscle atrophy 
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Of the 327 RNAi targets, 10 were suppressors of the DTS5 paralysis phenotype 
(Figure 2.7), 4 of which were further characterized for their effect on proteasome function 
until one candidate, a1 proteasome subunit, was chosen as the subject of my thesis.  
Figure 2.7. Candidate genes of proteasome modifiers. RNAi target genes identified as 
DTS5 induced muscle atrophy suppressors in screen. Percentage was calculated per 
genotype as number of crawling larvae per total larvae placed on apple plate.  
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2.3.4 Suppressors of DTS5-induced muscle atrophy 
From the screen, four genes were selected for further characterization as to their 
specific proteasome related effects. In addition to their suppression of DTS5-induced 
paralysis, they were characterized by three more criteria: rough eye phenotype, in vitro 
proteasome activity, in vivo proteasome activity (summary in table 2.1). 
This list of genes was chosen based on interest from preliminary literary data: 
1. FKH (Forkhead) – this transcription factor plays a role in a variety of valuable
processes such as cell cycle, metabolic regulation and development (salivary gland
morphogenesis). The human orthologues, FOXO proteins, are known inducers of
proteasome activity and promoters of muscle atrophy through the elevation of
MuRF1 and MAFbx (muscle specific E3 ligases) [(Bodine et al., 2001),(Sandri et
al., 2004)]. FOXOs expression usually correlates with enhanced muscle atrophy.
One exception is in sarcopenia, where the induction of FOXO forcibly or through
dietary restriction helps to delay ageing syndrome through improved protein
degradation (Demontis and Perrimon, 2010).
2. CG11221 – to date very little is known of this uncharacterized gene. It was
identified in a screen for regulators of glucose metabolism, where knockdown in
the musculature resulted in hyperglycemia (Ugrankar et al., 2015). Based on
domain prediction it contains serine/threonine kinase like domain (fly base IntelPro
database).
3. SIFR – SIFamide Receptor, is a G-protein coupled receptor. It was previously
shown through screen methodology that, when overexpressed, it can cause defects
in early spermatogenesis (Schulz et al., 2004) and increase adult life span (Paik et
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al., 2012). Though SIFR was never studied for proteasome related functions, both 
spermatogenesis and life span are dependent on proteasome regulation.  
4. Pros a1- core subunit of the 20S proteasome particle (detailed description in
introduction).
My aim was to identify proteasome regulators in muscle tissue, in which the 
proteasome plays a unique role in atrophy. Since I did not want to assume that each gene 
behaves similarly in different tissues, all modifiers identified in the previous rough eye 
screen were also screened for muscle phenotypes, whether they were identified as 
enhancers or suppressors of phenotype. As seen in Figure 2.8 knockdown of SIFR and a1 
suppressed this phenotype and produced eyes comparable to normal controls. This 
recapitulated suppression seen in the muscle screen and expected from increase in 
proteasome activity. Knockdown of FKH did not rescue the rough eye phenotype and 
resembled that seen with DTS5 alone. Discrepancies between muscle and eye are possible 
due to tissue-specific interaction and likely different needs for proteasome activity in the 
tissues. Also, it is important to note that proteasome interference was carried in different 
developmental stages of the fly and each respective tissue. Targeted expression of 
CG11221 RNAi in the eye was lethal and did not yield adults at all. GMR is considered 
empirically to be expressed only in the eye and not expected to have effects on whole 
organism viability. However, several reports (Firth et al., 2006; Mallik and Lakhotia, 2009; 
2014; Morris et al., 2006) reported lethality following expression of certain transgenes 
under GMR driver, notwithstanding the fact that eye is not essential for survival of the fly. 
An explanation to this observation can be found in a recent thorough study of GMR 
expression (Ray and Lakhotia, 2015) which showed that this driver is indeed expressed in 
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additional tissues, including a common set of specific neuronal cells in larval and pupal 
ventral and cerebral ganglia. 
I next asked whether these proteins influence proteasome activity directly in muscle 
tissue. For this purpose, I employed two assays to measure proteasome activity using in 
vitro and in vivo methodology. I assayed proteasome activity in wild-type, DTS5 mutant, 
and the strains of DTS5 introduced with each target RNAi respectively. Flies were raised 
as described for the screen and samples were collected only from larvae fed on inducer at 
the permissive temperature. For in vitro activity assay muscle tissue from these larvae was 
lysed in a native lysis buffer containing ATP to preserve the 26S proteasome holocomplex. 
Differences in proteasome activity were detected by measuring the hydrolysis of a 
fluoregenic peptide. DTS5 induction reduced proteasome activity significantly by 40% 
compared to measured levels in wild-type. With the exception of CG11221 knockdown, 
knockdown of the other candidates increased proteasome activity by roughly 2-fold in 
comparison to the DTS5 strain. This observed increase even crossed the wild-type activity 
level, which may suggest some synergistic contribution, however this rise was not 
significant especially given the inherent noise in this assay (Figure 2.8). Activity levels 
remained low as in the DTS5 strain when CG11221 RNAi was introduced; possibly 
indicative of non-specific targets which are independent of proteasome activity. A similar 
trend was observed in analysis of in vitro proteasome activity from head samples of DTS5 
mutants; inhibition of proteasome activity by DTS5 in the permissive temperature and 
suppression of DTS5-dependent inhibition by a1 knockdown (Figure 2.8C). However, the 
results obtained from head samples were statistically insignificant. In addition to inherent 
technical noise, some variability can be accounted for by low fraction of GMR-expressing 
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cells out of the whole head tissue, therefore measurements represent a mixed population. 
In summary RNA interference of a1, SIFR and FKH relieved DTS5 inhibition of 
proteasome activity. 
Figure 2.8. Candidate genes modify DTS5 dependent proteasome inhibition. A. Proteasome 
function is required for eye development and morphology. DTS5 is a temperature-sensitive mutant, 
expression at permissive temperature (28.3°C) results in a rough eye phenotype, which can be 
rescued by two candidate genes: SIFR and Pros a1. CG11221 is not shown since it was lethal for 
viability. DTS5 and RNAi were driven by the GMR driver. B. Muscle tissue from DTS5 strain 
displayed significant decrease in proteasome activity.  With the exception of CG11221, knockdown 
of candidate proteins elevated proteasome activity significantly in comparison to the DTS5 strain 
(**P<0.001 n=3). Total protein (75 µg) was extracted from dissected muscle tissue of indicated 
genotype and proteasome activity was detected by measuring fluorogenic-peptide hydrolysis after 
10 minutes. Measurements were normalized to wild-type and plotted as relative luminescence units. 
The standard deviation was measured from three independent repeats. MG-132, proteasome 
inhibitor was used to confirm specificity of read out. C. In vitro proteasome activity assay of head 
tissue (n=3).  
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The in vitro assay has a few caveats; in addition to variability it measures only 
chymotryptic activity and is not ubiquitin-dependent; therefore, it might measure also 20S 
activity and not exclusively 26S proteasome activity. To address this point, I used an in 
vivo assay to assess proteasome activity in the muscle tissue. This assay was adapted from 
(Neuburger et al., 2006) and monitors the degradation of a heat shock inducible fluorescent 
copy of a known target of the ubiquitin-proteasome pathway, the Drosophila Nintra 
protein. Unstable EGFP was constructed by fusing EGFP with a portion of Notch 
containing its PEST degradation signal, which is rich in ubiquitin dependent degradation 
motifs (Wesley and Saez, 2000), marking it as a target for proteasome dependent 
degradation. For in vivo imaging and following heat shock, the larvae muscles were 
dissected, fixed and stained for Phalloidin, DAPI and GFP (to enhance signal). When 
transgenic larvae were subjected to  heat shock  the EGFP-Nintra reporter protein is 
ubiquitously expressed, reaching peak fluorescence within 1 hour and then steadily 
diminishing until it is only weakly detectable after 4 hours (Figure 2.9C-D). This reduction 
in signal is proteasome dependent and specific to the un-stable EGFP-Nintra fusion.  Stable 
GFP, without the Nintra fusion, demonstrated persistent GFP signal past 4 hours of HS 
induction; indicating it was not sensitive to proteasome dependent degradation at the time 
scale of the assay (Figure 2.9A-B). In the DTS5 strain the GFP signal significantly 
persisted 4 hours post induction, indicative of impaired proteasome activity (Figure 2.9E-
F). Phalloidin staining confirmed that heat shock and the transgenic expression EGFP do 
not disturb muscle architecture, hence any observed atrophy is proteasome dependent as 
seen before. FKH, SIFR and Pros a1 (Figure 2.9G, H, I respectively) knockdown 
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effectively abrogated GFP persistence and DTS5-dependent proteasome inhibition; 
reduction in signal was significant in comparison to DTS5, 5-10 fold reduction on average, 
and comparable to levels seen in the wild-type strain (Figure 2.9K). As demonstrated by 
the in vitro measurements, CG11221 knockdown did not significantly restore proteasome 
activity. Yet, GFP induction was relatively reduced already at 1-hour post induction, 
therefore this result was inconclusive (Figure 2.9I,K).  
In conclusion the screen was successful in identifying genes that modify proteasome 
activity. DTS5 inhibited proteasome activity which is required to maintain functional 
musculature and motility. Proteasome inhibition was relieved through depletion of either 
of these candidate proteins: FKH, SIFR and Pros a1. 
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Figure 2.9 DTS5 and candidate genes effect on in vivo proteasome activity. Larvae of all 
genotypes were subjected to 30 minutes heat shock at 37°C 20 hours after RU-486 feeding and 
transfer to permissive temperature. At indicated time points muscles were dissected, fixed and 
stained for Phalloidin, DAPI and GFP. A-B. In vivo induction of EGFP reporter transgene: 
Protein stability is marked by GFP signal persistence at 4-hours post heat shock. C-D. In vivo 
induction of EGFP-Nintra reporter transgene: GFP signal reduction by 4-hours post heat shock 
marks proteasome dependent degradation of un-stable protein. E-F. In vivo induction of EGFP-
Nintra reporter transgene and DTS5 mutant: GFP signal dramatically persisted 4-hours post 
heat shock, indicative of inhibition in proteasome activity. G-J. In vivo induction of EGFP-
Nintra reporter transgene, DTS5 mutant and respective RNAi: FKH, SIFR and a1 knockdown 
displayed GFP signal reduction 4-hours post heat shock indicative of functional proteasome 
activity. All images were taken with the same conditions of laser intensity and exposure. Scale 
bar 50 µm. K. Quantification of GFP signal. Bars represent the means of percent values 4-
hours versus 1-hour post HS induction of each respective strain. Statistical analysis was carried 
out on a total of 12 larvae (images) from 3 independent experiments. **P<0.001 significance 
in comparison to DTS5 signal, with a two-tailed, paired, t test. 
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Table 2.1 Summary of candidate genes characterization. All results represent DTS5 induction 
at permissive temperature with knockdown of respective gene and are compared to DTS5 effect 
alone on the indicated tissue. The rough eye phenotype repeated at my hands. 
2.3.5 Knockdown validation of candidate genes 
To validate specificity of the RNAi knockdowns, additional RNAi strains were 
tested. All a1 RNAi lines repeated their effect on paralysis suppression as their previously 
used counterpart a1-27557 (Figure 2.10A). However, of the FKH RNAi lines only the 
previously used FKH-33760 suppressed DTS5 induced paralysis (Figure 2.10A). This 
result may indicate non-specific off target effects or incompetence of the RNAi transgene. 
Therefore, I next checked expression levels of target proteins. To assess FKH expression 
levels I extracted protein for Western blot analysis with FKH antibody. Overall there was 
a substantial reduction in protein expression levels. Despite displaying a dramatic reduction 
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in protein levels, FKH-27072 strain did not suppress paralysis (Figure 2.10B). 
Immunofluorescence analysis with FKH antibody found reduced expression levels in strain 
FKH-33760 (Figure 2.10C), quantification of relative signal, normalized to DAPI levels, 
showed a 4-fold reduction compared to wild-type (not shown).  
Due to lack of available antibody against a1, I performed RT-PCR in order to assess 
its expression levels. I extracted mRNA from wild-type and two different strains expressing 
a1-RNAi. All material was extracted from muscle-targeted a1-RNAi as knockdown of a1 
is not viable at the whole organism level. This analysis revealed more mRNA in wild-type 
animal already at cycle 25 compared to either RNAi strain (Figure 2.10D). All a1 
knockdown experiments in this thesis refer to strain 27557. 	
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Figure 2.10 RNAi validation of target genes. A. In the crawling larvae assay all RNAi lines 
targeting a1 behaved similarly and recapitulated paralysis suppression, whereas of the FKH- 
targeting strains only FKH-33760. The percentage was calculated per genotype as number of 
crawling larvae per total larvae placed on apple plate. B. RNAi-dependent reduction in FKH 
expression levels was assessed by Western blotting of protein extracts from dissected muscle. 
Conclusion can be deducted only for lines 33760 and 27072 as loading control for the other two 
lines was not comparable to wild-type. a-tubulin protein levels served as loading control. C. 
Immunofluorescence analysis of fkh antibody revealed the reduction in protein levels in muscles 
of fkh-33760. Scale bar 50 µm. D. RT-PCR analysis of a1 transcripts collected from wild-type, 
a1-27557, a1-43705 larval muscles. More transcripts were detected in wild-type indicted that 
RNAi suppresses a1 expression. 
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2.4 Materials and Methods 
Fly stocks 
John Belote generously provided us with UAS-DTS5 and UAS-DTS7 strain (Belote and 
Fortier, 2002), as well as the hs-EGFP-Nintra lines used for the in vivo proteasome activity 
assay (Neuburger et al., 2006). MHC-GS driver was kindly given to us by Thomas 
Osterwalder and Haig Keshishian (Osterwalder et al., 2001). RNAi fly library was procured 
from Bloomington stock center. All stocks were in a yw or w1118 background and were 
cultured on cornmeal–molasses medium supplemented with 3% active yeast at indicated 
temperature or room temperature.    
RU486 induction protocols and mobility assays 
Larvae were raised on apple juice plates or in standard fly food to the desired age. Up to 
10 mg/ml of RU486 (Mifepristone, Sigma) was dissolved in ethanol. For larval feeding, 
RU486 was diluted 26.6-fold from the working concentration in ethanol followed by 25-
fold dilution in sterile water to get a final concentration of 15 µg/ml in 4% ethanol which 
was directly mixed in culture food. RU486 was allowed to saturate in the food overnight 
prior to larvae placement. For induction of the UAS transgene, staged third instar larvae 
were transferred into food containing RU486 or 4% ethanol alone (−RU486 control) for 
defined periods at 28.3°C, up to 24 h. Motility was expressed as the percentage of larvae 
climbing on vial walls or the percentage of mobile larvae on apple-juice/agar plates. Initial 
scoring of motility on apple plates was performed 6 hours following placement, however 
mobile larvae started crawling immediately whereas paralyzed larvae never regained 
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motility (not even after 24 hours), therefore for the majority of the experiments motility 
was scored immediately after larvae were placed on apple plates. 
Muscle immunohistochemistry 
Body wall muscles were dissected in PBS (130 mM NaCl, 7 mm Na2HPO4, 3 mm 
NaH2PO4, pH 7.0) as follows: third instar larvae were dissected along the dorsal midline, 
taking out body fat and secured flat with insect pins (Fine Science Tools) on silgard plates. 
Tissue was fixed in 4% formaldehyde in PBS for 30 min, rinsed three times with PBS for 
5 min and afterwards transferred into Eppendorf tubes for the following steps. Tissue was 
permeabilized with PBT (PBS + 0.1% Triton X-100) for 15 min and rinsed twice with PBS 
for 10 min. Muscles were than incubated for 1 hour in blocking buffer (PBS, 1%BSA, 0.1% 
Triton X-100, 5% Normal Goat Serum and 5% Normal Donkey Serum purchase from 
Jackson ImmunoResearch) and incubated overnight on a shaker with primary antibody 
(diluted in blocking buffer) at 4°C. After rinsing with PBS, three times for 10 min, muscles 
were incubated on a shaker for 1 hour at room temperature with Alexa secondary antibody 
diluted 1:200 in PBS (Invitrogen) with 1:300 dilutions of TRITC-Phalloidin (Sigma), 
followed by PBS rinse, three times for 10 minutes, and mounted in Vectashield mounting 
medium with DAPI (Vector Laboratories). For poly-ubiquitin staining the mouse 
monoclonal antibody FK2 (Stressgen) was used at 1:500 dilution. For cleaved-caspase-3 
staining a rabbit polyclonal anti-cleaved Caspase-3 (Asp175) antibody (Cell Signaling 
technology) was used at 1:100 dilution. For FKH staining rabbit polyclonal was used at 
1:500 dilution (Acris).  All pictures were taken with a Zeiss confocal microsocopy.  
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Head immunohistochemistry 
Heads were cut off and collected in Eppendorf tube on dry ice.  Prior to collection one eye 
was finely nicked with a scalpel to facilitate medium penetration into brain tissue. Tubes 
were incubated while spinning over night at 4°C with 4% paraformaldehyde in PBS. 
Following steps were carried while spinning at 4°C.  Heads were rinsed in PBS, three times 
for 10 min, followed by tissue dehydration with sequential incubation for 20 min at 
increasing sucrose concentration: 5%, 10% and 20%. Incubation at 20% sucrose was 
carried out overnight. Heads were embedded in OCT (TissueTek) and frozen at -80°C over 
night. Cryostat sections were placed on slides and fixed with 0.5% paraformaldehyde for 
30 min and rinsed with PBS. Steps of permeabilization, blocking and staining were carried 
out as described for muscle immuhistochemistry but were performed on slides using rinsle 
coverslips and in a humid chamber. 24B10 and Elav antibodies were procured from 
Developmental Studies Hybridoma Bank and used at 1:500 dilution. Rpt3 mouse 
monoclonal antibody was used at 1:100 dilution (Enzo). All pictures were taken with a 
Zeiss confocal microscopy.  
In vitro proteasome activity assay 
Dissected muscle tissue of 30 larvae per genotype was lysed in native lysis buffer: 50 mM 
Tris-HCl (pH 8.0), 5 mM MgCl2, 0.5 mM EDTA, 2 mM ATP (added fresh), 0.2% NP40 
(added fresh), and homogenized using pellet pestle motor (Kontes). Protein concentration 
was measured in a Bradford assay. 75 µg protein was mixed at a 1:1 ratio with Proteasome-
Glo chymotrypsin activity detection kit (Promega) at room temperature. Reactions were 
divided into three so each independent experiment represents an average of triplicates. All 
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reactions were conducted in a 96-well plate according to manufacturer’s protocol. 
Measurements were read by a SpectraMax M-2 micro-plate reader (Molecular Devices). 
In vivo proteasome activity assay 
To assess the degradation of EGFP-Nintra in the presence of dominant proteasome 
mutants, females of genotype wP{hs-EGFP-Nintra}15(X) were crossed with males of 
pP{MHC-GeneSwitch}(3) and propagated for a stable line. Females of this stable line were 
later crossed with males of the different genotypes. Late third instar larvae were placed in 
pre-warmed small petri dishes containing apple-juice/agar supplemented with active yeast 
and heat-shocked by placing them in a 37°C water bath for 30 min. The larvae were then 
placed in a 25°C incubator and allowed to recover for 1 or 4 hours. Larvae were dissected 
for muscles and were prepared for immunohistochemistry as described in muscle 
immunohistochemistry. Since GFP gets somewhat bleached during the preparation 
polyclonal chicken anti-GFP was used at 1:1000 dilution (Aves) to strengthen signal. 
Fluorescence images were quantified using Image J software. 
Western blot 
Protein extracts were produced from dissected muscle tissue of 30 larvae, homogenized in 
lysis buffer (20mM Hepes pH7.6, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 2mM 
EDTA, 1 mM DTT) and spun at 14,000 rpm for 15 minutes at 4°C. Protein concentration 
was determined by Bradford assay (Biorad). 10 µg of total protein was dissolved in SDS 
loading buffer and resolved on 4-20% Mini-PROTEAN TGX precast protein gel. 
Electrophoresis was carried for 1.5 hour at 100V voltage and protein transfer to immobilon-
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P membrane (Milipore) for 1 hour at 100V voltage. Membranes were blocked with 5% milk 
in PBST (0.5% Tween20 in PBS) overnight at 4°C. Afterwards, samples were washed three 
times for 10 min in PBST and incubated with primary antibody for 1 to 2 hours at room 
temperature. Primary antibodies were diluted and kept in PBST supplemented with 0.02% 
Azide and 3% BSA. Following additional wash steps, membranes were incubated in HRP-
conjugated secondary antibody (1:5000 dilution) for 1 hour and washed three more times 
with PBST before developing with ECL Western blotting detection reagent (Amersham) 
and Kodak Biomax MR film. Forkhead antibody was used at a dilution of 1:1000 (Acris). 
RNA isolation and RT-PCR analysis 
Total RNA was extracted by using Micro Total RNA purification system 
(Invitrogen) according to manufacturer’s reccomendations. Dissected muscle tissue 
of 10-20 larvae was used to obtain RNA for RT-PCR reactions. The samples were 
collected on ice with 300 µl of Invitrogen lysis buffer and 3 µl of b-
mercaptoethanol, ahomogenized with motorized pestle (Kontes) and subsequent 
RNA purification was continued with commercial kit (Invitrogen). Genomic DNA 
was removed with RQ1 DNase (Promega). RNA was used for RT-PCR reactions 
using the SuperScriptTM III One-Step RT-PCR System with Platinum Taq DNA 
polymerase (Invitrogen). For RT-PCR reaction Mastercycler Gradient PCR 
machine (Eppendorf) was programmed as follows: 50°C for 30 min, 94°C for 2 min 
and amplification steps of: 30 seconds of 94°C, 30 seconds of 60°C and 1 min of 
68°C. Amplification was carried out for 25 and 30 cycles. Genomic DNA absence 
was verified with substituting RT/Taq mix with Taq DNA polymerase (Invitrogen). 
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3. Pros-a1 knockdown aids proteasome stability through
Ecm29 chaperone recruitment
3.1 Summary 
The Ubiquitin-Proteasome system catalyzes the degradation of most intracellular 
proteins. Although ubiquitination of proteins is the primary determinant of their stability, 
there is growing evidence that proteasome function is also regulated and it plays a key 
part in cellular homoeostasis. In this chapter, I describe the functional characterization of 
Pros-a1 in muscles and how its knockdown in stressed muscles mitigates proteotoxicity. 
I identified that DTS5 inhibits proteasome activity by facilitating the dis-assembly of the 
26S holocomplex to its constituting particles, the 20S core particle and 19S regulatory 
particle. Pros-a1 knockdown promoted stable proteasomes by recruiting the Ecm29 
chaperone. This genetic interaction was needed for restoring functional proteasome 
activity to maintain muscle architecture and motility. Although Ecm29 has been reported 
to regulate the proteasomal CP–RP interactions in yeast, its physiological role in 
Drosophila have not been characterized. In this chapter, I present the first functional study 
of Ecm29 in flies and the first one to characterize its role in proteasome regulation. These 
findings demonstrate a role for controlled proteolysis during muscle function and 
illuminate proteasome stability as a target of stress adaptation. 
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3.2 Introduction 
Cells have evolved numerous and often overlapping homeostatic pathways to adapt 
to changes in their environment and to survive under adverse conditions. Ecm29 is a 205 
kDa protein associated with the proteasome and was reported to regulate proteasome 
function via several mechanisms. Ecm29 was initially identified by its binding to yeast 26S 
proteasomes under low salt conditions, classifying it as an interacting protein rather than a 
stoichiometric subunit (Leggett et al., 2002). Like Blm10, Ecm29 is a HEAT-repeat protein 
and is conserved in yeast (Ecm29), humans (KIAA00368) and Drosophila (CG8858). 
These repeats characterize flexible proteins and are thought to be important for its function 
in binding both the RP on the one hand and CP on the other (Kajava et al., 2004).   
Ecm29 can positively regulate proteasomes by stabilizing the 26S proteasome 
complex (Gorbea et al., 2004; Kleijnen et al., 2007; Leggett et al., 2002). It was shown to 
keep RP-CP complexes intact even in the absence of ATP, whereas when it was missing, 
ATP was needed to prevent dissociation of such complexes. In yeast extracts Ecm29 was 
found bound only to proteasome species which contained both RP and CP; an apparently 
unique property, that may reflect the requirement for both particles in stable association of 
Ecm29 to  proteasomes (Leggett et al., 2002; Panasenko and Collart, 2011). Furthermore, 
evidence suggested that Ecm29 may function in proteasome quality control by either 
sequestering aberrantly formed proteasomes or repairing them. First, Ecm29 was purified 
with 26S proteasomes lacking b3 but still associated with a RP. These proteasomes were 
classified as immature due to the presence of unprocessed b5 (Lehmann et al., 2010). 
Reconstitution assays suggested that exogenous addition of Ecm29 was sufficient to drive 
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the maturation of the β5 subunit in these complexes. Additional reports confirmed Ecm29 
preference to aberrant or mis-assembled proteasomes, these include proteasomes with 
mutant a or Rpt subunits (Lee et al., 2011; Park et al., 2011) and proteasomes assembled 
in the absence of Ump1 or Pac2 (Park et al., 2011). Ecm29 has pleiotropic effects; 
conflicting studies showed that  it can  either promote gate closure or opening (Kleijnen et 
al., 2007; Lee et al., 2011). Since Ecm29 was mostly studied under non-physiological 
conditions, these divergent observations may be explained by distinctive environmental 
conditions and/or association with alternative mutants in the existing studies. Ecm29 may 
function in the UPS pathway through additional mechanisms such as in maintaining 
proteasome integrity via the ubiquitin ligase Not4 (Panasenko and Collart, 2011), in 
playing a role in proteasome trafficking in mammalian axons (Hsu et al., 2015) and as 
proteasome adaptor protein in endocytic pathways (Gorbea et al., 2004; 2010). Despite the 
many intriguing observations linking Ecm29 to proteasomes, its exact mechanism of action 
remains uncertain. There is an existing gap in our understanding of what triggers Ecm29 
recruitment to proteasomes, but the consent is that its ability to identify atypical or 
abnormal proteasomes is at the core of its function. Knowledge of Ecm29 function is 
largely derived from yeast and cell cultures analyses, therefore its physiological impact in 
insects and higher organisms is largely unknown.  Nonetheless, it is considered a strong 
and evolutionarily conserved regulator of the proteasome.  
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3.3 Results 
3.3.1 Pros-a1 characterization in eye and muscle models 
The screen from Chapter 2 identified Pros-a1 (a1) knockdown as a suppressor of 
DTS5-dependent effects both in eye and muscle models. But two questions remained open 
which are addressed here: 
1. Do pros-a1 levels specifically modify observed phenotypes?
2. How do a1 levels modify observed phenotypes independent of DTS5 stress?
The first question was addressed by overexpressing a a1 transgene (EP-a1) to complement 
reduced a1 levels due to RNAi expression. Overexpressing a1 in the DTS5;a1-RNAi 
strain abrogated suppression of the rough eye phenotype (Figure 3.1C). Additionally, 
immunofluorescence examination of OCT embedded heads revealed disrupted 
photoreceptor morphology and showed signs of retinal degeneration (Figure 3.1D, see 
inset). In conclusion, a1 levels were specifically responsible for modifying DTS5-
dependent effects. 
The second question was addressed in the muscle model, by applying RNA 
interference of a1 in a wild-type background. Despite a1 being a core subunit of the 
proteasome, these larvae displayed normal motility, not significantly different from wild 
type values, in the crawling assay (Figure 3.1I,L). I followed behavioral assays of larvae 
by examining changes at the molecular level. Even though there was no induction of 
paralysis, muscles still endured proteotoxic stress as presented in moderate accumulation 
of poly-ubiquitinated proteins (Figure 3.1J). Actin staining with phalloidin and DAPI 
displayed normal sarcomeric pattern and normal nuclei distribution with no signs of 
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atrophy (Figure 3.1J’). Photoreceptors were affected by a1 RNA interference in the same 
manner (Figure 3.1K). With no DTS5 expression, poly-ubiquitinated proteins rose in 
photoreceptors expressing a1 RNAi but not enough to initiate gross degeneration (Figure 
3.1K’). I conclude that diminished a1 levels were not enough to activate a full muscle 
atrophy program or complete photoreceptor degeneration. Alternatively, distressed 
homeostasis was countered by triggering an adaptation response. 
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Figure 3.1 a1 role in stress and development. A-C. Shown is GMR-driven expression of 
indicated genotype at permissive temperatures.  Overexpressing a1 over its RNAi re-suppressed 
a1-dependent rescue of DTS5-induced rough eye. D-E. Vertical sections of OCT embedded heads 
immunostained for 24B10 (green), ELAV (red) and DAPI (blue). Photoreceptors degeneration is 
dependent on a1 levels. F-I. Shown is MHC-GS driven expression of indicated genotype at 
permissive temperature. a1 RNAi expression is not sufficient to promote muscle atrophy in a 
wild-type background. J. a1 KD muscle stained for poly-ubiquitinated proteins (green) merged 
with Phalloidin (red) and DAPI (blue) in panel J’. Low a1 levels present some proteotoxic stress 
revealed by moderate accumulation of poly-ubiquitinated proteins but not sufficient to disturb 
muscle morphology. K. Cross sections of OCT embedded heads immunostained for FK2 
(green) merged with ELAV (red) and DAPI (blue) in panel J’. Low a1 levels present some 
proteotoxic stress revealed by moderate accumulation of poly-ubiquitinated proteins but not 
sufficient to induce photoreceptor degeneration. L. Bars represent mean values from 5 
independent experiments, 100 larvae in total. Percentage was calculated per genotype as number 
of crawling larvae per total larvae placed on apple plate. **P<0.001 two-tailed Student’s t-test). 
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3.3.2 Atrophy salvage by a1 KD correlates with altered 
localization of proteasomes 
Nature has evolved several mechanisms to detoxify intracellular protein aggregates 
that arise upon proteotoxic challenges. These include controlled deposition of misfolded 
proteins at distinct cellular sites, protein disaggregation and refolding by molecular 
chaperones and/or degradation of this toxic aggregates by the proteasome. To facilitate 
increased demand for degradation at specific sites, localized degradation is mediated by 
proteasome compartmentalization. Targeted proteasome deposition and transport are not 
only important in stress adaptation but are also vital for organismal development, especially 
for neuronal plasticity and sperm individualization.  
To further explore molecular effects of the genetic interaction of DTS5 and a1 on 
proteasome localization, muscles were counterstained for the 19S RP subunit Rpt3. 
Proteasome assembly is initiated in the cytoplasm followed by transfer of its sub-particles 
to the nucleus where final stages of assembly are completed. Under normal growth of cells, 
the proteasome is usually found in the nucleus (Reits et al., 1997; Wilkinson et al., 1998). 
As expected Rpt3 showed predominant nuclear staining in wild-type flies (Figure 3.2A). 
Additionally, a1 knockdown flies also showed predominant nuclear staining (Figure 3.2D) 
demonstrating that they experience only mild proteotoxic stress. For flies expressing DTS5 
and those introduced with a1 RNAi the Rpt3 staining pattern stood out. In flies 
experiencing DTS5-dependent proteotoxic stress, Rpt3 staining was mostly excluded from 
nuclei revealing an un-defined distribution pattern along the length of the muscle (Figure 
3.2B). Proteasome subunits are usually expressed in stoichiometric quantities and are 
assumed to be fully incorporated into holo-proteasome particles with no free subunit 
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deposits. The appearance of an un-defined pattern led me to think that it could result from 
proteasome dis-assembly, therefore I continued with a more thorough examination of 
proteasome assembly using native gel assays in the following sections. Yet, it cannot be 
ruled out that the atrophy and its associated loss of architecture could account for this 
diffused pattern.  
Especially intriguing was the observed pattern in flies expressing both DTS5 and 
the a1 RNAi (Figure 3.2C). Instead of a predominant nuclear staining, majority of the Rpt3 
was now found in the cytoplasm. Staining was prevalently in the peri-nuclear compartment 
known to harbor the ER-Golgi network. Counterstaining for Rpt2, another 19S RP subunit, 
repeated same observations, reaffirming this result. Of special note is that the differential 
localization is observed only in muscle tissues, where expression of this genetic interaction 
is targeted. Soma tissue was comparable to wild-type and retained predominant nuclear 
localization of proteasomes (Figure 3.2C, see arrow). 
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Figure 3.2 Distribution of proteasomes under proteotoxic stress and stress adaptation. Larvae 
were raised as described before, muscles were dissected at a 24-hour time point and counterstained 
for either Rpt3 or Rpt2 to visualize proteasomes. Prevalent nuclear staining of Rpt3 was observed 
in wild-type and a1 knockdown in muscle tissue, whereas in DTS5-expressing muscles Rpt3 
staining was dispersed un-defined. Differential localization was seen in DTS5;a1-KD muscles, 
with prevalent peri-nuclear staining of Rpt3 in DTS5 and a1 RNAi-targeted muscle cells, as 
opposed to predominant nuclear staining in soma tissue (marked with arrow).  A-D Left panels 
depict Rpt3 staining marked by green, right panels (A’-D’) depict the merge of Rpt3 staining with 
DAPI (blue) and Phalloidin (red). E. Left panel depicts Rpt2 staining marked by magenta, right 
panel (E’) depicts merge of Rpt2 staining with DAPI (blue) and Phalloidin (green).     
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Rpt3 alone is not enough to depict where active proteasomes may reside. In order 
to complete the picture, a 20S core particle marker was needed. Co-localization of 19S and 
20S markers depict where active holo-proteasomes are found. For this purpose, I used 
transgenic flies expressing GFP-tagged a2 subunits from an endogenous promoter 
reconstructed with the genetic transgenes that I studied (Figure 3.3A-C). Proteasomes 
containing fused proteins exhibited normal function in vivo (Ma et al., 2002). In wild-type 
flies a2-GFP merged with the Rpt3 staining displaying the same nuclear pattern expected 
from functioning proteasomes in normal growth (Figure 3.3A). In DTS5 flies a2-GFP co-
localized with Rpt3 in the same diffusive pattern depicted before (Figure 3.3B). In DTS5 
flies constructed with a1 RNAi, a2-GFP was predominantly found in the nucleus, but 
abundant co-localization with the Rpt-3 signal was found primarily in the peri-nuclear 
domain (Figure 3.3C). 
The peri-nuclear area is an intracellular site that exhibits high levels of ubiquitin-
dependent proteolysis and is known to host molecular chaperones responsible for re-
folding mis-folded aggregates and/or sorting them for cellular clearance pathways.  
Compartmentalized degradation could be one of the mechanisms that make these flies 
better equipped to cope with proteotoxic stress. 
More rigorous examination of these observations was carried by inducing genetic 
clones using the Flp-FRT system (Golic and Lindquist, 1989; Harrison and Perrimon, 
1993). This technology that allows for the spatial and temporal restriction of transgene 
expression relies on the use of the yeast site-specific recombinase, flipase (Flp) and its 
recognition target sequence (FRT). The Flp-out technique uses transgenes that are silenced 
by a transcriptional stop signal flanked by FRT sites that can be removed by the expression 
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of Flp to activate the gene of interest (Bischof and Basler, 2008; McLeod et al., 1986). 
Only progenitors in which flipase was active in would express the GAL4-UAS system. 
This genetic technique can be used to label single cells or multiple cells sharing a single 
progenitor. The Flp-FRT-dependent mitotic recombination results in genetic marking of 
clones, which express a transgene that is otherwise repressed in the adjacent wild-type non-
recombined clones. This method provides a tool to study transformed tissues in the 
background of a phenotypically wild-type un-altered cells. To induce mosaic clones, I used 
the flipase under a heat-shock promoter (hs-FLP) for temporal control. Mosaic prevalence 
can be controlled by timing and duration of heat shock exposure, so that only a subset of 
progenitors will go through a flipase-FRT recombination. After Flp-FRT- dependent 
recombination, clones in which the stop signal was removed now express GAL4 under 
tubulin promoter and are genetically marked with ds-Red. Only ds-Red marked cells also 
drive expression of the DTS5 and a1-RNAi transgenes that are under GAL4-UAS control. 
Non-marked tissue is comparable to wild-type tissue. In line with the former results, ds-
Red clones displayed aberrant Rpt3 localization whereas non-marked clones behaved 
similarly to wild-type revealing nuclear staining (Figure 3.3D). Rpt3 staining was aberrant 
but still not quite the same as seen beforehand. There are two possible explanations to this 
discrepancy. First this observation can be classified as a non-autonomous effect. With this 
method, transgenic clones may appear in other tissues such as brain. Albeit these random 
clones are not enough to effect whole organism viability and morphology, they could be 
enough to instruct dissimilar signal transduction in other tissues. Second in this model 
GAL4 is under a tubulin promoter and not MHC, which might explain altered expression. 
80 
Figure 3.3 26S proteasomes concentration in peri-nuclear sites correlates with stress-
adaptation. A-C genetic backgrounds of: wild-type, DTS5 and DTS5;a1-KD respectively were 
constructed in flies expressing a transgenic GFP tagged a2 subunits (green, first to left column). 
Muscles were counterstained with anti-GFP to enhance signal, Rpt3 (red, second to left column), 
Phalloidin (magenta) and DAPI. Third to left column depicts a merge of green and red channels, 
marking co-localization of 20S (a2-GFP) and 19S (Rpt3) markers. Fourth column depict a merge 
including DAPI (blue) and Phalloidin (magenta). In wild-type tissue co-localization was observed 
primarily in the nucleus. In muscles derived from DTS5;a1-KD, a2 tagged proteins were found 
both in nucleus and cytoplasm but co-localized with Rpt3 primarily in peri-nuclear sites. D. Flp-
FRT system was used to create clones expressing DTS5 and a1 RNAi, which were visualized with 
ds-Red marker (first left column) and counterstained for Rpt3 (green, second left column). Third 
and fourth column depict a merge without and with DAPI (blue) and Phalloidin (magenta) 
respectively. Clones displayed altered distribution as opposed to predominant nuclear staining in 
non-clonal muscles, indicating that localization pattern was likely dependent on transgenic 
expression of DTS5 and a1 RNAi.  
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3.3.3 Atrophy salvage is mediated by a general mechanism 
of compromised 20S proteasome complex 
Recently Tsvetkov et al. showed that compromising 19S proteasome complex can 
protect cells against proteotoxic stress incurred by the proteasome inhibitors MG-132 or 
Bortezomib (Tsvetkov et al., 2015). They performed a screen on a collection of mutant 
human CML cells looking for resistance to proteasome inhibitors. Surprisingly, cells which 
had reduced expression of various 19S subunits, including both Rpt and Rpn subunits, were 
more resistant, however no mutants of 20S subunits were enriched in the screen. Strong 
reduction was cytotoxic but a modest reduction protected cells from inhibition. In light of 
this finding, I postulated that mitigating the DTS5 proteotoxic stress might not be a unique 
characteristic of a1 subunit and instead might represent a more general mechanism of 
compromising either the 20S complex or 19S complex. 
I addressed this notion by expanding the screen to include almost all subunits of the 
a ring (a3 is not represented since it has no RNAi stock), some b ring subunits and both 
Rpn and Rpt representatives of the 19S particle. All a ring subunits except a6 were 
successful at rescuing larval paralysis (Figure 3.4A). Yet, b2 and b5 RNAi did not relieve 
atrophy. It is possible that their inability to relieve atrophy had to do with their catalytic 
function, thus they are needed in stoichiometric levels. Reduced expression of almost all 
of the 19S subunits, notwithstanding Rpn2, which exhibited moderate rescue, did not 
alleviate larval paralysis significantly (Figure 3.4B). I also tested the effect of knocking 
down a subunits for their ability to suppress the rough eye phenotype. Similarly, to what I 
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observed in regards to muscle atrophy, all a subunits RNAi reverted the eye phenotype 
back to normal, except a6. 
 In conclusion a1 action in the context of DTS5 stress is not exclusive but rather 
part of a general stress adaptation mechanism enlisted when compromising the 20S 
complex. The role of a6 does seem to be unique. The discrepancy in 19S role between my 
study and that of Tsvetkov and colleagues (Tsvetkov et al., 2015; 2017) can be explained 
by the mode of proteasome disruption that was used. In their study, they used proteasome 
inhibitors which target the catalytic activity of the proteasomes whereas I used a mutant 
form of a proteasome subunit, which could target other aspects of proteasome function 
such as assembly. Up to date the mechanism of action of DTS5 is largely unknown and is 
addressed in this thesis. 
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Figure 3.4 Atrophy is relieved when compromising the 20S complex but not 19S. A-B. 
Quantification of RNAi effects on DTS5 induced larval paralysis categorized by 20S and 19S 
subunits respectively. Percentage was calculated per genotype as number of crawling larvae per 
total larvae placed on apple plate. C-J. Analysis of rough eye phenotype as describe before. Flies 
were constructed with the GMR driver to promote transgenes expression. 
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3.3.4 Alternative compensatory mechanisms for proteasome 
inhibition
Proteasome activity is regulated at several levels to preserve homeostasis. Upon 
proteasome inhibition, a concerted de novo synthesis of all 26S proteasomal subunits with 
subsequent whole proteasome formation, was observed in several organisms (Li et al., 
2011; London et al., 2004; Lundgren et al., 2005; Meiners et al., 2003; Mitsiades et al., 
2002). A common regulatory pathway in response to reduced proteasome function or 
general stress is induction of transcription factors to elevate subunit abundance 
(Radhakrishnan et al., 2010; Steffen et al., 2010; Xie and Varshavsky, 2001). In Drosophila 
deletion of the Rpn10/S5a subunit or its depletion with RNA interference increased the 
level of 26S proteasome (Lundgren et al., 2003; Szlanka et al., 2003). Accordingly 
Drosophila cell lines lacking Rpn10/S5a showed only minor increases in ubiquitin 
conjugate levels with no observable loss of in vivo proteasome activity (Lundgren et al., 
2003). 
To investigate compensatory induction of proteasome subunits I performed 
Western blots assaying protein levels of the proteasome subunits Rpt3 and a7 (Figure 
3.5A). It is believed that all proteasome subunits are expressed in comparable 
stoichiometric levels and are found in cells in the context of their respective complex with 
no free subunits. An exception to this rule is Rpn10/S5a which can be found in a free state 
(Piterman et al., 2014).  Proteasome inhibition with DTS5 did not result in augmented 
abundance of these proteins. Like Rpn10/S5a depletion, proteasome interference with a1 
RNAi presented mild proteotoxic stress with accumulation of poly-ubiquitinated proteins 
but no observable loss of proteasome activity (Lundgren et al., 2003), but it did not result 
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in increased expression of other proteasome subunits. In conclusion, it is unlikely that 
a1depletion restored proteasome activity in DTS5 flies through transcriptional regulation 
of proteasome subunits as no elevated expression was observed in its presence. If anything, 
expression levels seemed to decrease, but Tubulin levels were also reduced in that sample. 
The UPS and autophagy are the two main systems involved in the regulation of 
protein homeostasis and housekeeping functions. The UPS presents a selective pathway 
for protein degradation, whereas autophagy is responsible for bulk destruction. These 
protein degradation pathways share some common regulators so they can act 
simultaneously and in conjunction to preserve protein homeostasis and quality control 
(Mammucari et al., 2007; Zhang et al., 2014; Zhao et al., 2014; 2015). Specifically, 
activated FoxO3 stimulated both proteasome and autophagy-dependent degradation to 
promote muscle atrophy (Zhao et al., 2014). The UPS acts constitutively as the first line of 
defense in the elimination of protein aggregates. But when proteasomal degradation is 
compromised, cells have been shown to recruit autophagy as a compensatory mechanism 
(Fusco et al., 2012; Kageyama et al., 2014; Pandey et al., 2007).  
To explore if autophagy contributes to induced atrophy and/or its rescue I applied 
RNA interference of two autophagy key players, ATG4 and ATG13 (Figure 3.5B). ATG4 
is responsible for LC3 processing in the elongation and expansion phase of the 
autophagosome (Satoo et al., 2009). ATG13 participates in the initiation and nucleation of 
the autophagosome (Alers et al., 2014). Depletion of autophagy components mildly 
rescued larval paralysis, though not statistically significant, denoting some contribution to 
autophagy activity in induced atrophy. As discussed in Chapter 2 muscle atrophy was 
accompanied with a mild elevation in ATG8 puncta, a sign for increased autophagy. On 
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the other hand, depletion of autophagy components from the DTS5;a1-RNAi strain did not 
impair paralysis suppression gained by expression of a1 RNAi. This observation implies 
that a1-RNAi did not rescue muscle atrophy through triggering compensatory autophagy 
and that another general mechanism is in play. 
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Figure 3.5 a1 knockdown does not mitigate proteasome inhibition through alternative 
compensatory mechanisms. A. Proteasome inhibition by DTS5 and its rescue by a1 do not 
enhance expression of proteasome subunits, as assessed by Western blotting for Rpt3 and a7 of 
protein extracts from dissected muscles. Tubulin protein levels served as loading control. B. 
Autophagy had insignificant contribution to DTS5 induced larval paralysis but was not required 
for a1 RNAi mechanism of action. Bars represent mean values from 3 independent experiments, 
90 larvae in total. Percentage was calculated per genotype as number of crawling larvae per total 
larvae placed on apple plate. Significance measured in respect to DTS5 values **P<0.001 (two-
tailed Student’s t-test). 
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3.3.5 a1 knockdown alters 26S composition 
Proteasome function is derived from the processivity of its catalytic activity and 
assembly rate. Despite the spread use of the DTS mutants as a standard model for 
proteasome disruption, their mechanism of action is not fully resolved. While it is clear 
that they impair proteasome activity, they could do so through two distinct mechanisms. 
First, they could perhaps directly inhibit the catalytic sites through allosteric effects, or 
alternatively attenuate 26S assembly. In fact, b2 and b6 assume at a unique position which 
stabilizes two half proteasomes together. 
To examine whether DTS5 and a1 function relates to proteasome biogenesis, I 
examined proteasomal particles from muscle lysates resolved by non-denaturing PAGE 
(native gel), followed by immunoblotting. Native gel allows for fine resolution of the 
multiple species of the proteasome and analysis of ratio between proteasome holoenzymes 
(RP2-CP and RP-CP) to free CP, indicative of proteasome assembly (Elsasser et al., 2005). 
Dissected tissue was lysed in an ATP rich buffer to protect proteasome holoenzymes from 
dis-association. Membranes were immunoblotted with a7 (Figure 3.6A) to assess 
holoenzymes and free particles, and Rpt3 (Figure 3.6B), which can detect holoenzymes 
and RP assembly intermediates. DTS5 led to a dramatic reduction in 26S to 20S ratio and 
increased presence of free RP, revealing for the first time that DTS5 inhibits proteasomes 
due to reduced assembly. 
One might expect RNA interference of a1 to weaken the interaction between the 
RP and CP and consequently lead to a reduction in the ratio of proteasome holoenzyme 
(RP2-CP and RP-CP) to free CP. On the contrary, these proteasomes were found 
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predominantly in the holoenzyme form, and the level of free CP fell below detection limit 
(Figure 3.6). Among holoenzymes, the RP2-CP species predominated over RP-CP 
whenever a1 RNAi was applied. I assume that stoichiometric imbalance in 20S subunits 
created an imbalance in favor of RP over CP, which led to preferential formation of RP2-
CP over RP-CP. Remarkably, a1 RNAi also accumulated RP assembly intermediates 
(Figure 3.6B). Together these observations suggest that a CP assembly defect did follow 
a1 depletion. However, formed holoenzymes were more stable so overall active 
proteasomes were present at higher levels in flies expressing RNAi, whether in a wild-type 
or DTS5 background, compared to wild-type or DTS5 at permissive temperature 
respectively. In conclusion, increased proteasome activity could be accounted for with 
increased stability of holoproteasomes. 
In addition to the features described above, proteasomes from a1-RNAi flies also 
exhibited reduced electrophoretic mobility in native gels. This effect could be seen for both 
the RP-CP and RP2-CP forms of the proteasome (Figure 3.6). The mobility shift pointed to 
a major structural difference. I hypothesized this structural difference might account for a1 
role in mitigating proteotoxic stress and continued with this line of premise. 
a1 mode of action on proteasome species was not unique to muscle tissue. Native 
gel was also used to resolve proteasome species of heads only tissue (Figure 3.6C-D). For 
holoenzyme analysis in heads I relied mostly on Rpt3 signal. a7 antibody is a more 
sensitive and less robust antibody and often failed in distinguishing holoenzyme species, 
especially in head samples. In this respect, increasing the sample size was beneficial 
although same amount of protein was loaded as in native gel with muscle tissue. Even 
though GMR is expressed only in a fraction of the cells in heads, it still remarkably 
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captured similar key observations as seen in the muscle analysis. In its permissive 
temperature proteasomes from the DTS5 strain were found mostly in a CP free, in line with 
proteasome dissociation. Moreover, proteasomes from a1-RNAi flies displayed reduced 
electrophoretic mobility, suggesting a general stress adaptation response.  
Figure 3.6 a1 knockdown promotes holoenzyme complex assembly. A-B. Protein extracts (25 
µg) of dissected muscle tissue from indicated strains were resolved on native gels and subjected to 
immunoblot for subunit of the CP (a7) and subunit of the RP (Rpt3) respectively. C-D. As in A-B 
Proteasome species were assayed with native gel of protein extracts (25 µg) from head tissue. Free 
CP was examined with a7 and RP-CP with Rpt3. For control 10 µg of protein extracts was resolved 
on SDS-PAGE and immunoblotted for tubulin. 
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3.3.6 Identification of Ecm29 role in novel proteasome particles 
a1-RNAi resistance to DTS5 proteotoxic stress suggested a1 reduction triggered 
an adaptation response to promote proteasome stability, that may account for structural 
changes depicted in the previous section. Based on the native gel observations I proposed 
proteasomes were modified by a regulatory protein that should comply with three key 
criteria: 
I. Must be a large enough protein to account for significant mobility shift. 
II. Bind to complexes composed of both RP and CP.
III. Support holoenzyme complexes.
Knowledge of proteasome regulators in Drosophila is limited to the 19SRP and PI31, 
whereas several regulatory complexes are known in mammals and yeast: PA28, 
PA200/Blm10, Usp14/Ubp6, KIAA00368/Ecm29. Ecm29 is the only one conserved in 
flies, sharing 18% identity with the yet un-characterized CG8858. Ecm29 stood out as a 
promising candidate as it fulfills all three criteria I predicted. First it is a very large protein, 
205KDa, and has been shown to confer a mobility shift of proteasomes (Kleijnen et al., 
2007; Park et al., 2011). Ecm29 is known to associate with the proteasome holoenzyme in 
preference to its sub-complexes, the RP and CP (Kleijnen et al., 2007; Leggett et al., 2002; 
Park et al., 2011). Moreover, Ecm29 has been implicated in supporting RP-CP association 
and stabilizing the proteasome holoenzyme (Kleijnen et al., 2007; Leggett et al., 2002; 
Lehmann et al., 2010; Park et al., 2011).  
To better understand how CG8858 (from now on referred as Ecm29) might regulate 
proteasome function I used a hypomorphic P-element allele construct of this gene 
93 
(Ecm29MI482). Ecm29 is known as a chaperone: under normal conditions loss of Ecm29 
had no effect on organismal growth but when proteasome function was compromised its 
function was required (Haratake et al., 2016; La Mota-Peynado et al., 2013). I therefore 
examined Ecm29MI482 effect on Ecm29 expression both in wild-type background and when 
proteasome function was compromised by a1 depletion. Ecm29MI482’s ability to deplete 
Ecm29 protein expression was confirmed both by Western blot (Figure 3.7A) and 
immunofluorescence (Figure 3.7B). While it seemed that a1 reduction led to upregulation 
in Ecm29 expression this observation was not consistent with the Western blot. 
I next asked if Ecm29 depletion effected muscle atrophy and proteotoxic stress. As 
expected Ecm29 depletion by itself did not disrupt larval motility and muscle function, 
regardless of whether a1 was present at normal or reduced levels (Figure 3.7C). 
Nonetheless it did enhance accumulation of poly-ubiquitinated proteins which was even 
more enhanced when a1 was present at low levels (Figure 3.7D). This result signifies a1 
and Ecm29 association in alleviating proteotoxic stress. The Ecm29MI482 effect was not 
enough to stop poly-ubiquitinated proteins from accumulating but was sufficient to prevent 
gross atrophy induction It will be interesting to see what would happen with a null form of 
Ecm29.  
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Figure 3.7 Ecm29 is not needed for normal muscle function. A-B Validation of the Ecm29MI482 
mutant. A. Protein extracts from muscle tissue of the indicated strain were resolved on SDS-PAGE 
and immunoblotted for Ecm29. Ecm29MI482 disturb Ecm29 expression. Tubulin was used as 
loading control. B. Dissected muscles were fixed and immunoassayed against Ecm29. In line with 
the idea that Ecm29 has no function under normal conditions its signal was low in wild-type tissue 
(left panel) but enhanced upon a1 interference (middle panel). Enhanced signal was dependent on 
Ecm29 expression as Ecm29MI482 diminished that signal (right panel). C. RU-486 fed larvae of 
indicated genotype were placed on apple plates after 24-hours incubation in 28.3°C. Depletion of 
Ecm29 did not halt motility independent of a1 levels (middle and right panel). Quantification of 
motility in panel C’. Bars represent mean values from 5 independent experiments, 100 larvae in 
total. Percentage was calculated per genotype as number of crawling larvae per total larvae placed 
on apple plate. D. Muscles of larvae from panel C were assayed for poly-ubiquitinated protein 
accumulation with FK2 antibody. High levels of Ecm29 are required to diminish proteotoxic stress 
resulting from a1 interference, see Figure 3.1 for comparison (right panel), yet remaining Ecm29 
expression was sufficient to prevent muscle atrophy and maintain normal muscle architecture. 
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After characterizing Ecm29 requirement in normal conditions I followed suit in 
DTS5-dependent proteotoxic stress. Ecm29MI482 expression significantly diminished the 
ability of a1 knockdown to rescue DTS5 induced larval paralysis (Figure 3.8A). Abolished 
rescue was not complete with still roughly 40% of larvae remaining motile (Figure 3.8A’). 
The DTS5 allele carries a wild-type Ecm29, which might account for preserved motility. 
For a more accurate genetic analysis of Ecm29 activity, I will employ two strategies for 
future experiments: DTS5 recombined with Ecm29MI482 and null Ecm29. I started in the 
construction of strains, for null strains applying the CRISPR method but they remain to be 
validated and therefore were not assayed yet. As expected from behavioral assays high 
levels of Ecm29 were needed for a1-RNAi to counter accumulation of poly-ubiquitinated 
proteins (Figure 3.8B). Larval paralysis followed deformed muscle architecture as 
presented before. Not surprisingly, by itself Ecm29MI482 had no effect on DTS5-dependent 
paralysis or poly-ubiquitin accumulation (Figure 3.8A-B, right column). These 
observations highlight both a1-RNAi and Ecm29’s functional requirements in mitigating 
DTS5 proteotoxic stress. 
I tested whether a1-RNAi and Ecm29 association was specifically related to 
proteasome activity with in vivo assay for proteasome activity (previously described in 
section 2.3.4). High levels of Ecm29 were needed for a1-RNAi to relieve DTS5-dependent 
inhibition of proteasome activity. In short, the combined action of a1 RNA interference 
and Ecm29 function was needed to sustain proteasome activity required for normal 
function of muscles. 
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Figure 3.8 a1 RNAi requires Ecm29 to suppress DTS5 dependent stress. A. Following RU-
486 feeding and 24-hours incubation in 28.3°C larvae of indicated strain were assayed for their 
movement on apple plates. High levels of Ecm29 were needed for a1-RNAi to suppress DTS5 
dependent larval paralysis (third column). A’. Bars represent mean values from 5 independent 
experiments, 100 larvae in total. Percentage was calculated per genotype as number of crawling 
larvae per total larvae placed on apple plate. Significance in respect to wild-type motility 
(Figure 3.7C’) **P<0.001, statistical analysis was performed with a two-tailed paired t test. B. 
Muscles of larvae from panel A were assayed for poly-ubiquitinated protein accumulation with 
FK2 antibody. Ecm29MI482 de-suppress accumulation of poly-ubiquitinated proteins observed 
in DTS5/a1-RNAi strains (middle panels). C. In vivo proteasome activity of indicated strains 
reveal Ecm29 prerequisite for a1-RNAi to relieve DTS5 inhibition of proteasome activity. 
Analysis was carried out as described Figure 2.9, GFP signal persistence at 4-hours post heat 
shock depict inhibition of in vivo proteasome activity. C’. Quantification of GFP signal. Bars 
represent the means of percent values 4-hours versus 1-hour post HS induction of each 
respective strain. Statistical analysis was carried out on a total of 12 larvae (images) from 3 
independent experiments. **P<0.001 significance in comparison to WT signal, with a two-
tailed, paired, t test. 
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3.3.7 a1-RNAi induces recruitment of Ecm29 to promote RP-
CP association 
The mobility shift I observed in Figure 3.6 pointed to a major structural difference 
between wild-type and proteasomes assembled in in the presence of a1-RNAi, which can 
be indicative of Ecm29 binding to proteasomes. To test whether Ecm29 binding produced 
a reduction in electrophoretic mobility of proteasomes, I introduced Ecm29MI482 to the 
DTS5;α1-RNAi strain. Resolving muscle protein extracts of this strain on native gels, 
revealed dependence of the mobility shift on Ecm29 levels compared to wild-type 
proteasomes (Figure 3.9A,C). Ecm9 mutant strongly reduced the level of RP-CP species 
in DTS5;α1-RNAi and the level of free CP was correspondingly increased (Figure 3.9A). 
Reduced ratio of 26S to 20S is the hallmark of holoenzyme assembly defects and clear 
indication that Ecm29 was needed to maintain RP-CP association. Proteasomes resolved 
from Ecm29MI482/DTS5;α1-RNAi strain, which preserved their holo-complex  likely 
represent residual binding of Ecm29 protein and therefore also displayed reduced mobility. 
It is possible that this strain still had some Ecm-29 free holo-complexes but their levels 
were too low for this assay to detect. In conclusion DTS5;α1-RNAi strain carrying a mutant 
Ecm29 could not initiate an adaptive response to proteotoxic stress, despite experiencing 
one due to DTS5 and a1-RNAi presence, because of depleted Ecm29 levels. 
To confirm Ecm29 recruitment by aberrant proteasomes (formed in strains carrying 
a1-RNAi) I immunoblotted native gels for Ecm29 (Figure 3.9B). Wild-type Ecm29 
presence on aberrant proteasomes was significantly higher. In Ecm29MI482, Ecm29 binding 
was reduced most likely due to reduced total levels of Ecm29 and not due to decreased 
affinity. I repeated my analysis with purified proteasomes to test physical association of 
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Ecm29 (Figure 3.9C). The proteasome CP subunit b5, carrying a protein GFP tag, was 
chosen to selectively isolate proteasome holoenzymes. Using this tag I also isolated free 
CP, but previous reports and my observations showed this complex does not bind Ecm29 
and Ecm29 preferentially binds to RP-CP species (Lehmann et al., 2010; Park et al., 2011). 
Ecm29 was enriched on proteasomes purified from DTS5;a1-RNAi strain compared to 
wild-type proteasomes. 
Proteasomes were also tested for a possible effect of Ecm29 on the proteasome gate 
(Figure 3.9D). Gate opening was assessed using in-gel peptidase assay, in which native 
gels are exposed to the fluorogenic peptide LLVY-AMC. Band intensity in this assay 
correlates to peptide hydrolysis rate, serving as an indicator of gate state and proteasome 
levels. SDS is applied to open latent species, such as the CP and possible holoenzymes 
with closed gate. If a proteasome species has an open channel, the intensity of the 
corresponding band is comparable in the presence and absence of SDS. If the intensity of 
the band is elevated with SDS, it indicates a closed or partially closed gate (Groll et al., 
2000; Smith et al., 2007). Some fraction is always found in a closed form so it is natural 
for the bands depicting the holoenzyme forms to increase to a certain extent in the presence 
of SDS. The results indicated that aberrant proteasomes found with bound Ecm29 had 
comparable activity to wild-type proteasomes. Holoenzyme activity was barely detectable 
with mutant Ecm29 whether SDS was present or not (Figure 3.9D); this result was probably 
a measure of significantly lower levels of proteasomes (Figure 3.9A) as opposed to gate 
opening state. 
Of special interest is the discrepancy in CP activity of DTS;a1-RNAi strain 
carrying normal versus mutant Ecm29. When Ecm29 is depleted CP levels rise due to RP-
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CP dissociation (Figure 3.9A), however in-gel peptidase assay revealed higher activity for 
CP derived of strain expressing wild-type Ecm29 (Figure 3.9D). One possible explanation 
for this observation is alterations in rate of CP maturation. Several studies suggested a role 
for Ecm29 in facilitating CP maturation (Lee et al., 2011; Lehmann et al., 2010; Park et al., 
2011). Ecm29 recognized RP-CP species in which CP maturation was stalled and 
functioned as a scaffold protein during the remodeling of incompletely matured RP-CP 
assemblies into active holoenzymes. One hypothesis is that limited amounts of a ring 
subunits could create a maturation defect that would enlist Ecm29 to act as a proteasome 
quality control chaperone, further investigations regarding this mechanism are underway.  
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Figure 3.9 Ecm29 is enriched on aberrant proteasomes to promote RP-CP association. A. 
Protein extracts (90µg) of muscle were resolved on native gel as described before in section 3.3.4. 
Membranes were blotted for Rpt3 and a7 to analyze prevalence of the different proteasome species. 
RP-CP association was weakened in DTS5;a1-RNAi in a manner dependent on Ecm29 presence. 
B. Same membrane from panel A was stripped and re-blotted for Ecm29. Ecm29 was enriched on 
proteasomes resolved from strains depleted of a1 protein in an Ecm29-dependent manner. * 
denotes un-specific bands. C. Proteasomes were purified from muscles extracts (0.4 mg) expressing 
b5-GFP tagged subunits. Proteasomes were analyzed by SDS-PAGE and immunoblotted with 
either Ecm29 (upper panel) or Rpt3 (lower panel) as loading control and measure for proteasome 
selectivity. Lower amounts of proteasomes were purified from an a1-RNAi strain (likely a 
technical aberration in the purification process) but Ecm29 levels were still comparable to wild-
type, depicting Ecm29 enrichment. D. 90 µg of protein extracts (same extracts used in panel A) 
from indicated strains were resolved on 5% native gels and subjected to in-gel peptidase assay with 
fluorogenic substrate LLVY-AMC. The addition of SDS activates latent particles. 
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3.3.9 Suggested alternative subunit composition of aberrant 
proteasome 
Proteasome assembly is a multi-step process coordinated by a specific set of 
conserved chaperones (Hirano et al., 2005; Kunjappu and Hochstrasser, 2014; 
Kusmierczyk et al., 2008; 2011). In recombinant systems, in the absence of chaperones, a 
subunits retained the ability to self-assemble into homo-multimeric rings but could not 
form functional proteasomes (Gerards et al., 1997; Zwickl et al., 1994). Several hypotheses 
could explain how cells compensate for depleted a subunits and preserve high proteasome 
function. The remaining α subunits might arrange themselves into a six-membered ring 
analogous to the homo-hexamer formed by the bacterial proteasome-related protease 
(Baumeister et al., 1998). Alternatively, a gap could exist in the α ring lacking a1, which 
might be stabilized by contacts among the remaining subunits. Finally, the position 
normally occupied by a1 might be taken by another protein, such as another proteasome 
subunit. In yeast loss of a3 subunit or the 20S chaperones Pba3-Pba4 produced remodeling 
of proteasomes with the appearance of alternative species containing a double copy of a4 
subunits (Kusmierczyk et al., 2008; Velichutina et al., 2004). These alternative 
proteasomes can be formed naturally albeit at a slower pace than the canonical 
proteasomes, and they have an advantage under specific stresses such as high metal and 
oxidative stress (Kusmierczyk et al., 2008).  
To assess subunit composition in the different proteasome populations I purified 
proteasomes as described before with b5-GFP tagged subunits. Proteasomes were purified 
from protein extracts of dissected muscle tissue and were resolved on SDS-PAGE gel for 
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further analysis with silver stain. Amongst the a subunits bands one band was absent in 
genotypes expressing a1-RNAi compared to wild-type, it stands reason that this band 
might depict a1 protein (Figure 3.10*). Interestingly there was one band amongst the a 
subunits which was especially enriched in proteasomes derived of DTS5;a1-RNAi strain. 
This intriguing band may depict an alternative a subunit, which took over a1 position and 
explain how alternative proteasomes are formed. This hypothesis is still at its preliminary 
stages and requires more rigorous investigation. For instance, specific bands can be excised 
and be sent for mass-spectometry for further identification. 
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Figure 3.10 a1 RNAi produce proteasomes with an alternative composition of a subunits. 
Proteasomes were purified from protein muscle extracts (0.4mg) of indicated genotype using a b5-
GFP tagged subunit and were resolved on SDS-PAGE gel for Silver stain. There are less bands 
than total subunits of the proteasome since some bands contain more than one subunit. 
*disappearance of band in a1 RNAi-expressing strain comparable to wild-type is likely depicting
depletion of a1 subunit. **Band was intensified in a1 RNAi-expressing strain compared to wild-
type, could indicate doubled amount of a specific subunit instead of a1. ***by size this band could 
possibly be of Ecm29 and depict its enrichment on proteasomes of a1-RNAi strains compared to 
wild-type 
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3.4 Materials and Methods 
Fly stocks 
John Belote generously provided us with transgenic proteasome reporters a2-GFP and b5-
GFP (Ma et al., 2002). RNAi fly stocks was procured from Bloomington stock center and 
Vienna Drosophila research center. Ecm29 mutant Mi{MIC}CG8858MI00482 was obtained 
from Blomington stock center and used following P-element excision. All stocks were in 
a yw or w1118 background and were cultured on cornmeal–molasses medium 
supplemented with 3% active yeast at indicated temperature or room temperature.    
Immunohistochemistry 
Muscles or heads were dissected and prepared for immunohistochemistry as described in 
chapter 2 methods. ELAV, 24B10, Rpt3, GFP antibodies were used as described before. 
Rpt-2 was stained with rabbit polyclonal antibody at 1:100 dilution (Enzo). For Ecm29 
detection rabbit polyclonal antibody was used at 1:200 dilution (Abcam). 20S rabbit 
polyclonal antibody was kindly provided from Dr. Udvardy and used at 1:100 dilution. 
Western blot 
Protein lysates were prepared for Western blot as described in chapter 2. For Rpt3 detection 
rabbit polyclonal antibody was used at 1:1000 dilution (Enzo). For a7 detection mouse 
monoclonal antibody was used at 1:1000 dilution (Enzo). For Ecm29 detection rabbit 
polyclonal antibody was used at 1:1000 dilution (Abcam).  
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FLP/FRT Induction of Mitotic Recombination 
The FLP/FRT system is a site-directed recombination technology based on the targeting of 
a recombination enzyme (flipase - FLP) to specific DNA regions designated as flipase 
recognition target (FRT) sites (Golic and Lindquist, 1989). To generate mosaic clones 
hsflp;sp/cyo;DsRed,tub<y+GFP>GAL4 females were crossed with DTS5;a1-RNAi 
(TRiP27557) males. Crosses were carried in fly cages at 25°C for a duration of 6 hours, 
egg laying on apple-juice/agar plates. In order to induce the flipase enzyme for mitotic 
recombination, after 24-hours apple plates were subjected to a 30-minutes heat shock at a 
37°C water bath in order to induce mitotic recombination. Early third instar larvae were 
seeded on food vials and left for 24-hours incubation in 28.3°C. Muscles were dissected 
and prepared for immunohistochemistry.  
In vitro and in vivo proteasome activity 
Detailed description is provided in Chapter 2 materials and methods 
Native gel analysis 
30 muscles of each genotype were dissected and lysed in native lysis buffer (50 mM Tris-
HCl (pH 8.0), 5 mM MgCl2, 0.5 mM EDTA, 2 mM ATP (added fresh), 0.2% NP40 (added 
fresh), Protease and Phosphatase inhibitors (added fresh)) and homogenized using pellet 
pestle motor (Kontes) on ice. Samples were left on ice for 30 minutes with homogenization 
taking place every 10 min. Protein extracts were spun at 14,000 rpm for 15 minutes at 4°C, 
supernatant was moved to a fresh tube. Protein concentration was determined with a BSA 
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titration column, measured with SpectraMax M-2 micro-plate reader (Molecular Devices). 
Native running buffer (5X, diluted 1:5 for use) was prepared as follows: 0 .45M Tris, 
0.45M Boric Acid, 5mM EDTA, 12.5 mM MgCl2. Running buffer was chilled at 4°C while 
0.5mM ATP and 0.5 mM DTT were added fresh prior to use. 25 µg of total protein was 
dissolved in native loading buffer at 1:1 ratio and resolved on 3–8% Criterion™ XT Tris-
Acetate Gel. Along samples purified bovine proteasome 19S, 20S and 26S particles were 
loaded for control (UBPBio). Electrophoresis was carried for 1 hour at room temperature 
at 60V voltage and continued for additional 4 hours in 4°C at 120V. Protein transfer to 
immobilon-P membrane (Milipore) was carried at 12V for 3 hours at room temperature 
with Tris-Glycine transfer buffer devoid of methanol. Membranes were blocked with 5% 
milk in PBST (0.5% Tween20 in PBS) over night at 4°C. Afterwards, membranes were 
washed three times for 10 min in PBST and incubated with primary antibody for 2 hours 
at room temperature. Primary antibodies were diluted and kept in PBST supplemented with 
0.02% Azide and 3% BSA. Following additional wash steps, membranes were incubated 
in HRP-conjugated secondary antibody (1:5000 dilution) for 1 hour and washed three more 
times with PBST before developing them with Western Lighting ECL blotting detection 
reagent (Perkin Elmer) on a Kodak Biomax MR film. Rpt3, a7 and Ecm29 antibodies were 
used as described for Western blot application.  
In gel peptidase assay 
Protein extracts preparation and electrophoresis was carried out as described for native gel 
with a few differences. Lysis buffer was prepared without protease and phosphatase 
inhibitors. For this assay 90 µg protein was resolved on gels. Gels were placed in a clean 
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tray containing 20 mL of buffer A (50 mM Tris-HCL pH 7.5, 150 mM NaCl, 5mM MgCl2, 
10% glycerol). Following a short rinse, buffer A was decanted and replaced with 20mL of 
developing buffer (50 mM Tris-HCL pH 7.5, 150 mM NaCl, 5mM MgCl2, 5mM ATP 
added fresh, 200 µM Suc-LLVY-AMC added fresh). For the preparation of 10mM Suv-
LLVY-AMC (Becham) 10 mg of the compound were dissolved in 1.3 mL DMSO and 
stored at -20°C. Gels were incubated for 45 min in 37°C incubator with slow agitation (~30 
RPM). For imaging gels was were placed on a UV illuminator and pictures were taken with 
an iPhone7. For 20S visualization gels were placed back in the tray containing developing 
buffer supplemented with 0.02% SDS and incubated at 37°C as before. Following 
incubation, gels were visualized as before on a UV illuminator. 
Immunoprecipitation 
Dissected muscle tissue from 30 larvae of each genotypes were lysed in native lysis buffer 
(Hepes 20mM (pH 7.4), 5 mM MgCl2, 150 mM NaCl, 0.2% NP40, 10% glycerol, 2 mM 
ATP (added fresh), protease and phosphatase inhibitors (added fresh)) and homogenized 
using a pellet pestle motor (Kontes) on ice. Samples were left on ice for 30 minutes with 
homogenization taking place every 10 min. Protein extracts were spun at 14,000 rpm for 
15 minutes at 4°C and the supernatant was moved to a fresh tube. GFP-TrapA beads 
(ChromoTek) were washed with 500 µl of wash buffer (10mM Tris-HCL pH7.5, 150 mM 
NaCl, 0.5 mM EDTA) and spun down for 2 min at 2500 g, wash and spin steps were 
repeated three times. Equal amounts of protein extracts were mixed with 20 µl washed 
beads per reaction. Of each reaction 20 µl was left aside for total protein control. For 
immunoprecipitation samples were rotated for 2 hours in 4°C. Afterwards samples were 
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washed with 200 µl lysis buffer and spun down for 2 min at 2500g, wash and spin steps 
were repeated three times. Elution was carried with 50 µl of 0.2M glycine pH 2.5 and 
neutralized after 30 seconds of vortex with 5 µl 1M Tris pH 10.4.  
Silver stain 
Purified proteasomes obtained by immunoprecipitations were mixed with SDS loading 
buffer and resolved on 4-20% Mini-PROTEAN TGX precast protein gel. Electrophoresis 
was carried for 2.5 hours at 100V voltage. Gel was placed in a clean tray and assay was 
carried as specified by the protocol of Thermo ScientificTM PierceTM Silver Stain kit. 
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4. a1 role as general proteasome regulator: function in
physiologic stress 
4.1 Summary 
This chapter summarizes supplementary information regarding the contribution of 
a1 knockdown in coping with two models of physiologic stress. First I used an in vivo 
assay of oxidative stress to show that a1 knockdown can attenuate oxidative stress, 
furthermore this attenuation was dependent on Ecm29. A second model that I used was of 
dietary restriction (DR). Muscle wasting plays a beneficial role in response to nutrient 
deprivation by funneling amino acids to sustain vital organs of the organism. At chronic 
DR stress, wild-type larvae experienced severe growth retardation which was suppressed 
by a1 knockdown. The data suggested that despite some moderate disassembly, 
suppression of stress is more likely to originate from a general response to nutrient 
deprivation such as autophagy. The last section describes a brief analysis of the PI31-
tankyrase network in muscle function. 
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4.2 Results 
4.2.1 Muscle atrophy progress with oxidative stress 
In previous chapters I described how a1 knockdown relieved DTS5 dependent 
proteotoxic stress. Whereas DTS5 is a useful system to study proteasome regulation it is 
still a mutant that does not occur in nature. To investigate a1 role in proteasome regulation 
at physiological stress models, I studied oxidative stress and caloric starvation, both 
described previously to promote muscle atrophy.  
Oxidative stress has been implicated in aging and many human diseases, notably in 
neurodegenerative disorders (Aiken et al., 2011; Finkel and Holbrook, 2000; Page et al., 
2010; Smith et al., 1991). The reactive oxygen species that are generated by aerobic 
metabolism and environmental stressors can chemically modify proteins and alter their 
biological functions (Boveris, 1984; Chou et al., 2010; Leach et al., 2001; Turrens and 
Boveris, 1980; Watanabe et al., 2003). Cells have developed various mechanisms to 
remove oxidized proteins or restore their functions. If oxidized proteins are allowed to 
accumulate they may become cytotoxic to cells. Cell homeostasis and viability are 
therefore dependent on the removal of oxidized damaged proteins. Although there is 
evidence to suggest that chaperone-mediated autophagy is activated during oxidative stress 
response (Kiffin et al., 2004); numerous studies have demonstrated that the proteasome 
plays a pivotal role in the selective recognition and degradation of oxidized proteins 
(Breusing and Grune, 2008; Davies, 2001; Goldberg, 2003; Jung and Grune, 2008).  
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Several reports signify reactive oxygen species (ROS) production role in muscle 
atrophy, both in insects and in mammals (Davis et al., 1993; Dodd et al., 2010; Jang and 
Van Remmen, 2011; Muller et al., 2006). Since there is no way to control for larvae feeding 
behavior I developed my own protocol to study oxidative stress in muscles in vivo. Muscle 
tissue is still viable in situ and can be manipulated for in vivo assays. Muscles were 
incubated with hydrogen peroxide (H2O2) followed by wash and incubation steps to allow 
for ROS accumulation. ROS production was measured with a commercial kit based on a 
fluoregenic dye, flouresence intensity correlates with ROS prevalence. As seen in figure 
4.1A level of ROS production was dose-dependent with H2O2. As before Phalloidin (actin 
marker) was used to assess damage to sarcomeric pattern in order to observe muscle 
atrophy. Loss of sarcomeric pattern worsened progressively with increase in oxidative 
stress. At 50 µM H2O2 muscles still presented normal architecture but by 100 µM H2O2
muscle width was reduced by 3.3, fold on average (n=12). 150 µM was too damaging for 
muscles and tissues were completely disintegrated and could not be used for analysis, 
hence all future assays were carried with 100 µm H2O2. To confirm oxidative stress, I also 
stained muscles with a red-mitotracker. Mitochondrial fission is a common consequence 
of oxidative stress (Lee et al., 2012a) and therefore can serve to measure it. Tracking 
mitochondrial fission confirmed these observations. Fission worsened progressively with 
increase in H2O2 concentration, 100 µm was sufficient to produce significant fission. 
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Figure 4.1 Atrophy progressed with increased oxidative stress. A. Muscles of early third wild-
type larvae with no pretreatment were incubated in situ with increasing dosage of hydrogen 
peroxide (H2O2). The green channel shows the fluorogenic dye reactive with ROS, signal intensity 
depends on ROS prevalence. Phalloidin (red) depicts sarcomeric pattern (actin fibers)..B. Muscles 
treated as in panel A were stained with red mitochondrial tracker. Mitochondrial fission progressed 
with severity of oxidative stress. 
116 
4.2.2 Muscles expressing a1 RNAi are more resistant to 
oxidative stress 
a1 role in muscle atrophy was further investigated and generalized using the 
oxidative stress model. I first asked how does a1 reduction effect ROS production when 
muscles are exposed to acute H2O2 stress. For this purpose, I used the same method describe 
in the previous section. As a1 reduction helped in salvaging muscles expressing DTS5, so 
it also helped in recovery of muscles from oxidative stress. Untreated muscles displayed 
very base levels of ROS, as depicted by ROS marker, whether they had normal or reduced 
levels of a1 protein. However, when treated with 100 µM H2O2 wild-type muscles 
displayed enhanced accumulation of ROS, 3.7-fold, whereas muscles derived from a1-
RNAi no significant accumulation was detected (Figure 4.2A). It is possible that a1 RNAi 
completely halted production or it expedited their removal once formed. Plotting time 
course of ROS production over different time points may address this open question. 
I next investigated proteasome action in response to oxidative stress by observing 
accumulation of poly-ubiquitinated proteins (Figure 4.2B). Unsurprisingly a1-RNAi 
muscles had higher levels of FK2 staining when no oxidative stress was applied. a1 RNAi 
function in base levels of proteotoxic stress was already discussed in Chapter 3. On the 
other hand, under acute oxidative stress, poly-ubiquitinated proteins were significantly 
accumulated in wild-type muscles whereas in muscles of a1-RNAi background levels 
remained at levels comparable to un-treated muscles. This observation implies that 
proteasome activity was disrupted in response to oxidative stress  
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Figure 4.2 Reduced a1 levels facilitate oxidative stress response. A. In situ muscles from 
indicated genotype were treated with H2O2 and analyzed for ROS production with DCFDA marker 
(green) as described in section 4.3.1. Phalloidin (red) and DAPI (blue) were used to delineate 
muscles. A’. Quantification of ROS marker signals normalized to counterstained DAPI signals. 
Bars represent mean values (relative to the ROS signal in non-treated wild-type tissue) from 2 
independent experiments, 8 larvae in total. B. Muscles prepared as in A were immunostained with 
FK2 (green) to observe accumulation of poly-ubiquitinated proteins. Phalloidin (magenta) and 
DAPI (blue) were used to delineate muscles. Scale bar 50 µm. 
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4.2.3 a1 knockdown relief of oxidative stress is Ecm29 
dependent 
Ecm29 is thought to strengthen the tethering between 20S CP and 19S RP. 
However, Wang and colleagues showed that acute H2O2 stress promoted RP-CP 
dissociation because of Ecm29-dependent disassembly of the 26S proteasome complex 
(Wang et al., 2010b). Ecm29-dependent proteasome dissociation was important for 
recovery following oxidative stress, suggesting that Ecm29 may have multiple functions 
in controlling 26S proteasome structure. Haratake and colleagues studied KIAA0368, 
Ecm29 mammalian orthologue, role in oxidative stress - to date the only physiological 
study of Ecm29 in mammals (Haratake et al., 2016).  KIAA0368-deficient mice were more 
resistant to oxidative stress as opposed to DEcm29 yeast. Unexpectedly, resistance was 
accounted to by increased stability of 26S and efficient degradation of damaged proteins. 
They suggested that Ecm29 absence might have been compensated by Psme4, the 
mammalian orthologue of PA200. Both studies highlight Ecm29 as a key regulator of 26S 
proteasome structure in response to H2O2 stress, though they disagree on its functional 
mechanism.   
As opposed to knockdown in a wild-type strain (Figure 4.2A) when a1 RNAi was 
introduced into Ecm29MI0482, Ecm29 hypomorphic mutant strain, ROS prevalence was 
enhanced following acute oxidative stress by 2.9-fold (Figure 4.3A lower panel). Likewise, 
high levels of Ecm29 were needed for a1 knockdown to prevent subsequent accumulation 
of poly-ubiquitinated proteins, indicative of impaired proteasome activity (Figure 4.3B 
lower panel). Diminished Ecm29 levels did not alter oxidative strain response compared to 
wild-type muscles, and displayed enhanced accumulation of both ROS and poly-
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ubiquitinated proteins under acute oxidative stress (Figure 4.3A-B upper panel). In 
conclusion a1 knockdown was dependent on Ecm29 to alleviate acute oxidative stress. 
Though Ecm29 was critical to mitigate acute oxidative stress as shown for DTS5-
dependent proteotoxic stress, it still remains to be determined whether it does so through 
promoting RP-CP association as described in Chapter 3 or through other mechanisms of 
action.  
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Figure 4.3 Ecm29 role in a1 knockdown mediated oxidative stress response. A. In situ muscles 
from indicated genotype were treated with H2O2 and analyzed for ROS production with DCFDA 
marker (green) as described in section 4.3.1. Phalloidin (red) and DAPI (blue) were used to 
delineate muscles. A’. Quantification of ROS marker signals normalized to counterstained DAPI 
signals. Bars represent mean values (relative to the ROS signal in non-treated wild-type tissue) 
from 2 independent experiments, 8 larvae in total. B. Muscles as in A were immunostained with 
FK2 (green) to observe accumulation of poly-ubiquitinated proteins. Phalloidin (magenta) and 
DAPI (blue) were used to delineate muscles. Scale bar 50 µm. 
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4.2.4 Dietary restriction reduced size is suppressed by a1 
knockdown 
Skeletal muscle serves two essential functions, a contractile function for 
locomotion/maintenance of posture and a metabolic function as the protein reservoir of the 
body. Upon fasting, body homeostasis is maintained through muscle protein degradation 
though it comes at a cost of loss of muscle mass. Muscle atrophy provides amino acids as 
building blocks for new protein synthesis in the body vital organs (Bilodeau et al., 2016). 
The UPS is the main driving force of muscle atrophy upon fasting and caloric restriction 
(Medina et al., 1991; 1995; Wing and Goldberg, 1993). 
Food can be a scarce resource; therefore, organisms have developed various 
strategies to cope with acute periods of absent or limited food supply. Dietary restriction 
(DR) in Drosophila usually involves reduction of the yeast and sugar components of the 
diet (Partridge et al., 2005), and yeast appeared to account for the majority of the DR effect 
on life span (Chippindale et al., 2011; Mair et al., 2005). Dietary restriction conditions were 
achieved by limiting yeast, the protein resource , food was prepared with 0.25% compared 
to 3% yeast in control food (CF) yeast (Bass et al., 2007). Initial experiments were also 
compared to dietary restriction food devoid of sugar source however these conditions were 
found to be too stringent. Additionally, each intervention could operate through different 
molecular pathways thus complicating interpretations. In previous chapters, egg laying was 
carried on apple plates, yet transfer from apple plates to DR or CF constitutes nutritional 
downshift which might obscure results, thus plates with control yeast food were prepared 
for this assay. Larvae were raised on yeast plates for 72 hours; early third instar larvae were 
subsequently seeded in DR versus CF vials, that were supplemented with RU-486. Ensuing 
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growth was carried out in 25°C till eclosion. Changes in growth were observed only after 
48 hours of feeding on DR food, whereas at 24 hours there was still no comparable 
difference in larvae size (Figure 4.4 A-B). Organisms developed a multi stress response to 
nutritional deprivation, differing from acute to chronic deprivation. Distinction between 
these time points is in line with previous analysis of rodents response to starvation (Kee et 
al., 2003; Mizushima et al., 2004). Most striking was that after 48 hours of DR wild-type 
larvae were reduced in size compared to a1 RNAi transgenic larvae. Both genotypes 
showed loss in mass after 48 hours of DR, however there was no significant disparity in 
their average weight in comparison to each other (Figure 4.4 C). Larvae of a1 RNAi 
genotype displayed slightly higher eclosion levels, which could suggest better adaptation 
to DR conditions, however it was not statistically significant (Figure 4.4D). Loss in size 
could be from reduced intake of food. To monitor food intake, I supplemented food with 
bromophenol blue dye so it can be observed in the larvae gut. Wild-type larvae were still 
consuming food by the appearance of dyed food in their gut but at lower levels, therefore 
reduced intake cannot be completely excluded. It is possible that food intake was 
diminished due to reduced contractile force of muscles effecting also muscles involved in 
digestion. Adult flies commonly do grow on DR food, but it stands reason that interfering 
with protein balance during the early stage of development would be more detrimental to 
larval growth. 
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Figure 4.4 a1 knockdown suppressed size loss due to DR. A-B. Larvae were age-matched and 
grown on yeast plates for 72 hours, then seeded on vials containing DR and CF supplemented with 
RU-486 and were left to propagate at 25°C. At 48 hours of DR wild-type larvae shrunk in size 
compared to a1-RNAi expressing larvae. B. Food was supplemented with bromophenol dye to 
track feeding behavior. At 48 hours of DR wild-type larvae showed reduced intake of food. C. 
Average weight per one larvae, measured over three independent repeats, for each measurement 20 
larvae were taken and measured on analytical measurements. D. Percentage of larvae reaching 
adulthood out of total larvae seed on DR and CF vials, measured over three independent repeats, 
they showed no significant changes. 
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4.2.5 Dietary restriction effects on the proteasome 
In the aim of characterizing proteasome role in response to DR I examined 
proteasome activity and distribution. For activity measurements, I used the in vivo activity 
assay supplemented with in vitro activity assay as described before. Both assays depicted 
disruption in proteasome activity in wild-type musculature after 48 hours of DR. This 
disruption was not observed after 24 hours only, neither in CF environment, suggesting it 
was dependent on chronic stress of nutrient deprivation (Figure 4.5 A-B,E). In comparison, 
a1 knockdown suppressed this disruption and presented suitable activity like in control 
food, independent of food content or incubation time. Both genotypes displayed proper in 
vivo activity in control food independent of incubation time (data not shown).  Moreover, 
significant accumulation of poly-ubiquitinated proteins was observed only in wild-type 
muscles after chronic DR stress, in line with concomitant disruption in proteasome activity. 
Phalloidin staining revealed no damage to cyto-architecture of the muscle in either 
genotypes or conditions, sarcomeric pattern was intact in all analyzed muscles (Figure 4.5 
C and data not shown). If indeed organismal protein balance was maintained by 
redistribution of amino acids from the muscle, it did not elicit destruction of sarcomeric 
proteins and overhaul atrophy of complete muscle. Interestingly, like in the DTS5-
dependent stress (Figure 3.2) changes in distribution of Rpt3 were observed when a1 was 
knocked down (Figure 4.5 D). Localization changes correlated with stress, as Rpt3 
distribution remained primarily nuclear after 24 hours of growth in either DR or CF. Clonal 
analysis of a1 RNAi depicted distinguished Rpt3 staining in cytoplasm compared to wild-
type clones, however it was still primarily nuclear (data not shown).  
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Figure 4.5 DR stress effects correlate with loss in proteasome activity. A-B. In vivo proteasome 
activity of indicated genotypes after acute and chronic stress (24-hours versus 48-hours incubation 
respectively) reveal apparent proteasome inhibition in wild-type flies following DR chronic stress, 
whereas a1 RNAi genotype maintained intact activity. Analysis was carried out as described in 
Figure 2.9, GFP signal persistence at 4-hours post heat shock depicts inhibition of in vivo 
proteasome activity. C. Muscles were dissected and stained for phalloidin (actin), DAPI and poly-
ubiquitinated proteins (FK-2) following 48-hours incubation in DR food. Significant accumulation 
of Poly-ubiquitinated proteins correlated with loss in proteasome activity. D. Rpt3 distribution in 
dissected muscles of indicated genotype following 48-hours incubation in DR food. E. In vitro 
analysis of proteasome activity as described in Figure 2.8. Measurements were normalized to wild-
type after 48-hours incubation in CF and plotted as relative luminescence units. Standard deviation 
measured from three independent repeats. Scale bar 50 µm. 
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To distinguish effects on proteasome biogenesis I examined dissected muscles 
using native gel analysis. DR chronic stress of wild-type levels reduced the 26S/20S ratio. 
This observation indicates disassembly of holoenzymes and increase in the free pool of CP. 
While this ratio remained relatively steady in transgenic larvae of a1 RNAi, still 26S levels 
were not significantly different in wild-type musculature; which makes dis-assembly an 
un-likely basis to reduced proteasome activity. It is more likely to speculate that intact 
proteasomes were inhibited directly, perhaps by an upstream signal. Of special note was 
the mobility shift observed for a1 RNAi genotype. Though not further characterized in this 
model it goes in line with Ecm29 presence as discussed in chapter three.   
One possible mechanism to increase proteasome activity is through induction of 
subunits expression. Western blot analysis specified a puzzling observation in regard to 
this hypothesis. Rpt3 levels remained constant and comparable to CF in both genotypes, 
while a7 was induced in an a1 RNAi genotype. Though the prevalent theory is that 
proteasome subunits are expressed in a stoichiometric fashion, perhaps a7 mediates a 
tightly regulated step in proteasome biogenesis and its induction is enough to drive the 
whole process forward. For example b7 overexpression stimulates 20S assembly by 
overcoming a Ump1 dependent checkpoint (Li et al., 2007). Alternatively, increased levels 
of 20S were enough to confer an advantage under DR conditions. Though 20S is considered 
a latent particle it is still capable of degrading small, partially unfolded substrates. For 
example 20S activity is thought to be advantageous in resolving oxidative stress (Wang et 
al., 2010b).  
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Figure 4.6 DR stress promotes moderate disassembly of 26S holoenzyme. A. To differentiate 
26S/20S ratio, protein extracts (25 µg) of muscle tissue from indicated strains, following 48-hours 
incubation, were resolved on native gels and subjected for a7 immunoblot. B. To differentiate 
subunits induction protein extracts (10 µg) of specified muscles were resolved on SDS-PAGE gels 
and immunoblotted for Rpt3, a7 and tubulin.    
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It is possible that a1 knockdown in the muscle was beneficial to whole body 
homeostasis under DR by expediting proteasome-dependent degradation of muscle 
proteins. Alternatively, a1 knockdown may have activated a response of compensatory 
autophagy. Nutrient deprivation is a potent inducer of autophagy. Deprivation of only 
essential amino acids has been shown to activate autophagy through the mTOR pathway 
(Sancak et al., 2010). In atrophying muscles, both the UPS and autophagy catalyzed the 
degradation of different cellular components. While proteasomes degrade myofibrillar and 
soluble proteins (Goldberg, 1996); organelles (especially mitochondria) are degraded 
primarily in lysosomes (Scott and Klionsky, 1998). Still in both studies muscles were found 
with relatively normal composition, but displayed reduced strength and endurance. It is 
commonly accepted that autophagy is activated as a compensatory mechanism when 
proteasome function is inhibited (Kageyama et al., 2014; Pandey et al., 2007). In addition 
to compensatory mechanisms, nutrient deprivation is a unique catabolic condition that 
simultaneously activates both pathways by a common FoxO3 and mTOR regulation; both 
are negatively regulated by rich food signals (IGF1/Insulin) (Mammucari et al., 2007; Zhao 
et al., 2007). I hypothesize that beneficial adaptation to DR stress was afforded by 
coordinated activation of the UPS and autophagy through common signaling pathways and 
activation of compensatory mechanisms. A compromised 20S complex due to a1 depletion 
may have triggered those pathways and signaling cascades. For in depth analysis of this 
hypothesis, examination of autophagy function is needed, however I did not follow up with 
this line of investigation. 
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4.2.6 Analysis of the PI31-Tankyrase regulatory pathway in 
muscle atrophy 
PI31 is physiologically required for optimal 26S proteasome activity in vivo, and 
inactivation of the corresponding gene in Drosophila causes reduced protein breakdown 
and organismal lethality (Bader et al., 2011). PI31 is regulated by Tankyrase-mediated 
ADP-ribosylation, altering the affinity of PI31 for 20S proteasome α subunits and 19S 
assembly chaperones, thereby stimulating 26S proteasome assembly (Cho-Park and 
Steller, 2013). 
In chapter 2 I carried an RNAi screen of DTS5 induced proteasome inhibition and 
larval paralysis to identify proteasome activators. Overexpression of PI31 was previously 
shown to suppress DTS5 dependent retinal degeneration. I used my muscle atrophy model 
to assay for PI31 function. As expected for a positive regulator of the proteasome, PI31 
overexpression attenuated larval paralysis and suppressed proteasome inhibition (Figure 
4.7 A,C), while muscle wasting and proteasome inhibition persisted when PI31 was 
knocked down. PI31 knockdown was validated with Western blot (Figure 4.7 D). Yet, PI31 
RNAi alone was not enough to elicit muscle atrophy (data not shown). Either minimum 
levels of PI31 are enough to sustain proteasome activity or more likely at physiological 
conditions multiple mechanisms cooperate to sustain proteasome activity. This assay also 
served as positive control to my screen, validating its ability to identify proteasome 
regulators. 
Likewise, Tankyrase knockdown did not promote muscle wasting, but I did not 
observe reduced Tankyrase protein either (figure 4.8 A-B). I next investigated Tankyrase 
significance using a pharmacological approach. For this purpose, I took advantage of 
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XAV939, a small-molecule inhibitor of human Tankyrase (Huang et al., 2009). XAV939 
is a highly specific inhibitor of hTNKS1/2 but is also able to inhibit the auto-ADP-
ribosylation activity of dTNKS, making him a highly specific and effective inhibitor of 
Tankyrase in Drosophila as well (Cho-Park and Steller, 2013; Smith et al., 1998). Together 
with XAV939 I tested IWR1. IWR1 is a potent inhibitor of hTNK which works through a 
disparate mechanism to XAV939. TNK functions by consuming NAD+, IWR1 interferes 
with TNK’s nicotinamide binding site (Narwal et al., 2012). Feeding larvae with XAV939 
resulted in a severe growth impairment, likely from a systemic effect. At the time DMSO 
treated larvae reached pupation, XAV939 fed larvae were still estimated to be the size of a 
third instar larvae and ultimately never reached adulthood (Figure 4.8 C). Their delayed 
growth is likely not due to impaired feeding behavior (figure 4.8D).  IWR1 fed larvae were 
comparable to control. However, discrepancies between XAV939 and IWR1 could stem 
from their pharmacological suitability and indicate differences in digestion and absorption 
rather than a true result.  
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Figure 4.7 PI31 suppressed muscle atrophy. A. MHC-GS driving expression of indicated 
genotype at permissive temperature. Induction of DTS5 together with PI31 overexpression was 
comparable to control with intact muscle function and motility. B. PI31 overexpression suppressed 
accumulation of poly-ubiqitinated proteins and protected muscle architecture. Muscles were 
dissected and stained for FK2 (green) and 20S (magenta) on the left, merged with phalloidin (red) 
on the right. C. In vivo proteasome activity is shown for indicated genotypes. 4 hours after GFP-
Nintra induction signal was lost when PI31 was overexpressed but persisted when PI31 was 
knocked down. Muscles of DTS5;PI31-RNAi transgenic larvae displayed a wasted architecture 
(right panel). D. Western blot analysis of PI31 antibody confirmed knockdown by RNAi.  
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Figure 4.8 Analysis of Tankyrase inhibition. A. transgenic expression of Tankyrase RNAi 
displayed comparable motility to wild-type. B. Western blot analysis of Tankyrase exhibited no 
knockdown by RNAi. C. Equal amounts (50) of wild-type second instar larvae were seeded on 
yeast dry food supplemented with Tankyrase inhibitors, XAV939 and IWR1 (4 µm) or DMSO as 
control. Growth was monitored at 25°C. D. Food was supplemented with blue bromophenol dye to 
track feeding behavior. No discernable disturbance in feeding was observed at 48-hours post 
exposure to drugs.  
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4.3 Materials and Methods 
Fly stocks 
Overexpression line was procured from Dr. Maya Bader (Bader et al., 2011). RNAi lines 
of PI31 and Tankyrase were obtained from the Vienna Drosophila research center. 
In vivo oxidative stress assay 
Muscles were dissected in PBS (130 mM NaCl, 7 mm Na2HPO4, 3 mm NaH2PO4, pH 7.0) 
along their dorsal mid line, taking out body fat and secured flat with insect pins (Fine 
Science Tools) on silgard plates. Dissected muscles were incubated with hydrogen 
peroxide (H2O2) for 1 hour at concentration ranging from 50-150 µM, followed by 3 wash 
steps with PBS 10 min each. Muscles were incubated for 45 min with freshly prepared 
CM-H2DCFDA kit (life technologies) for detection of ROS. Muscles were then transferred 
to Eppendorf tubes, washed three times with PBS.  Following steps of fixation, 
permeabilization and staining were carried out immediately as described for 
immunohistochemistry in chapter 2.  
Dietary restriction 
For dietary restriction assays food was prepared with 0.25% (3 g/L) versus 3% (36 g/L) of 
active dry yeast (Red Star). Food was prepared with: 1.2L H2O, 87.5 g/L cornmeal, 10 g/L 
agar, 83 mL molasses, 8.3 mL 30% tegosept and 0.89 mL propionic acid. Bromphenol dye 
was obtained from Sigma. Instant dry yeast food was procured from Carolina. 
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Immunohistochemistry, Western blot and in vivo proteasome activity assay 
For detailed description refer to chapter 2. 
Native gel 
For detailed description refer to chapter 3. 
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5 Discussion 
5.2 A screen for proteasome modifiers in muscle atrophy 
model 
The work described in this thesis originated in a screen for genes that can suppress 
proteasome inhibition induced by DTS5. DTS5 is a b subunit of the 26S proteasome 
previously shown to dominantly block proteasome function dependent on permissive 
temperature. I employed an inducible transgenic approach with the benefits of in vivo 
analyses, specifically targeting proteasome inhibition only within muscle cells and tight 
temporal control of the period of proteasome inhibition via induction with the 
transcriptional activator RU486. The screen was based on the primary observation that 
DTS5 induction in muscles resulted in a rapid muscle atrophy, signs of atrophy appeared 
as early as 12 hours but severely progressed by 24 hours (Figure 2.3). Muscle wasting was 
evident by a loss of the sarcomeric cyto-architecture, irregular nuclei pattern, aggregates 
of poly-ubiquitinated proteins and autophagic vesicles. Loss of contractile activity was 
scored on apple plates (Figure 2.2). 
5.1.1 Apoptosis involvement in muscle atrophy 
Some studies reported induction of active caspase-3 and apoptotic cell death of 
muscle cultures upon proteasome inhibition (Goldbaum et al., 2006; Lang-Rollin et al., 
2004). In contrast to these studies muscles in my study showed no indication of apoptotic 
cell death. There was no increase in active capase-3 staining or ultrastructural changes in 
nuclear architecture (Figure 2.4). Likewise, there was no decline in nuclei number, only 
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loss in muscle width. This discrepancy is first primarily due to the employment of different 
systems. Past studies that did look for apoptotic observations employed in vitro analysis in 
mammalian cultures, whereas my system is an in vivo one in Drosophila muscles. Greene 
et al. saw that in vivo UPS obstruction in Parkin mutant flies led to apoptotic muscle 
degeneration (Greene et al., 2003). However, Parkin is an E3 ligase therefore its inactivity 
translates first to a ubiquitin stress and not a direct inhibition of the proteasome. Protein 
ubiquitination plays a role in the apoptotic cascade and can explain dissimilar responses. 
As a general rule atrophy does not depict cellular degeneration but rather elimination of 
mass from cell bodies, therefore accordingly should not involve apoptotic response. 
However more detailed analysis is needed, as up to date the vast majority of studies that 
investigated proteasome inhibition in vivo in muscles did not assay for apoptosis role. 
5.1.2 Autophagy involvement in muscle atrophy 
Increased autophagy has been previously reported in other models of proteasome 
inhibition (Pan et al., 2008; Pandey et al., 2007) (Ding et al., 2007; Kitajima et al., 2014). 
This is commonly considered to be a compensatory mechanism, allowing cells to resolve 
protein accumulation left by absence of UPS dependent degradation. Indeed, treatment 
with rapamycin to upregulate autophagy both in mice and in mammalian cell culture, was 
demonstrated to protect against cell death caused by proteasome inhibition (Pan et al., 
2008). In Drosophila as well upregulation of autophagy alleviated retinal degeneration. 
Retinal degeneration was induced by loss of proteasome function due to DTS7 expression 
(Pandey et al., 2007). In accordance with previous observations I also noted mild 
upregulation of autophagosome formation, evident by ATG8 puncta (Figure 2.4). 
140 
However, that response was not enough to prevent muscle atrophy. Interestingly, recently 
it was reported that chronic induction of DTS5 attenuates ATG8 puncta formation in larval 
muscles (Zirin et al., 2015). Autophagy is a double edge sword for the system studied in 
this thesis. On the one end, it can help mitigate proteotoxic stress by filling the gap in 
protein degradation left by UPS inhibition. On the other hand autophagy itself plays an 
active role in propagating muscle wasting (Dobrowolny et al., 2008; Mammucari et al., 
2007; Wang et al., 2005; Zhao et al., 2007). Indeed, when autophagy was incapacitated by 
RNA interference of ATG genes, DTS5 induced muscle atrophy was moderately alleviated 
(Figure 3.5B). 
Impaired autophagy is known to induce skeletal myofiber degeneration and muscle 
weakness (Masiero et al., 2009; Raben et al., 2010). Similar alterations in muscle 
architecture were found in an Rpt3-/- mice as in an Atg7-/- mice, but the extent of muscle 
wasting or failure in muscle development was apparently more severe in the Rpt3-/- mice 
(Kitajima et al., 2014; Masiero et al., 2009). Moreover, shortened life expectancy was 
observed only for Rpt3-/- mice.  This data suggest that the UPS pathway is far more 
important in maintaining muscle homeostasis and function, alternatively ATG7 loss is 
compensated by other redundant factors. 
5.1.3 Etiology of muscle wasting due to proteasome 
inhibition 
My primary finding that proteasome inhibition promoted muscle wasting stands in 
contrast to the notion that muscle degeneration proceeds through proteasome dependent 
degradation. In agreement, Haas et al. also reported that proteasome function was vital for 
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muscle integrity and function, using DTS5 induction in a similar manner (Haas et al., 
2007). Additionally, supporting my finding is the observation that conditional knockout of 
Rpt3 in muscles of mice resulted in loss of contractile function and muscle wasting. Muscle 
wasting correlated with similar morphological and molecular alterations like the ones I 
observed (Kitajima et al., 2014). 
Studies which reported that pharmacologic inhibition of the proteasome improved 
muscle wasting mostly used MG-132 (Bailey et al., 1996; Carmignac et al., 2011; Tawa et 
al., 1997). Yet, MG-132 administration might have systemic effects independent of 
muscular inhibition of the UPS system. Same goes to every drug, however MG-132 
specifically is known to salvage IkB which inhibits NFkb in inflammatory cells (Lee and 
Goldberg, 1998). It is possible that an attenuated inflammatory response is what protected 
muscles from atrophy in these models. However, this does not explain the apparent 
contradiction as a whole.  
In living cells, polypeptide chains emerging from ribosomes and preexisting 
polypeptide chains face constant threat of mis-folding and aggregation, this threat is 
especially magnified in muscle tissue. Muscles are especially susceptible to such damage 
in comparison to other tissues, due to mechanical and thermal stressors and continuous 
oxidative insults during muscle contraction (Arndt et al., 2010). Mounting evidence 
suggests that protein aggregation is often part of the cellular response to an imbalanced 
protein homeostasis. Abnormal protein accumulation and/or mis-folded protein 
aggregation generates multifactorial toxic effects in cells (Chhangani et al., 2012; Olzscha 
et al., 2011; Taylor et al., 2002). Protein aggregates are often associated with the 
perturbation of protein degradation in many physiological processes and various human 
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pathologies, especially neurodegeneration diseases (Chai et al., 2002; Dobson, 1999; 
Martin, 1999; Nucifora, 2001; Steffan et al., 2000). Preventing the accumulation of 
aggregation-prone proteins is the first and most effective intervention point to control 
protein aggregation. Cells of all kingdoms of life have evolved an elaborate protein quality-
control system to prevent such toxic aggregates. This cellular response is termed unfolding 
protein response (UPR) and it involves various strategies. The UPR involves foremost 
chaperones to facilitate correct protein folding or target them for proteolytic degradation 
by either the UPS or autophagy, thereby preventing protein aggregation (Ellgaard and 
Helenius, 2003; Goldberg, 2003; Hartl and Hayer-Hartl, 2009; Rubinsztein, 2006). Many 
intracellular cytosolic misfolded and aggregated proteins are targeted and degraded by UPS 
(Reinstein and Ciechanover, 2006). Decreased proteasome activity seems to be a feature 
of many cellular models and proteinopathic diseases in which intracellular aggregates are 
formed (Bedford et al., 2008; McNaught et al., 2003; Seo et al., 2004). The progressive 
appearance of autophagocytic vacuoles, and more decisively the progressive accumulation 
of poly-ubiquitinated proteins in punctate aggregates, suggest that proteasome inhibition 
in the musculature triggered a UPR that may stand as the mechanistic cause for the rapid 
muscle wasting. Such mechanism might also explain age-related decline in muscle 
strength. Demontis and Perrimon found that increasing FOXO signaling in muscles can 
prevent muscle wasting in aged flies and increase life span (Demontis and Perrimon, 2010). 
Accumulation of poly-ubiquitinated proteins in aggregates is a hallmark feature of aging 
muscles. FOXO signaling reduced protein aggregation and preserved muscle function, 
through elevated activation of the autophagy system. These results present a similar 
contradiction as autophagy like the UPS has been identified in propagating muscle atrophy. 
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The observation that muscle aging is characterized by loss of proteostasis further suggests 
some similarity between muscle aging and neurodegenerative diseases. 
In addition to toxicity of protein aggregates, proteasome inhibition may cause 
deficiency in metabolic resources.  Protein degradation by the ubiquitin proteasome 
systems might provide resources, such as oligopeptides and amino acids, for maintaining 
cellular integrity in skeletal muscle tissue (Bonaldo and Sandri, 2013). Therefore, 
proteasome inhibition might have resulted in deprivation of resources needed for cellular 
maintenance. However, I would assume muscles have enough resources to sustain them in 
the time frame of my experiments. In conclusion, chronic inhibition of the UPS may have 
resulted in atrophy and impaired muscle function, since this pathway plays a critical role 
in cell homeostasis through the removal of protein aggregates. Therefore, the key is in 
balanced protein homeostasis, with both excessive catabolism and insufficient proteasome 
activity leading to muscle atrophy. 
5.3 a1 knockdown aids proteasome stability through Ecm29 
chaperone recruitment 
The screen I carried resulted in the identification of various possible modifiers of 
proteasome activity, amongst them most surprising was the identification of proteasome 
subunit a1 in this process. This subunit is a core subunit of the 20S catalytic particle, and 
therefore one would expect for its depletion to exacerbate proteasome inhibition rather 
that alleviate it. Further characterization demonstrated a functional significance to the 
recruitment of CG8588, the Drosophila orthologue of Ecm29, in relieving proteasome 
inhibition and preventing muscle wasting. These findings highlight a quality control 
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response to compromised proteasome assembly through the enlistment of alternative 
proteasome interacting protein. This study demonstrates the significance of controlled 
proteasome assembly for muscle function and adaptation to proteotoxic stress. 
5.3.1 DTS5 disrupts proteasome stability 
DTS5 and DTS7 are widely used to study the UPS due to their dominant 
temperature-sensitive nature making them useful for manipulating proteasome function in 
vivo. These mutants encode abnormal β6 and β2 subunits that incorporate into proteasome 
particles and interfere with their function (Saville and Belote, 1993; Schweisguth, 1999; 
Smyth and Belote, 1999). Due to their excessive expression and the structure of the 20S 
proteasome these mutants act as ‘poison subunits’ in a dominant manner (Herskowitz, 
1987). According to this model when an abnormal protein is part of a multimeric complex, 
as the 20S is, its integration can poison and disrupt the function of the entire structure. This 
hypothesis explains how DTS mutants work in a dominant fashion to disrupt proteasome 
function. However, the exact mechanism by which these abnormal subunits are interfering 
with proteasome activity is not known. In DTS7 a highly-conserved glycine is replaced by 
an arginine and in DTS5 there is a threonine to isoleucine substitution. High resolution 
structural analysis of both bovine and yeast 26S proteasomes showed extensive interactions 
between β2 and β6 (Groll et al., 1997; Huber and Groll, 2016). The b2 mutation might have 
a direct effect on its catalytic function, since the amino acid substitution is only 3.0 Å from 
the amino group of its active site threonine (Smyth and Belote, 1999). Though b6 is not a 
catalytic subunit, the location of its substitution might sterically interfere with b2 catalytic 
activity. Alternatively, each mutant is altered near the β2-β6 interfacing regions, in areas 
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critical for stabilizing the interaction between the β2 and β6 subunits on opposing rings. 
This hindrance might result in a conformational shift destabilizing the 26S structure. I 
expect this shift to occur more readily at elevated temperatures, thus explaining the 
temperature sensitivity of these mutants. Examining proteasome activity is not enough to 
differentiate between these two hypotheses. For this goal, I performed native gel analysis 
which can differentiate distribution of the different particles that make up the holocomplex. 
DTS5 led to a reduction in 26S to 20S ratio and increased presence of free RP (Figure 3.6). 
This observation signifies DTS5 role in proteasome assembly, providing a mechanistic 
functional explanation for the first time as to how DTS mutants disturb proteasome 
function. Still the question remains whether this mechanism favors disassembly or prevents 
assembly. I have begun a more in depth analysis, which could shed light on this missing 
link. For this purpose, I am using a gel filtration system (fast protein liquid chromatography 
[FPLC]) to purify specific particles in combination with native gels. Purified 26S will be 
incubated for different times at permissive temperature and analyzed for their dynamic 
disassembly.  
5.3.2 Compromised 20S proteasome assembly mitigates 
proteotoxic stress 
Knocking down a1 reversed the diminution in 20S/26S ratio caused by DTS5 
expression, in favor of 26S over 20S (Figure 3.6). Suggesting that relief of larval paralysis 
and proteasome inhibition was a derivative of an increase in protein assembly and 
stability. Though the identification of a1 involvement in this system was unexpected, it 
does have a precedent (Gerlinger et al., 1997). crl3-2 (cyclohexamide resistance) is an 
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Rpt6 mutant exhibiting growth defects and accumulation of poly-ubiquitinated proteins, 
indicating reduced proteasome activity. Double mutant of crl3-2 and SCL1-1, a1 mutant, 
displayed reduced accumulation of poly-ubiquitinated proteins at 30°C and was viable at 
37°C, compared to crl3-2 mutant alone. Cloning of the SCL1–1 mutant allele showed that 
the suppressor mutation is due to an exchange of tyrosine 30 against cysteine. Tyr 30 is 
located at an N-terminal H0-helix domain and is entirely conserved in all 20S proteasome 
α-type subunits known so far. In addition, all cloned crl mutations reside in different types 
of 19S cap as well as 20S core subunits. Leading to the assumption that these mutations 
do not impair a specific function of the proteasome but cause a general defect in 
proteasomal protein degradation.  
An earlier study showed that compromising 19S proteasome complex can protect 
cells against proteotoxic stress incurred by the proteasome inhibitors MG-132 or 
Bortezomib (Tsvetkov et al., 2015). Under toxic levels of inhibition, most intriguingly 
suppressing individual components of the 19S regulatory complex increased cell survival. 
In light of these observations I also found that all a ring subunits except a6 were 
successful at rescuing larval paralysis (Figure 3.4). Supporting the notion that a1 role 
might not be exclusive but rather part of a general stress adaptation mechanism enlisted 
when compromising the 20S complex. Additional mechanisms that may contribute 
include the induction of autophagy, induction of alternative proteasome regulatory 
components, or the disruption of normal gating. Preliminary observations hint that 
compensatory autophagy or subunits up regulation can be excluded (Figure 3.5).  
Depiction of other a subunits capability to rescue paralysis suggests some general 
adaptation, nonetheless it still cannot be assumed that all subunits compensate for 
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proteasome inhibition in a similar manner. In fact, despite attenuation of larval paralysis, 
knockdown of all the remaining subunits did not restore in vivo proteasome activity or 
presented localization changes, with the exception of a2 knockdown (Supplementary 
figure 5.1). Although, general features of the structure and function of the proteasome are 
known, the exact roles of each of the individual subunits are less well understood. From 
structure analysis we do know they likely play different roles in gate closing as they do 
not contribute equally to this mechanism, with N-terminal tails of α2, α3, and α4 and an 
internal loop of α5 sealing the 20S chamber (Groll et al., 2000; Unno et al., 2002). It is 
possible they have specific functions in facilitating 19S assembly and binding of different 
activators. Previous studies have suggested that Rpt ring assembly in yeast is guided, in 
part, by pre-existing α-rings (Kusmierczyk et al., 2008; Park et al., 2009; 2010; Roelofs 
et al., 2009). To date, only core particle α3 has been implicated in Rpt ring assembly 
(Kusmierczyk et al., 2008), but a thorough analysis of all subunits is still missing.  
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Figure 5.1 a subunits role in proteasome activity and localization. A. Transgenic larvae 
expressing DTS5 and indicated RNAi were analyzed for in vivo proteasome activity. GFP signal 
persisted past 4 hours indicating proteasome inhibition. B. Muscles were dissected, fixed and 
stained for Phalloidin, DAPI and Rpt3. All but a2 were found in normal nuclear localization, a2 
displayed differential localization similarly to a1 knockdown. 
149 
The question that still remains is if and how proteasomes lacking a1 are formed. 
From the native gels analysis, it can be deduced that novel alternative forms of 
holocomplexes are formed when a1levels are minimal (Figure 3.6). Velichutina and 
colleagues showed in yeasts that in the absence of the chaperone dimer pba-3-pba4 or a3 
subunit, alternative proteasomes can be created with a4 as a substituting for a3 
(Velichutina et al., 2004). These proteasomes had an advantage under specific stresses 
such as high metal and oxidative stress (Kusmierczyk et al., 2008), hence I suggest these 
novel forms act as a safety net under stress. Though assembly of these proteasomes might 
be slower and less efficient, if proteotoxic stress is already present an increase in net 
assembly of proteasomes will be advantageous. Preliminary examination of proteasome 
composition using silver stain suggests altered subunit composition (Figure 3.10), 
nevertheless additional investigation of these bands using mass-spectrometric analysis is 
necessary. 
5.2.3 a1-RNAi induces recruitment of Ecm29 to promote RP-
CP association 
Interestingly, proteasomes from a1-RNAi flies also exhibited reduced 
electrophoretic mobility in native gels, observed in both RP-CP and RP2-CP forms (Figure 
3.6). Simple substitution of subunits cannot account for the magnitude of this shift as they 
are roughly the same size. I suggest this shift is due to a major structural difference, 
conferred by the binding of an exterior proteasome regulator. I focused my attention first 
on Ecm29, because Ecm29 is a large protein described to interact with both RP and CP 
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and to contribute to proteasome stability. In agreement with its function as a quality 
control chaperone of proteasomes, both yeast and mice (KIAA00368) can grow normal in 
its absence, but are sensitized to proteotoxic stress (Haratake et al., 2016; Lee et al., 2011; 
Lehmann et al., 2010; Park et al., 2011). Genetic analysis determined that larval paralysis 
and accumulation of poly-ubiquitinated proteins in the Ecm29 mutant correlates with 
modifications of the proteasome in biochemical assays. Moreover, suppression of 
proteasome inhibition by a1 RNAi was dependent on Ecm29 (Figure 3.8-3.9). Transgenic 
flies of a1 RNAi did not suffer from gross phenotypical stress nor were they more 
sensitive to proteotoxic stress, on the contrary they were more resistant, advocating the 
enlistment of a quality control pathway. 
The relevant question is obviously how Ecm29 may contribute to the functional 
assembly of the proteasome. Since Ecm29 was important for the stability of aberrant 
proteasomes in comparison to wild-type, these findings suggest that Ecm29 is a 
proteasome chaperone when proteasome assembly is at risk. Interactions between Ecm29 
and proteasome intermediates might contribute to dynamic alterations of proteasome 
composition or assembly. Upon a1 knockdown CP fell below the detection limit, and the 
predominant holoenzymes were the RP2-CP species. Remarkably, there were also more 
RP assembly intermediates (Figure 3.6B). Together these observations suggest that a CP 
assembly defect do follow a1 exhaustion. Accumulation of RP intermediates fit with the 
model that RP assembly is dependent on the CP as template. I propose that Ecm29 
compensate for deficiencies in CP assembly and acts at the juncture of CP maturation and 
RP-CP assembly (Figure 5.2).  
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Figure 5.2 A model for balanced proteasome assembly. A. Homeostatic balance between 
holocomplexes and free 19S and 20S pools. Balance is dynamic based on cell needs at a given 
environment and developmental stage. B. Balance in favor of free RP and CP: DTS5 complexes 
are less stable and in the restrictive temperature disassembly over comes assembly. C. a1 
knockdown presents an affinity switch, which recruits Ecm29, so that assembly defects are 
counteracted by increased stability of the holocomplex. The cost to increased assembly could be 
in reduced dynamic flexibility of the holocomplex. Loss in dynamic assembly-disassembly could 
sensitize this strain to various proteasome mutants and stress conditions but has the advantage 
when disassembly is favored. 
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Currently there is no molecular insight into how Ecm29 is regulated and how it 
recognizes defective proteasomes, yet mounting evidence suggest that it does show 
preference to such proteasomes. The prevailing model suggests that Ecm29 is selectively 
enriched on structurally aberrant holoenzymes due to increased affinity. Other proposed 
models are first Rpn4 dependent induction of Ecm29. Though Ecm29 does have a PACE 
element, when its promoter was replaced with a synthetic one it was still enriched on 
aberrant proteasomes (Lee et al., 2011). A second alternative model suggests that Ecm29 
is a proteasome substrate, and as such would be stabilized when proteasome is inhibited, 
however Ecm29 was found to be a stable protein (Park et al., 2011).  
Though minor induction in Ecm29 levels was apparent (Figure 3.7), it is highly 
unlikely to be enough to account for the massive recruitment observed in Figure 3.9. I 
envision two ways by which proteasomes from a1-RNAi transgenic flies would attract 
Ecm29. Ecm29 could specifically recognize conformations in either alternative assembly 
of CP or RP, or it might be able to recognize a specific signal at some integration point at 
the RP-CP interface. If Ecm29 were to recognize some misalignment between CP and RP, 
it would have the potential to be able to “sense” a variety of faulty proteasomes, even if 
the cause is from a different origin. Because Ecm29 has been reported to bind to the CP 
as well as the RP, one can imagine that subtle changes affecting the relative position of 
the two binding sites might function as a sensor of improper RP-CP alignment. As Rpt 
tails dock in pockets formed between a-subunits, substitution of a subunits might account 
for such mis-alignment. Additionally, alteration of the a subunits ring could manifest 
itself in different allosteric hindrances that might affect the proteasome affinity to 
chaperone. In support of this model Yashiroda and colleagues showed that deletion of 
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both Fub1 (PI31 yeast orthologue) and the 20S chaperone Pba4 is lethal (Yashiroda et al., 
2015). This lethality is suppressed by deletion of a7 N-terminus. Crystal structures reveal 
that while in wild-type a7 N terminal region protrudes from the molecular surface of the 
a ring, when this region is deleted a1 N terminus protrudes instead. 
Alternatively, since a1 is in short supply it could stall 20S assembly such that 
proteasome maturation is delayed. Lehmann et al. found that Ecm29 was enriched on 
proteasomes missing b3, moreover these proteasomes were abnormal in their immaturity, 
containing un-process b5 (Lehmann et al., 2010). In accordance Kusmierczyk et al. 
suggested that the arecheal chaperones PbaA-PbaB recognize immature 20S particles due 
to the presence of b subunits pro-peptides, implying their binding is regulated 
allosterically by changes that are initiated at distant sites (Kusmierczyk et al., 2011). 
Intuition suggests that active sites buried inside the CP should not be able to modify events 
occurring on the surface of the proteasome. Yet it was shown that that proteasome 
inhibitors can stabilize proteasomes by engagement of the proteolytic sites, suggesting 
some form of retrograde communication from the CP to the RP (Kleijnen et al., 2007). 
Since I observed robust hydrolytic activity of Ecm29-bound proteasomes (Figure 3.9) it 
seems unlikely that defects in active sites cause the recruitment of Ecm29. However, it is 
still possible that reduced levels of a CP subunit lead to immature species recognized by 
Ecm29. Incorporation of immature CP species into holoenzyme might reflect a relaxation 
in a checkpoint which prevents premature incorporation. The β6 subunit has a 19-residue 
N-terminal extension that is expected to be in close proximity to β7 before β6 processing 
in the precursor half proteasome (Groll et al., 1999). The β5 pro-peptide, the β6 N-terminal 
extension, and the β7 tail are key appendages in guiding assembly of the 20S (Li et al., 
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2007). Especially intriguing is that the DTS5 mutation is located right adjacent to b6 NTE, 
and could possibly effect its interactions. Ump1 and the b5 pro-peptide have opposing 
functions in the joining and assembly of half-proteasome particles, with b5 pro-peptide 
driving it and Ump1 inhibiting stable dimerization until the rate-limiting insertion of the 
β7 subunit is completed. b5Dpro lethality is suppressed by deletion of the b6 NTE, 
suggesting b6 NTE collaborate with Ump1 in this assembly checkpoint. By passing the 
Ump1 checkpoint, perhaps due to the DTS5 mutation, could result in premature 
dimerization and immature proteasomes. This hypothesis can be tested with genetic 
analysis of mutants and assay proteasome maturity by observing b subunits processing. 
5.2.4. Atrophy salvage by a1 knockdown correlates with 
altered localization of proteasomes 
A striking feature of a1 knockdown effects under stress was re-distribution 
of proteasomes from primarily nuclear localization to the cytoplasm, both under 
DTS5 induced stress and DR related stress (section 3.3.2 and figure 4.5 D).  
Proteasomes cytosolic localization was primarily in peri-nuclear region known for 
the endoplasmic reticulum (ER) compartment which exhibits high level of 
ubiquitin-dependent proteolysis. It has long been established that this region is 
enriched in proteasomes especially when cells synthesize large amounts of 
abnormal proteins or when proteasomes are inhibited. This localization is 
presentation of the UPS function in mediating the ERAD (endoplasmic reticulum 
associated degradation), a critical pathway in the UPR for protein quality control 
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that clears un-folded and mis-folded proteins (Hampton, 2002; Kostova and Wolf, 
2003; McCracken and Brodsky, 2003). The ERAD response involves retro-
translocation of misfolded proteins from the ER back into the cytosol, where they 
are degraded by proteasomes. Interestingly, Ecm29 was also found localized in this 
area (Gorbea et al., 2004). Additionally, Ecm29 sequence is composed of domains 
which are characteristic of many other established adaptor proteins including 
HEAT repeats, VHS domain and potential clathrin-interacting domains 
(Bonifacino and Traub, 2003; Kajava et al., 2004; Lohi et al., 2002). Together with 
evidence linking Ecm29 to proteasomes trafficking (Gorbea et al., 2010; Hsu et al., 
2015), these observations suggest that Ecm29 can function as an adaptor protein 
recruiting proteasomes to compartments of intense degradation thus aiding the 
response to proteotoxic stress. In fact, a role for Ecm29 in the ERAD pathway is 
indicated by overexpression of the protein in mutant CHO cells that exhibit 
increased ERAD activity (Gorbea et al., 2004). This hypothesis could assign a 
mechanistic significance to my data and present a functional role to proteasome 
localization in mitigating proteotoxic stress. However, localization of the 
proteasomes remained perinuclear whether DTS5 and a1-RNAi were expressed in 
a wild-type or mutant Ecm29 genetic background (data not shown). This result 
implies that Ecm29 is not involved in the localization changes in my model or that 
using a heterozygotes background of Ecm29 is not enough of a loss to modify 
localization. Another possible explanation is that re-localization results from 
altering accessibility of the nuclear localization signal of the proteasome as a1 
bears one, though it still does not fully explain the stress context.  
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5.2.5 Summary
Cells have evolved numerous and often overlapping homeostatic pathways to 
adapt to changes in their environment and to survive under adverse conditions. Using a 
genetic screen of DTS5 impaired proteasomes I identified the collaborative mechanism of 
a1 knockdown and Ecm29 in mitigating proteotoxic stress through adaptation in 
proteasome assembly. Whereas much is known of proteasome stress response at the level 
of its expression, very little is known of adaptive responses through alternative assembly. 
My results suggest a new mechanism for proteasome stress adaption through modified 
assembly.  
The most fascinating but puzzling feature of Ecm29 is its function through diverse 
mechanisms and versatile effects on the proteasome, at times even opposing effects. For 
example, its effects on gate opening are sometimes at odds (Kleijnen et al., 2007; Lee et 
al., 2011). Whereas Ecm29 often promotes a strong association between the RP and CP, it 
can also promote their dissociation such as under oxidative stress of the holoenzyme 
(Panasenko and Collart, 2011; Wang et al., 2010b). Likewise, under adverse conditions, 
Ecm29 mutations may either promote or antagonize resistance to stress. Depending on the 
conditions and mutants, Ecm29 can either suppress or enhance proteasome activity and 
resistance to stress. To better understand these conflicting observations, additional studies 
are essential to signify its physiological function at higher organisms. The detailed 
mechanism of action of Ecm29 and how exactly does it stabilize proteasomes are still 
unknown. This gap in knowledge could be addressed by conducting careful Ecm29-
proteasme binding assays to understand the mechanism and stoichiometry of this 
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interaction. Such studies will address the question of whether the docking of one Ecm29 
molecule between the 19S-20S interface is enough; or the binding of several molecules is 
needed, providing some form of a cap function. If Ecm29 functions as a cap it could also 
possibly modify rate of degradation or even recruitment of specific substrates. Some of 
these questions could be answered by piloting electron microscopy on purified proteasomes 
and Ecm29. These types of experiments could show how the addition of Ecm29 affects the 
association of individual complexes and do new types of proteasomes form. In vitro studies 
will also come useful in manipulating stoichiometry of the 20S subunits. 
In summary, I find that Ecm29 functions as part of a large cellular response to the 
stress of compromised 20S assembly, but rather than compensating for aberrant 
proteasome output by simply enhancing proteasome activity, Ecm29 alters proteasome 
function by multiple mechanisms. Failed quality control mechanisms at protein level are 
typical preconditions of neurodegenerative disorders, cancer and aging. Therefore, 
understanding how the proteasome adapts to stress may help in identifying new therapeutic 
platforms. Existing drugs already encounter resistance in patients, hence exploring new 
sites of regulation as in assembly can be highly beneficial. 
158 
6 References 
Adams, G.M., Falke, S., Goldberg, A.L., Slaughter, C.A., DeMartino, G.N., and Gogol, E.P. 
(1997). Structural and functional effects of PA700 and modulator protein on proteasomes. Journal 
of Molecular Biology 273, 646–657. 
Aiken, C.T., Kaake, R.M., Wang, X., and Huang, L. (2011). Oxidative stress-mediated regulation 
of proteasome complexes. Mol. Cell Proteomics 10, R110.006924–R110.006924. 
Alers, S., Wesselborg, S., and Stork, B. (2014). ATG13. Autophagy 10, 944–956. 
Arendt, C.S., and Hochstrasser, M. (1997). Identification of the yeast 20S proteasome catalytic 
centers and subunit interactions required for active-site formation. Proc. Natl. Acad. Sci. U.S.a. 
94, 7156–7161. 
Arndt, V., Dick, N., Tawo, R., Dreiseidler, M., Wenzel, D., Hesse, M., Fürst, D.O., Saftig, P., 
Saint, R., Fleischmann, B.K., et al. (2010). Chaperone-Assisted Selective Autophagy Is Essential 
for Muscle Maintenance. Current Biology 20, 143–148. 
Bader, M., Benjamin, S., Wapinski, O.L., Smith, D.M., Goldberg, A.L., and Steller, H. (2011). A 
conserved F box regulatory complex controls proteasome activity in Drosophila. Cell 145, 371–
382. 
Baehr, L.M., Furlow, J.D., and Bodine, S.C. (2011). Muscle sparing in muscle RING finger 1 null 
mice: response to synthetic glucocorticoids. The Journal of Physiology 589, 4759–4776. 
Bailey, J.L., Wang, X., England, B.K., Price, S.R., Ding, X., and Mitch, W.E. (1996). The 
acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription 
of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J. Clin. Invest. 
97, 1447–1453. 
Baracos, V.E., DeVivo, C., Hoyle, D.H., and Goldberg, A.L. (1995). Activation of the ATP-
ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am. J. 
Physiol. 268, E996–E1006. 
Barthelme, D., and Sauer, R.T. (2012). Identification of the Cdc48bullet20S Proteasome as an 
Ancient AAA+ Proteolytic Machine. Science 337, 843–846. 
Bass, T.M., Grandison, R.C., Wong, R., Martinez, P., Partridge, L., and Piper, M.D.W. (2007). 
Optimization of dietary restriction protocols in Drosophila. J. Gerontol. a Biol. Sci. Med. Sci. 62, 
1071–1081. 
Bate, M. (1990). The embryonic development of larval muscles in Drosophila. Development 110, 
791–804. 
Baumeister, W., Walz, J., Zühl, F., and Seemüller, E. (1998). The proteasome: paradigm of a self-
compartmentalizing protease. Cell 92, 367–380. 
Beckett, K., and Baylies, M.K. (2006). The development of the Drosophila larval body wall 
159 
muscles. Int. Rev. Neurobiol. 75, 55–70. 
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D.G., Seth, R., Gray, T., Topham, I., Fone, K., 
Rezvani, N., et al. (2008). Depletion of 26S Proteasomes in Mouse Brain Neurons Causes 
Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies. Journal of 
Neuroscience 28, 8189–8198. 
Bell, R.A.V., Al-Khalaf, M., and Megeney, L.A. (2016). The beneficial role of proteolysis in 
skeletal muscle growth and stress adaptation. Skeletal Muscle 6, 16. 
Belote, J.M., Miller, M., and Smyth, K.A. (1998). Evolutionary conservation of a testes-specific 
proteasome subunit gene in Drosophila. Gene 215, 93–100. 
Belote, J.M., and Fortier, E. (2002). Targeted expression of dominant negative proteasome 
mutants in Drosophila melanogaster. Genesis 34, 80–82. 
Bédard, N., Jammoul, S., Moore, T., Wykes, L., Hallauer, P.L., Hastings, K.E.M., Stretch, C., 
Baracos, V., Chevalier, S., Plourde, M., et al. (2015). Inactivation of the ubiquitin-specific 
protease 19 deubiquitinating enzyme protects against muscle wasting. Faseb J. 29, 3889–3898. 
Bilodeau, P.A., Coyne, E.S., and Wing, S.S. (2016). The ubiquitin proteasome system in 
atrophying skeletal muscle: roles and regulation. Am. J. Physiol., Cell Physiol. 311, C392–C403. 
Bingol, B., and Schuman, E.M. (2006). Activity-dependent dynamics and sequestration of 
proteasomes in dendritic spines. Nature 441, 1144–1148. 
Bischof, J., and Basler, K. (2008). Recombinases and their use in gene activation, gene 
inactivation, and transgenesis. Methods Mol. Biol. 420, 175–195. 
Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., 
Panaro, F.J., Na, E., Dharmarajan, K., et al. (2001). Identification of ubiquitin ligases required for 
skeletal muscle atrophy. Science 294, 1704–1708. 
Bonaldo, P., and Sandri, M. (2013). Cellular and molecular mechanisms of muscle atrophy. Dis 
Model Mech 6, 25–39. 
Bonifacino, J.S., and Traub, L.M. (2003). Signals for sorting of transmembrane proteins to 
endosomes and lysosomes. Annu. Rev. Biochem. 72, 395–447. 
Boveris, A. (1984). Determination of the production of superoxide radicals and hydrogen 
peroxide in mitochondria. Meth. Enzymol. 105, 429–435. 
Brand, A.H., and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates 
and generating dominant phenotypes. Development 118, 401–415. 
Breusing, N., and Grune, T. (2008). Regulation of proteasome-mediated protein degradation 
during oxidative stress and aging. Biol. Chem. 389, 203–209. 
Cai, D., Frantz, J.D., Tawa, N.E., Melendez, P.A., Oh, B.-C., Lidov, H.G.W., Hasselgren, P.-O., 
Frontera, W.R., Lee, J., Glass, D.J., et al. (2004). IKKbeta/NF-kappaB activation causes severe 
muscle wasting in mice. Cell 119, 285–298. 
 160 
Carmignac, V., Quéré, R., and Durbeej, M. (2011). Proteasome inhibition improves the muscle of 
laminin α2 chain-deficient mice. Hum. Mol. Genet. 20, 541–552. 
Cascio, P., Call, M., Petre, B.M., Walz, T., and Goldberg, A.L. (2002). Properties of the hybrid 
form of the 26S proteasome containing both 19S and PA28 complexes. The EMBO Journal 21, 
2636–2645. 
Chai, Y., Shao, J., Miller, V.M., Williams, A., and Paulson, H.L. (2002). Live-cell imaging 
reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a 
sequestration model of pathogenesis. Proc. Natl. Acad. Sci. U.S.a. 99, 9310–9315. 
Chen, J.C.J., and Goldhamer, D.J. (2003). Skeletal muscle stem cells. Reprod. Biol. Endocrinol. 
1, 101. 
Chen, S., Wu, J., Lu, Y., Ma, Y.-B., Lee, B.-H., Yu, Z., Ouyang, Q., Finley, D.J., Kirschner, 
M.W., and Mao, Y. (2016). Structural basis for dynamic regulation of the human 26S 
proteasome. Proc. Natl. Acad. Sci. U.S.a. 113, 12991–12996. 
Chhangani, D., Joshi, A.P., and Mishra, A. (2012). E3 Ubiquitin Ligases in Protein Quality 
Control Mechanism. Molecular Neurobiology 45, 571–585. 
Chippindale, A.K., Leroi, A.M., Kim, S.B., and Rose, M.R. (2011). Phenotypic plasticity and 
selection in Drosophila life-history evolution. I. Nutrition and the cost of reproduction. In 
Methuselah Flies, (WORLD SCIENTIFIC), pp. 122–144. 
Cho-Park, P.F., and Steller, H. (2013). Proteasome regulation by ADP-ribosylation. Cell 153, 
614–627. 
Chondrogianni, N., Stratford, F.L.L., Trougakos, I.P., Friguet, B., Rivett, A.J., and Gonos, E.S. 
(2003). Central role of the proteasome in senescence and survival of human fibroblasts: induction 
of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. 
Journal of Biological Chemistry 278, 28026–28037. 
Chondrogianni, N., Tzavelas, C., Pemberton, A.J., Nezis, I.P., Rivett, A.J., and Gonos, E.S. 
(2005). Overexpression of proteasome beta5 assembled subunit increases the amount of 
proteasome and confers ameliorated response to oxidative stress and higher survival rates. Journal 
of Biological Chemistry 280, 11840–11850. 
Chou, A.P., Li, S., Fitzmaurice, A.G., and Bronstein, J.M. (2010). Mechanisms of rotenone-
induced proteasome inhibition. Neurotoxicology 31, 367–372. 
Chuang, S.-M., and Madura, K. (2005). Saccharomyces cerevisiae Ub-conjugating enzyme Ubc4 
binds the proteasome in the presence of translationally damaged proteins. Genetics 171, 1477–
1484. 
Clarke, B.A., Drujan, D., Willis, M.S., Murphy, L.O., Corpina, R.A., Burova, E., Rakhilin, S.V., 
Stitt, T.N., Patterson, C., Latres, E., et al. (2007). The E3 Ligase MuRF1 Degrades Myosin Heavy 
Chain Protein in Dexamethasone-Treated Skeletal Muscle. Cell Metabolism 6, 376–385. 
Cohen, S., Brault, J.J., Gygi, S.P., Glass, D.J., Valenzuela, D.M., Gartner, C., Latres, E., and 
Goldberg, A.L. (2009). During muscle atrophy, thick, but not thin, filament components are 
degraded by MuRF1-dependent ubiquitylation. The Journal of Cell Biology 185, 1083–1095. 
 161 
Cohen, S., Zhai, B., Gygi, S.P., and Goldberg, A.L. (2012). Ubiquitylation by Trim32 causes 
coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. The Journal of Cell 
Biology 198, 575–589. 
Dange, T., Smith, D., Noy, T., Rommel, P.C., Jurzitza, L., Cordero, R.J.B., Legendre, A., Finley, 
D., Goldberg, A.L., and Schmidt, M. (2011). Blm10 protein promotes proteasomal substrate 
turnover by an active gating mechanism. J. Biol. Chem. 286, 42830–42839. 
Davies, K.J. (2001). Degradation of oxidized proteins by the 20S proteasome. Biochimie 83, 
301–310. 
Davis, W.L., Jacoby, B.H., Jones, R.G., and Goodman, D.B. (1993). Superoxide formation 
preceding flight muscle histolysis in Solenopsis: fine structural cytochemistry and biochemistry. 
Histochem. J. 25, 478–490. 
Demontis, F., and Perrimon, N. (2010). FOXO/4E-BP signaling in Drosophila muscles regulates 
organism-wide proteostasis during aging. Cell 143, 813–825. 
Deng, H.-X., Chen, W., Hong, S.-T., Boycott, K.M., Gorrie, G.H., Siddique, N., Yang, Y., Fecto, 
F., Shi, Y., Zhai, H., et al. (2011). Mutations in UBQLN2 cause dominant X-linked juvenile and 
adult-onset ALS and ALS/dementia. Nature 477, 211–215. 
DeVorkin, L., Go, N.E., Hou, Y.-C.C., Moradian, A., Morin, G.B., and Gorski, S.M. (2014). The 
Drosophilaeffector caspase Dcp-1 regulates mitochondrial dynamics and autophagic flux via 
SesB. The Journal of Cell Biology 205, 477–492. 
Dey, D., Goldhamer, D.J., and Yu, P.B. (2015). Contributions of Muscle-Resident Progenitor 
Cells to Homeostasis and Disease. Current Molecular Biology Reports 1, 175–188. 
Dick, S.A., Chang, N.C., Dumont, N.A., Bell, R.A.V., Putinski, C., Kawabe, Y., Litchfield, 
D.W., Rudnicki, M.A., and Megeney, L.A. (2015). Caspase 3 cleavage of Pax7 inhibits self-
renewal of satellite cells. Proc. Natl. Acad. Sci. U.S.a. 112, E5246–E5252. 
Ding, W.-X., Ni, H.-M., Gao, W., Yoshimori, T., Stolz, D.B., Ron, D., and Yin, X.-M. (2007). 
Linking of autophagy to ubiquitin-proteasome system is important for the regulation of 
endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171, 513–524. 
Dobrowolny, G., Aucello, M., Rizzuto, E., Beccafico, S., Mammucari, C., Boncompagni, S., 
Bonconpagni, S., Belia, S., Wannenes, F., Nicoletti, C., et al. (2008). Skeletal muscle is a primary 
target of SOD1G93A-mediated toxicity. Cell Metabolism 8, 425–436. 
Dobson, C.M. (1999). Protein misfolding, evolution and disease. Trends Biochem. Sci. 24, 329–
332. 
Dodd, S.L., Gagnon, B.J., Senf, S.M., Hain, B.A., and Judge, A.R. (2010). Ros-mediated 
activation of NF-ÎºB and Foxo during muscle disuse. Muscle & Nerve 41, 110–113. 
Du, J., Wang, X., Miereles, C., Bailey, J.L., Debigare, R., Zheng, B., Price, S.R., and Mitch, W.E. 
(2004). Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in 
catabolic conditions. J. Clin. Invest. 113, 115–123. 
Edström, E., Altun, M., Hägglund, M., and Ulfhake, B. (2006). Atrogin-1/MAFbx and MuRF1 
 162 
are downregulated in aging-related loss of skeletal muscle. J. Gerontol. a Biol. Sci. Med. Sci. 61, 
663–674. 
Ellgaard, L., and Helenius, A. (2003). Quality control in the endoplasmic reticulum. Nat. Rev. 
Mol. Cell Biol. 4, 181–191. 
Elsasser, S., Schmidt, M., and Finley, D. (2005). Characterization of the Proteasome Using 
Native Gel Electrophoresis. In Ubiquitin and Protein Degradation, Part A, (Elsevier), pp. 353–
363. 
Fernando, P., Kelly, J.F., Balazsi, K., Slack, R.S., and Megeney, L.A. (2002). Caspase 3 activity 
is required for skeletal muscle differentiation. Proc. Natl. Acad. Sci. U.S.a. 99, 11025–11030. 
Finkel, T., and Holbrook, N.J. (2000). Oxidants, oxidative stress and the biology of ageing. 
Nature 408, 239–247. 
Finley, D. (2009). Recognition and processing of ubiquitin-protein conjugates by the proteasome. 
Annu. Rev. Biochem. 78, 477–513. 
Firth, L.C., Li, W., Zhang, H., and Baker, N.E. (2006). Analyses of RAS Regulation of Eye 
Development in Drosophila melanogaster. In Regulators and Effectors of Small GTPases: Ras 
Family, (Elsevier), pp. 711–721. 
Förster, A., Masters, E.I., Whitby, F.G., Robinson, H., and Hill, C.P. (2005). The 1.9 A structure 
of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 
interactions. Mol. Cell 18, 589–599. 
Freeman, M. (1996). Reiterative Use of the EGF Receptor Triggers Differentiation of All Cell 
Types in the Drosophila Eye. Cell 87, 651–660. 
Fuchs, Y., and Steller, H. (2011). Programmed cell death in animal development and disease. Cell 
147, 742–758. 
Furuno, K., Goodman, M.N., and Goldberg, A.L. (1990). Role of different proteolytic systems in 
the degradation of muscle proteins during denervation atrophy. J. Biol. Chem. 265, 8550–8557. 
Fusco, C., Micale, L., Egorov, M., Monti, M., D'Addetta, E.V., Augello, B., Cozzolino, F., 
Calcagnì, A., Fontana, A., Polishchuk, R.S., et al. (2012). The E3-ubiquitin ligase TRIM50 
interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated 
proteins into the aggresome. PLoS ONE 7, e40440. 
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, 
E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A.L., et al. (2016). Autophagy maintains 
stemness by preventing senescence. Nature 529, 37–42. 
Gerards, W.L., Enzlin, J., Häner, M., Hendriks, I.L., Aebi, U., Bloemendal, H., and Boelens, W. 
(1997). The human alpha-type proteasomal subunit HsC8 forms a double ringlike structure, but 
does not assemble into proteasome-like particles with the beta-type subunits HsDelta or 
HsBPROS26. J. Biol. Chem. 272, 10080–10086. 
Gerards, W.L.H., de Jong, W.W., Bloemendal, H., and Boelens, W. (1998). The human 
proteasomal subunit HsC8 induces ring formation of other α-type subunits. Journal of Molecular 
 163 
Biology 275, 113–121. 
Gerlinger, U.M., Gückel, R., Hoffmann, M., Wolf, D.H., and Hilt, W. (1997). Yeast 
cycloheximide-resistant crl mutants are proteasome mutants defective in protein degradation. 
Mol. Biol. Cell 8, 2487–2499. 
Glickman, M.H., and Ciechanover, A. (2002). The ubiquitin-proteasome proteolytic pathway: 
destruction for the sake of construction. Physiol. Rev. 82, 373–428. 
Goldbaum, O., Vollmer, G., and Richter-Landsberg, C. (2006). Proteasome inhibition by MG-132 
induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes 
but not in astrocytes. Glia 53, 891–901. 
Goldberg, A.L. (1996). Importance of the ATP-Ubiquitin-Proteasome Pathway in the 
Degradation of Soluble and Myofibrillar Proteins in Rabbit Muscle Extracts. Journal of 
Biological Chemistry 271, 26690–26697. 
Goldberg, A.L. (2003). Protein degradation and protection against misfolded or damaged 
proteins. Nature 426, 895–899. 
Goldberg, A.L., Cascio, P., Saric, T., and Rock, K.L. (2002). The importance of the proteasome 
and subsequent proteolytic steps in the generation of antigenic peptides. Molecular Immunology 
39, 147–164. 
Golic, K.G., and Lindquist, S. (1989). The FLP recombinase of yeast catalyzes site-specific 
recombination in the Drosophila genome. Cell 59, 499–509. 
Gomes, M.D., Lecker, S.H., Jagoe, R.T., Navon, A., and Goldberg, A.L. (2001). Atrogin-1, a 
muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. 
U.S.a. 98, 14440–14445. 
Gorbea, C., Goellner, G.M., Teter, K., Holmes, R.K., and Rechsteiner, M. (2004). 
Characterization of mammalian Ecm29, a 26 S proteasome-associated protein that localizes to the 
nucleus and membrane vesicles. Journal of Biological Chemistry 279, 54849–54861. 
Gorbea, C., Pratt, G., Ustrell, V., Bell, R., Sahasrabudhe, S., Hughes, R.E., and Rechsteiner, M. 
(2010). A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors 
and endosomal components. J. Biol. Chem. 285, 31616–31633. 
Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B., and Pallanck, L.J. (2003). 
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. 
Natl. Acad. Sci. U.S.a. 100, 4078–4083. 
Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T.P., Schild, H., Rammensee, H.-G., 
Koszinowski, U.H., and Kloetzel, P.-M. (1996). A role for the proteasome regulator PA28α in 
antigen presentation. Nature 381, 166–168. 
Groll, M., Bajorek, M., Kohler, A., Moroder, L., Rubin, D.M., Huber, R., Glickman, M.H., and 
Finley, D. (2000). A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE. 
Groll, M., Heinemeyer, W., Jäger, S., Ullrich, T., Bochtler, M., Wolf, D.H., and Huber, R. 
(1999). The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational 
 164 
and crystallographic study. Proc. Natl. Acad. Sci. U.S.a. 96, 10976–10983. 
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H.D., and Huber, R. (1997). 
Structure of 20S proteasome from yeast at 2.4Å resolution. Nature 386, 463–471. 
Grumati, P., Coletto, L., Schiavinato, A., Castagnaro, S., Bertaggia, E., Sandri, M., and Bonaldo, 
P. (2011). Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental 
for collagen VI-deficient muscles. Autophagy 7, 1415–1423. 
Guterman, A., and Glickman, M.H. (2004). Deubiquitinating Enzymes are IN(Trinsic to 
Proteasome Function). Current Protein and Peptide Science 5, 201–210. 
Haas, K.F., Woodruff, E., and Broadie, K. (2007). Proteasome function is required to maintain 
muscle cellular architecture. Biol. Cell 99, 615–626. 
Hampton, R.Y. (2002). ER-associated degradation in protein quality control and cellular 
regulation. Current Opinion in Cell Biology 14, 476–482. 
Hanna, J., Meides, A., Zhang, D.P., and Finley, D. (2007). A Ubiquitin Stress Response Induces 
Altered Proteasome Composition. Cell 129, 747–759. 
Haratake, K., Sato, A., Tsuruta, F., and Chiba, T. (2016). KIAA0368-deficiency affects 
disassembly of 26S proteasome under oxidative stress condition. Journal of Biochemistry 159, 
609–618. 
Harrison, D.A., and Perrimon, N. (1993). Simple and efficient generation of marked clones in 
Drosophila. Curr. Biol. 3, 424–433. 
Hartl, F.U., and Hayer-Hartl, M. (2009). Converging concepts of protein folding in vitro and in 
vivo. Nature Structural & Molecular Biology 16, 574–581. 
He, C., Bassik, M.C., Moresi, V., Sun, K., Wei, Y., Zou, Z., An, Z., Loh, J., Fisher, J., Sun, Q., et 
al. (2012). Exercise-induced BCL2-regulated autophagy is required for muscle glucose 
homeostasis. Nature 481, 511–515. 
Henchoz, S., De Rubertis, F., Pauli, D., and Spierer, P. (1996). The dose of a putative ubiquitin-
specific protease affects position-effect variegation in Drosophila melanogaster. Mol. Cell. Biol. 
16, 5717–5725. 
Hendil, K.B., Hartmann-Petersen, R., and Tanaka, K. (2002). 26 S proteasomes function as stable 
entities. Journal of Molecular Biology 315, 627–636. 
Hendil, K.B., Kriegenburg, F., Tanaka, K., Murata, S., Lauridsen, A.-M.B., Johnsen, A.H., and 
Hartmann-Petersen, R. (2009). The 20S proteasome as an assembly platform for the 19S 
regulatory complex. Journal of Molecular Biology 394, 320–328. 
Herskowitz, I. (1987). Functional inactivation of genes by dominant negative mutations. Nature 
329, 219–222. 
Hériché, J.-K., Ang, D., Bier, E., and O'Farrell, P.H. (2003). Involvement of an SCFSlmb 
complex in timely elimination of E2F upon initiation of DNA replication in Drosophila. BMC 
Genet. 4, 9. 
 165 
Hirano, Y., Hendil, K.B., Yashiroda, H., Iemura, S.-I., Nagane, R., Hioki, Y., Natsume, T., 
Tanaka, K., and Murata, S. (2005). A heterodimeric complex that promotes the assembly of 
mammalian 20S proteasomes. Nature 437, 1381–1385. 
Hirano, Y., Kaneko, T., Okamoto, K., Bai, M., Yashiroda, H., Furuyama, K., Kato, K., Tanaka, 
K., and Murata, S. (2008). Dissecting beta-ring assembly pathway of the mammalian 20S 
proteasome. The EMBO Journal 27, 2204–2213. 
Holden, J.J., and Suzuki, D.T. (1973). Temperature-sensitive mutations in Drosophila 
melanogaster. XII. The genetic and developmental effects of dominant lethals on chromosome 3. 
Genetics 73, 445–458. 
Hsu, M.-T., Guo, C.-L., Liou, A.Y., Chang, T.-Y., Ng, M.-C., Florea, B.I., Overkleeft, H.S., Wu, 
Y.-L., Liao, J.-C., and Cheng, P.-L. (2015). Stage-Dependent Axon Transport of Proteasomes 
Contributes to Axon Development. Dev. Cell 35, 418–431. 
Huang, S.-M.A., Mishina, Y.M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G.A., Charlat, O., 
Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009). Tankyrase inhibition stabilizes axin and 
antagonizes Wnt signalling. Nature 461, 614–620. 
Huang, X., Luan, B., Wu, J., and Shi, Y. (2016). An atomic structure of the human 26S 
proteasome. Nature Structural & Molecular Biology 23, 778–785. 
Huber, E.M., and Groll, M. (2016). Yeast 20S proteasome at 2.3 A resolution. 
Huh, W.-K., Falvo, J.V., Gerke, L.C., Carroll, A.S., Howson, R.W., Weissman, J.S., and O'Shea, 
E.K. (2003). Global analysis of protein localization in budding yeast. Nature 425, 686–691. 
Hwang, P.M., and Sykes, B.D. (2015). Targeting the sarcomere to correct muscle function. Nat 
Rev Drug Discov 14, 313–328. 
Isono, E., Nishihara, K., Saeki, Y., Yashiroda, H., Kamata, N., Ge, L., Ueda, T., Kikuchi, Y., 
Tanaka, K., Nakano, A., et al. (2007). The assembly pathway of the 19S regulatory particle of the 
yeast 26S proteasome. Mol. Biol. Cell 18, 569–580. 
Iwanczyk, J., Sadre-Bazzaz, K., Ferrell, K., Kondrashkina, E., Formosa, T., Hill, C.P., and 
Ortega, J. (2006). Structure of the Blm10-20 S proteasome complex by cryo-electron microscopy. 
Insights into the mechanism of activation of mature yeast proteasomes. Journal of Molecular 
Biology 363, 648–659. 
Jamart, C., Benoit, N., Raymackers, J.-M., Kim, H.J., Kim, C.K., and Francaux, M. (2012a). 
Autophagy-related and autophagy-regulatory genes are induced in human muscle after 
ultraendurance exercise. Eur. J. Appl. Physiol. 112, 3173–3177. 
Jamart, C., Francaux, M., Millet, G.Y., Deldicque, L., Frère, D., and Féasson, L. (2012b). 
Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running. J. 
Appl. Physiol. 112, 1529–1537. 
Jang, Y.C., and Van Remmen, H. (2011). Age-associated alterations of the neuromuscular 
junction. Exp. Gerontol. 46, 193–198. 
Jung, T., and Grune, T. (2008). The proteasome and its role in the degradation of oxidized 
 166 
proteins. IUBMB Life 60, 743–752. 
Kageyama, S., Sou, Y.-S., Uemura, T., Kametaka, S., Saito, T., Ishimura, R., Kouno, T., Bedford, 
L., Mayer, R.J., Lee, M.-S., et al. (2014). Proteasome dysfunction activates autophagy and the 
Keap1-Nrf2 pathway. J. Biol. Chem. 289, 24944–24955. 
Kajava, A.V., Gorbea, C., Ortega, J., Rechsteiner, M., and Steven, A.C. (2004). New HEAT-like 
repeat motifs in proteins regulating proteasome structure and function. J. Struct. Biol. 146, 425–
430. 
Kandarian, S.C., and Jackman, R.W. (2006). Intracellular signaling during skeletal muscle 
atrophy. Muscle & Nerve 33, 155–165. 
Kedar, V., McDonough, H., Arya, R., Li, H.H., Rockman, H.A., and Patterson, C. (2004). 
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. 
Proc. Natl. Acad. Sci. U.S.a. 101, 18135–18140. 
Kee, A.J., Combaret, L., Tilignac, T., Souweine, B., Aurousseau, E., Dalle, M., Taillandier, D., 
and Attaix, D. (2003). Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to 
insulin release and refeeding in starved rats. The Journal of Physiology 546, 765–776. 
Khor, B., Bredemeyer, A.L., Huang, C.-Y., Turnbull, I.R., Evans, R., Maggi, L.B., White, J.M., 
Walker, L.M., Carnes, K., Hess, R.A., et al. (2006). Proteasome activator PA200 is required for 
normal spermatogenesis. Mol. Cell. Biol. 26, 2999–3007. 
Kiffin, R., Christian, C., Knecht, E., and Cuervo, A.M. (2004). Activation of chaperone-mediated 
autophagy during oxidative stress. Mol. Biol. Cell 15, 4829–4840. 
Kim, Y.A., Kim, Y.S., and Song, W. (2012). Autophagic response to a single bout of moderate 
exercise in murine skeletal muscle. J. Physiol. Biochem. 68, 229–235. 
Kim, Y.-C., and DeMartino, G.N. (2011). C termini of proteasomal ATPases play nonequivalent 
roles in cellular assembly of mammalian 26 S proteasome. J. Biol. Chem. 286, 26652–26666. 
Kimura, A., Kato, Y., and Hirano, H. (2012). N-myristoylation of the Rpt2 subunit regulates 
intracellular localization of the yeast 26S proteasome. Biochemistry 51, 8856–8866. 
Kitajima, Y., Tashiro, Y., Suzuki, N., Warita, H., Kato, M., Tateyama, M., Ando, R., Izumi, R., 
Yamazaki, M., Abe, M., et al. (2014). Proteasome dysfunction induces muscle growth defects and 
protein aggregation. J. Cell. Sci. 127, 5204–5217. 
Kleijnen, M.F., Roelofs, J., Park, S., Hathaway, N.A., Glickman, M., King, R.W., and Finley, D. 
(2007). Stability of the proteasome can be regulated allosterically through engagement of its 
proteolytic active sites. Nature Structural & Molecular Biology 14, 1180–1188. 
Kloetzel, P.-M. (2004). Generation of major histocompatibility complex class I antigens: 
functional interplay between proteasomes and TPPII. Nature Immunology 5, 661–669. 
Knöll, R., and Marston, S. (2012). On mechanosensation, acto/myosin interaction, and 
hypertrophy. Trends Cardiovasc. Med. 22, 17–22. 
Koncarevic, A., Jackman, R.W., and Kandarian, S.C. (2007). The ubiquitin-protein ligase Nedd4 
 167 
targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced 
muscle tension. Faseb J. 21, 427–437. 
Kostova, Z., and Wolf, D.H. (2003). For whom the bell tolls: protein quality control of the 
endoplasmic reticulum and the ubiquitin-proteasome connection. The EMBO Journal 22, 2309–
2317. 
Koushika, S.P., Lisbin, M.J., and White, K. (1996). ELAV, a Drosophila neuron-specific protein, 
mediates the generation of an alternatively spliced neural protein isoform. Curr. Biol. 6, 1634–
1641. 
Krogan, N.J., Lam, M.H.Y., Fillingham, J., Keogh, M.-C., Gebbia, M., Li, J., Datta, N., Cagney, 
G., Buratowski, S., Emili, A., et al. (2004). Proteasome involvement in the repair of DNA double-
strand breaks. Mol. Cell 16, 1027–1034. 
Kudryashova, E., Kramerova, I., and Spencer, M.J. (2012). Satellite cell senescence underlies 
myopathy in a mouse model of limb-girdle muscular dystrophy 2H. J. Clin. Invest. 122, 1764–
1776. 
Kunjappu, M.J., and Hochstrasser, M. (2014). Assembly of the 20S proteasome. Biochimica Et 
Biophysica Acta (BBA) - Molecular Cell Research 1843, 2–12. 
Kusmierczyk, A.R., Kunjappu, M.J., Funakoshi, M., and Hochstrasser, M. (2008). A multimeric 
assembly factor controls the formation of alternative 20S proteasomes. Nature Structural & 
Molecular Biology 15, 237–244. 
Kusmierczyk, A.R., Kunjappu, M.J., Kim, R.Y., and Hochstrasser, M. (2011). A conserved 20S 
proteasome assembly factor requires a C-terminal HbYX motif for proteasomal precursor 
binding. Nature Structural & Molecular Biology 18, 622–629. 
La Mota-Peynado, De, A., Lee, S.Y.-C., Pierce, B.M., Wani, P., Singh, C.R., and Roelofs, J. 
(2013). The proteasome-associated protein Ecm29 inhibits proteasomal ATPase activity and in 
vivo protein degradation by the proteasome. J. Biol. Chem. 288, 29467–29481. 
Lagirand-Cantaloube, J., Offner, N., Csibi, A., Leibovitch, M.P., Batonnet-Pichon, S., Tintignac, 
L.A., Segura, C.T., and Leibovitch, S.A. (2008). The initiation factor eIF3-f is a major target for 
atrogin1/MAFbx function in skeletal muscle atrophy. The EMBO Journal 27, 1266–1276. 
Lam, Y.A., Xu, W., DeMartino, G.N., and Cohen, R.E. (1997). Editing of ubiquitin conjugates by 
an isopeptidase in the 26S proteasome. Nature 385, 737–740. 
Lang-Rollin, I., Vekrellis, K., Wang, Q., Rideout, H.J., and Stefanis, L. (2004). Application of 
proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway. J. 
Neurochem. 90, 1511–1520. 
Laporte, D., Salin, B., Daignan-Fornier, B., and Sagot, I. (2008). Reversible cytoplasmic 
localization of the proteasome in quiescent yeast cells. The Journal of Cell Biology 181, 737–745. 
Le Tallec, B., Barrault, M.-B., Courbeyrette, R., Guérois, R., Marsolier-Kergoat, M.-C., and 
Peyroche, A. (2007). 20S proteasome assembly is orchestrated by two distinct pairs of chaperones 
in yeast and in mammals. Mol. Cell 27, 660–674. 
 168 
Leach, J.K., Van Tuyle, G., Lin, P.S., Schmidt-Ullrich, R., and Mikkelsen, R.B. (2001). Ionizing 
radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res. 
61, 3894–3901. 
Lecker, S.H., Goldberg, A.L., and Mitch, W.E. (2006). Protein degradation by the ubiquitin-
proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 17, 1807–1819. 
Lecker, S.H., Jagoe, R.T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S.R., Mitch, 
W.E., and Goldberg, A.L. (2004). Multiple types of skeletal muscle atrophy involve a common 
program of changes in gene expression. Faseb J. 18, 39–51. 
Lee, C.S., Yi, J.-S., Jung, S.-Y., Kim, B.-W., Lee, N.-R., Choo, H.-J., Jang, S.-Y., Han, J., Chi, 
S.-G., Park, M., et al. (2010). TRIM72 negatively regulates myogenesis via targeting insulin 
receptor substrate-1. Cell Death Differ. 17, 1254–1265. 
Lee, D.H., and Goldberg, A.L. (1998). Proteasome inhibitors: valuable new tools for cell 
biologists. Trends Cell Biol. 8, 397–403. 
Lee, J., Giordano, S., and Zhang, J. (2012a). Autophagy, mitochondria and oxidative stress: 
cross-talk and redox signalling. Biochem. J. 441, 523–540. 
Lee, S.H., Moon, J.H., Yoon, S.K., and Yoon, J.B. (2012b). Stable Incorporation of ATPase 
Subunits into 19 S Regulatory Particle of Human Proteasome Requires Nucleotide Binding and 
C-terminal Tails. Journal of Biological Chemistry 287, 9269–9279. 
Lee, S.Y.-C., La Mota-Peynado, De, A., and Roelofs, J. (2011). Loss of Rpt5 protein interactions 
with the core particle and Nas2 protein causes the formation of faulty proteasomes that are 
inhibited by Ecm29 protein. J. Biol. Chem. 286, 36641–36651. 
Leggett, D.S., Hanna, J., Borodovsky, A., Crosas, B., Schmidt, M., Baker, R.T., Walz, T., Ploegh, 
H., and Finley, D. (2002). Multiple Associated Proteins Regulate Proteasome Structure and 
Function. Mol. Cell 10, 495–507. 
Lehmann, A., Janek, K., Braun, B., Kloetzel, P.-M., and Enenkel, C. (2002). 20 S proteasomes 
are imported as precursor complexes into the nucleus of yeast. Journal of Molecular Biology 317, 
401–413. 
Lehmann, A., Jechow, K., and Enenkel, C. (2008). Blm10 binds to pre-activated proteasome core 
particles with open gate conformation. EMBO Rep. 9, 1237–1243. 
Lehmann, A., Niewienda, A., Jechow, K., Janek, K., and Enenkel, C. (2010). Ecm29 Fulfils 
Quality Control Functions in Proteasome Assembly. Mol. Cell 38, 879–888. 
Li, X., Kusmierczyk, A.R., Wong, P., Emili, A., and Hochstrasser, M. (2007). beta-Subunit 
appendages promote 20S proteasome assembly by overcoming an Ump1-dependent checkpoint. 
The EMBO Journal 26, 2339–2349. 
Li, X., Matilainen, O., Jin, C., Glover-Cutter, K.M., Holmberg, C.I., and Blackwell, T.K. (2011). 
Specific SKN-1/Nrf stress responses to perturbations in translation elongation and proteasome 
activity. PLoS Genet. 7, e1002119. 
Lira, V.A., Okutsu, M., Akhtar, Y.N., Zhang, M., and Yan, Z. (2010). Autophagy in Skeletal 
 169 
Muscle is Required for Exercise Training-Induced Improvement in Glucose Tolerance. Medicine 
& Science in Sports & Exercise 42, 8. 
Liu, C.-C., Lin, Y.-C., Chen, Y.-H., Chen, C.-M., Pang, L.-Y., Chen, H.-A., Wu, P.-R., Lin, M.-
Y., Jiang, S.-T., Tsai, T.-F., et al. (2016). Cul3-KLHL20 Ubiquitin Ligase Governs the Turnover 
of ULK1 and VPS34 Complexes to Control Autophagy Termination. Mol. Cell 61, 84–97. 
Lohi, O., Poussu, A., Mao, Y., Quiocho, F., and Lehto, V.P. (2002). VHS domain -- a 
longshoreman of vesicle lines. FEBS Letters 513, 19–23. 
London, M.K., Keck, B.I., Ramos, P.C., and Dohmen, R.J. (2004). Regulatory mechanisms 
controlling biogenesis of ubiquitin and the proteasome. FEBS Letters 567, 259–264. 
Lopez, A.D., Tar, K., Krügel, U., Dange, T., Ros, I.G., and Schmidt, M. (2011). Proteasomal 
degradation of Sfp1 contributes to the repression of ribosome biogenesis during starvation and is 
mediated by the proteasome activator Blm10. Mol. Biol. Cell 22, 528–540. 
Lundgren, J., Masson, P., Mirzaei, Z., and Young, P. (2005). Identification and characterization 
of a Drosophila proteasome regulatory network. Mol. Cell. Biol. 25, 4662–4675. 
Lundgren, J., Masson, P., Realini, C.A., and Young, P. (2003). Use of RNA interference and 
complementation to study the function of the Drosophila and human 26S proteasome subunit S13. 
Mol. Cell. Biol. 23, 5320–5330. 
Ma, J., Katz, E., and Belote, J.M. (2002). Expression of proteasome subunit isoforms during 
spermatogenesis in Drosophila melanogaster. Insect Mol. Biol. 11, 627–639. 
Ma, M., and Liu, Z.L. (2010). Comparative transcriptome profiling analyses during the lag phase 
uncover YAP1, PDR1, PDR3, RPN4, and HSF1 as key regulatory genes in genomic adaptation to 
the lignocellulose derived inhibitor HMF for Saccharomyces cerevisiae. BMC Genomics 11, 660. 
Machiels, B.M., Henfling, M.E., Broers, J.L., Hendil, K.B., and Ramaekers, F.C. (1995). Changes 
in immunocytochemical detectability of proteasome epitopes depending on cell growth and 
fixation conditions of lung cancer cell lines. Eur. J. Cell Biol. 66, 282–292. 
Madura, K. (2004). Rad23 and Rpn10: perennial wallflowers join the melee. Trends Biochem. 
Sci. 29, 637–640. 
Mair, W., Piper, M.D.W., and Partridge, L. (2005). Calories do not explain extension of life span 
by dietary restriction in Drosophila. PLoS Biol. 3, e223. 
Malicdan, M.C., Noguchi, S., Nonaka, I., Saftig, P., and Nishino, I. (2008). Lysosomal 
myopathies: An excessive build-up in autophagosomes is too much to handle. Neuromuscular 
Disorders 18, 521–529. 
Mallik, M., and Lakhotia, S.C. (2009). The developmentally active and stress-inducible 
noncoding hsromega gene is a novel regulator of apoptosis in Drosophila. Genetics 183, 831–852. 
Mallik, M., and Lakhotia, S.C. (2014). RNAi for the large non-coding hsrω transcripts suppresses 
polyglutamine pathogenesis in Drosophilamodels. RNA Biology 6, 464–478. 
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S.J., 
 170 
Di Lisi, R., Sandri, C., Zhao, J., et al. (2007). FoxO3 Controls Autophagy in Skeletal Muscle In 
Vivo. Cell Metabolism 6, 458–471. 
Mannhaupt, G., Schnall, R., Karpov, V., Vetter, I., and Feldmann, H. (1999). Rpn4p acts as a 
transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and 
other genes in yeast. FEBS Letters 450, 27–34. 
Martin, J.B. (1999). Molecular basis of the neurodegenerative disorders. N. Engl. J. Med. 340, 
1970–1980. 
Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M., Metzger, D., 
Reggiani, C., Schiaffino, S., and Sandri, M. (2009). Autophagy is required to maintain muscle 
mass. Cell Metabolism 10, 507–515. 
Masson, P., Andersson, O., Petersen, U.M., and Young, P. (2001). Identification and 
Characterization of a DrosophilaNuclear Proteasome Regulator: A HOMOLOG OF HUMAN 11 
S REG  (PA28 ). Journal of Biological Chemistry 276, 1383–1390. 
McCracken, A.A., and Brodsky, J.L. (2003). Evolving questions and paradigm shifts in 
endoplasmic-reticulum-associated degradation (ERAD). BioEssays 25, 868–877. 
McLeod, M., Craft, S., and Broach, J.R. (1986). Identification of the crossover site during FLP-
mediated recombination in the Saccharomyces cerevisiae plasmid 2 microns circle. Mol. Cell. 
Biol. 6, 3357–3367. 
McNaught, K.S.P., Belizaire, R., Isacson, O., Jenner, P., and Olanow, C.W. (2003). Altered 
proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179, 38–46. 
Medina, R., Wing, S.S., and Goldberg, A.L. (1995). Increase in levels of polyubiquitin and 
proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem. J. 307 
( Pt 3), 631–637. 
Medina, R., Wing, S.S., Haas, A., and Goldberg, A.L. (1991). Activation of the ubiquitin-ATP-
dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed. 
Biochim. Acta 50, 347–356. 
Meiners, S., Heyken, D., Weller, A., Ludwig, A., Stangl, K., Kloetzel, P.-M., and Krüger, E. 
(2003). Inhibition of proteasome activity induces concerted expression of proteasome genes and 
de novo formation of Mammalian proteasomes. J. Biol. Chem. 278, 21517–21525. 
Milan, G., Romanello, V., Pescatore, F., Armani, A., Paik, J.-H., Frasson, L., Seydel, A., Zhao, J., 
Abraham, R., Goldberg, A.L., et al. (2015). Regulation of autophagy and the ubiquitin-
proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun 6, 
6670. 
Mitch, W.E., and Goldberg, A.L. (1996). Mechanisms of muscle wasting. The role of the 
ubiquitin-proteasome pathway. N. Engl. J. Med. 335, 1897–1905. 
Mitch, W.E., Medina, R., Grieber, S., May, R.C., England, B.K., Price, S.R., Bailey, J.L., and 
Goldberg, A.L. (1994). Metabolic acidosis stimulates muscle protein degradation by activating 
the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J. Clin. 
Invest. 93, 2127–2133. 
 171 
Mitsiades, N., Mitsiades, C.S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., 
Joseph, M., Libermann, T.A., Treon, S.P., et al. (2002). Molecular sequelae of proteasome 
inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. U.S.a. 99, 14374–14379. 
Mizushima, N., and Komatsu, M. (2011). Autophagy: renovation of cells and tissues. Cell 147, 
728–741. 
Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., and Ohsumi, Y. (2004). In vivo 
analysis of autophagy in response to nutrient starvation using transgenic mice expressing a 
fluorescent autophagosome marker. Mol. Biol. Cell 15, 1101–1111. 
Morris, E.J., Michaud, W.A., Ji, J.-Y., Moon, N.-S., Rocco, J.W., and Dyson, N.J. (2006). 
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS 
Genet. 2, e196. 
Moylan, J.S., and Reid, M.B. (2007). Oxidative stress, chronic disease, and muscle wasting. 
Muscle & Nerve 35, 411–429. 
Muller, F.L., Song, W., Liu, Y., Chaudhuri, A., Pieke-Dahl, S., Strong, R., Huang, T.-T., Epstein, 
C.J., Roberts, L.J., Csete, M., et al. (2006). Absence of CuZn superoxide dismutase leads to 
elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. 
Biol. Med. 40, 1993–2004. 
Murata, S., Sasaki, K., Kishimoto, T., Niwa, S.-I., Hayashi, H., Takahama, Y., and Tanaka, K. 
(2007). Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 316, 
1349–1353. 
Murata, S., Takahama, Y., and Tanaka, K. (2008). Thymoproteasome: probable role in generating 
positively selecting peptides. Curr. Opin. Immunol. 20, 192–196. 
Murata, S., Yashiroda, H., and Tanaka, K. (2009). Molecular mechanisms of proteasome 
assembly. Nat. Rev. Mol. Cell Biol. 10, 104–115. 
Murray, T.V.A., McMahon, J.M., Howley, B.A., Stanley, A., Ritter, T., Mohr, A., Zwacka, R., 
and Fearnhead, H.O. (2008). A non-apoptotic role for caspase-9 in muscle differentiation. J. Cell. 
Sci. 121, 3786–3793. 
Møller, A.B., Vendelbo, M.H., Christensen, B., Clasen, B.F., Bak, A.M., Jørgensen, J.O.L., 
Møller, N., and Jessen, N. (2015). Physical exercise increases autophagic signaling through 
ULK1 in human skeletal muscle. J. Appl. Physiol. 118, 971–979. 
Nakao, R., Hirasaka, K., Goto, J., Ishidoh, K., Yamada, C., Ohno, A., Okumura, Y., Nonaka, I., 
Yasutomo, K., Baldwin, K.M., et al. (2009). Ubiquitin ligase Cbl-b is a negative regulator for 
insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol. Cell. 
Biol. 29, 4798–4811. 
Narwal, M., Venkannagari, H., and Lehtiö, L. (2012). Structural basis of selective inhibition of 
human tankyrases. J. Med. Chem. 55, 1360–1367. 
Nederlof, P.M., Wang, H.R., and Baumeister, W. (1995). Nuclear localization signals of human 
and Thermoplasma proteasomal alpha subunits are functional in vitro. Proc. Natl. Acad. Sci. 
U.S.a. 92, 12060–12064. 
 172 
Neuburger, P.J., Saville, K.J., Zeng, J., Smyth, K.-A., and Belote, J.M. (2006). A genetic 
suppressor of two dominant temperature-sensitive lethal proteasome mutants of Drosophila 
melanogaster is itself a mutated proteasome subunit gene. Genetics 173, 1377–1387. 
Nie, J., Wu, M., Wang, J., Xing, G., He, F., and Zhang, L. (2010). REGγ proteasome mediates 
degradation of the ubiquitin ligase Smurf1. FEBS Letters 584, 3021–3027. 
Nucifora, F.C., Jr (2001). Interference by Huntingtin and Atrophin-1 with CBP-Mediated 
Transcription Leading to Cellular Toxicity. Science 291, 2423–2428. 
Olzscha, H., Schermann, S.M., Woerner, A.C., Pinkert, S., Hecht, M.H., Tartaglia, G.G., 
Vendruscolo, M., Hayer-Hartl, M., Hartl, F.U., and Vabulas, R.M. (2011). Amyloid-like 
aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 
67–78. 
Osmulski, P.A., Hochstrasser, M., and Gaczynska, M. (2009). A tetrahedral transition state at the 
active sites of the 20S proteasome is coupled to opening of the alpha-ring channel. Structure 17, 
1137–1147. 
Osterwalder, T., Yoon, K.S., White, B.H., and Keshishian, H. (2001). A conditional tissue-
specific transgene expression system using inducible GAL4. Proc. Natl. Acad. Sci. U.S.a. 98, 
12596–12601. 
Padmanabhan, A., Vuong, S.A.-T., and Hochstrasser, M. (2016). Assembly of an Evolutionarily 
Conserved Alternative Proteasome Isoform in Human Cells. Cell Rep 14, 2962–2974. 
Page, M.M., Robb, E.L., Salway, K.D., and Stuart, J.A. (2010). Mitochondrial redox metabolism: 
Aging, longevity and dietary effects. Mech. Ageing Dev. 131, 242–252. 
Paik, D., Jang, Y.G., Lee, Y.E., Lee, Y.N., Yamamoto, R., Gee, H.Y., Yoo, S., Bae, E., Min, K.-
J., Tatar, M., et al. (2012). Misexpression screen delineates novel genes controlling Drosophila 
lifespan. Mech. Ageing Dev. 133, 234–245. 
Pan, T., Kondo, S., Zhu, W., Xie, W., Jankovic, J., and Le, W. (2008). Neuroprotection of 
rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol. Dis. 
32, 16–25. 
Panasenko, O.O., and Collart, M.A. (2011). Not4 E3 ligase contributes to proteasome assembly 
and functional integrity in part through Ecm29. Mol. Cell. Biol. 31, 1610–1623. 
Pandey, U.B., Batlevi, Y., Baehrecke, E.H., and Taylor, J.P. (2007). HDAC6 at the Intersection 
of Autophagy, the Ubiquitin-proteasome System, and Neurodegeneration. Autophagy 3, 643–645. 
Park, S., Kim, W., Tian, G., Gygi, S.P., and Finley, D. (2011). Structural Defects in the 
Regulatory Particle-Core Particle Interface of the Proteasome Induce a Novel Proteasome Stress 
Response. J. Biol. Chem. 286, 36652–36666. 
Park, S., Roelofs, J., Kim, W., Robert, J., Schmidt, M., Gygi, S.P., and Finley, D. (2009). 
Hexameric assembly of the proteasomal ATPases is templated through their C termini. Nature 
459, 866–870. 
Park, S., Tian, G., Roelofs, J., and Finley, D. (2010). Assembly manual for the proteasome 
 173 
regulatory particle: the first draft. Biochem. Soc. Trans. 38, 6–13. 
Partridge, L., Piper, M.D.W., and Mair, W. (2005). Dietary restriction in Drosophila. Mech. 
Ageing Dev. 126, 938–950. 
Paul, P.K., Bhatnagar, S., Mishra, V., Srivastava, S., Darnay, B.G., Choi, Y., and Kumar, A. 
(2012). The E3 Ubiquitin Ligase TRAF6 Intercedes in Starvation-Induced Skeletal Muscle 
Atrophy through Multiple Mechanisms. Mol. Cell. Biol. 32, 1248–1259. 
Paul, P.K., Gupta, S.K., Bhatnagar, S., Panguluri, S.K., Darnay, B.G., Choi, Y., and Kumar, A. 
(2010). Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. The Journal of Cell 
Biology 191, 1395–1411. 
Piterman, R., Braunstein, I., Isakov, E., Ziv, T., Navon, A., Cohen, S., and Stanhill, A. (2014). 
VWA domain of S5a restricts the ability to bind ubiquitin and Ubl to the 26S proteasome. Mol. 
Biol. Cell 25, 3988–3998. 
Polge, C., Heng, A.-E., Jarzaguet, M., Ventadour, S., Claustre, A., Combaret, L., Béchet, D., 
Matondo, M., Uttenweiler-Joseph, S., Monsarrat, B., et al. (2011). Muscle actin is 
polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1. 
Faseb J. 25, 3790–3802. 
Raben, N., Schreiner, C., Baum, R., Takikita, S., Xu, S., Xie, T., Myerowitz, R., Komatsu, M., 
Van der Meulen, J.H., Nagaraju, K., et al. (2010). Suppression of autophagy permits successful 
enzyme replacement therapy in a lysosomal storage disorder--murine Pompe disease. Autophagy 
6, 1078–1089. 
Rabl, J., Smith, D.M., Yu, Y., Chang, S.-C., Goldberg, A.L., and Cheng, Y. (2008). Mechanism 
of gate opening in the 20S proteasome by the proteasomal ATPases. Mol. Cell 30, 360–368. 
Radhakrishnan, S.K., Lee, C.S., Young, P., Beskow, A., Chan, J.Y., and Deshaies, R.J. (2010). 
Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition 
in mammalian cells. Mol. Cell 38, 17–28. 
Ramos, P.C. (2004). Role of C-terminal Extensions of Subunits  2 and  7 in Assembly and 
Activity of Eukaryotic Proteasomes. Journal of Biological Chemistry 279, 14323–14330. 
Ramos, P.C., Höckendorff, J., Johnson, E.S., Varshavsky, A., and Dohmen, R.J. (1998). Ump1p 
Is Required for Proper Maturation of the 20S Proteasome and Becomes Its Substrate upon 
Completion of the Assembly. Cell 92, 489–499. 
Ray, M., and Lakhotia, S.C. (2015). The commonly used eye-specific sev-GAL4 and GMR-
GAL4 drivers in Drosophila melanogaster are expressed in tissues other than eyes also. J. Genet. 
94, 407–416. 
Reinke, R., Krantz, D.E., Yen, D., and Zipursky, S.L. (1988). Chaoptin, a cell surface 
glycoprotein required for Drosophila photoreceptor cell morphogenesis, contains a repeat motif 
found in yeast and human. Cell 52, 291–301. 
Reinstein, E., and Ciechanover, A. (2006). Narrative review: protein degradation and human 
diseases: the ubiquitin connection. Ann. Intern. Med. 145, 676–684. 
 174 
Reits, E.A., Benham, A.M., Plougastel, B., Neefjes, J., and Trowsdale, J. (1997). Dynamics of 
proteasome distribution in living cells. The EMBO Journal 16, 6087–6094. 
Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, 
A.L. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the 
generation of peptides presented on MHC class I molecules. Cell 78, 761–771. 
Rock, K.L., York, I.A., and Goldberg, A.L. (2004). Post-proteasomal antigen processing for 
major histocompatibility complex class I presentation. Nature Immunology 5, 670–677. 
Roelofs, J., Park, S., Haas, W., Tian, G., McAllister, F.E., Huo, Y., Lee, B.-H., Zhang, F., Shi, Y., 
Gygi, S.P., et al. (2009). Chaperone-mediated pathway of proteasome regulatory particle 
assembly. Nature 459, 861–865. 
Rubinsztein, D.C. (2006). The roles of intracellular protein-degradation pathways in 
neurodegeneration. Nature 443, 780–786. 
Sakata, E., Yamaguchi, Y., Kurimoto, E., Kikuchi, J., Yokoyama, S., Yamada, S., Kawahara, H., 
Yokosawa, H., Hattori, N., Mizuno, Y., et al. (2003). Parkin binds the Rpn10 subunit of 26S 
proteasomes through its ubiquitin-like domain. EMBO Rep. 4, 301–306. 
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A.L., Nada, S., and Sabatini, D.M. (2010). 
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its 
activation by amino acids. Cell 141, 290–303. 
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., 
Lecker, S.H., and Goldberg, A.L. (2004). Foxo transcription factors induce the atrophy-related 
ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399–412. 
Sartori, R., Schirwis, E., Blaauw, B., Bortolanza, S., Zhao, J., Enzo, E., Stantzou, A., Mouisel, E., 
Toniolo, L., Ferry, A., et al. (2013). BMP signaling controls muscle mass. Nat. Genet. 45, 1309–
1318. 
Satoo, K., Noda, N.N., Kumeta, H., Fujioka, Y., Mizushima, N., Ohsumi, Y., and Inagaki, F. 
(2009). The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing and 
delipidation during autophagy. The EMBO Journal 28, 1341–1350. 
Saville, K.J., and Belote, J.M. (1993). Identification of an essential gene, l(3)73Ai, with a 
dominant temperature-sensitive lethal allele, encoding a Drosophila proteasome subunit. Proc. 
Natl. Acad. Sci. U.S.a. 90, 8842–8846. 
Schmidt, M., Haas, W., Crosas, B., Santamaria, P.G., Gygi, S.P., Walz, T., and Finley, D. 
(2005a). The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core 
particle. Nature Structural & Molecular Biology 12, 294–303. 
Schmidt, M., Hanna, J., Elsasser, S., and Finley, D. (2005b). Proteasome-associated proteins: 
regulation of a proteolytic machine. Biol. Chem. 386, 725–737. 
Schulz, C., Kiger, A.A., Tazuke, S.I., Yamashita, Y.M., Pantalena-Filho, L.C., Jones, D.L., 
Wood, C.G., and Fuller, M.T. (2004). A misexpression screen reveals effects of bag-of-marbles 
and TGF beta class signaling on the Drosophila male germ-line stem cell lineage. Genetics 167, 
707–723. 
 175 
Schwalm, C., Jamart, C., Benoit, N., Naslain, D., Prémont, C., Prévet, J., Van Thienen, R., 
Deldicque, L., and Francaux, M. (2015). Activation of autophagy in human skeletal muscle is 
dependent on exercise intensity and AMPK activation. Faseb J. 29, 3515–3526. 
Schweisguth, F. (1999). Dominant-negative mutation in the beta2 and beta6 proteasome subunit 
genes affect alternative cell fate decisions in the Drosophila sense organ lineage. Proc. Natl. 
Acad. Sci. U.S.a. 96, 11382–11386. 
Schweitzer, A., Aufderheide, A., Rudack, T., Beck, F., Pfeifer, G., Plitzko, J.M., Sakata, E., 
Schulten, K., Förster, F., and Baumeister, W. (2016). Structure of the human 26S proteasome at a 
resolution of 3.9 Å. Proc. Natl. Acad. Sci. U.S.a. 113, 7816–7821. 
Scott, S.V., and Klionsky, D.J. (1998). Delivery of proteins and organelles to the vacuole from 
the cytoplasm. Current Opinion in Cell Biology 10, 523–529. 
Seeger, M., Hartmann-Petersen, R., Wilkinson, C.R.M., Wallace, M., Samejima, I., Taylor, M.S., 
and Gordon, C. (2003). Interaction of the Anaphase-promoting Complex/Cyclosome and 
Proteasome Protein Complexes with Multiubiquitin Chain-binding Proteins. Journal of Biological 
Chemistry 278, 16791–16796. 
Seo, H., Sonntag, K.-C., and Isacson, O. (2004). Generalized brain and skin proteasome 
inhibition in Huntington's disease. Ann. Neurol. 56, 319–328. 
Shi, J., Luo, L., Eash, J., Ibebunjo, C., and Glass, D.J. (2011). The SCF-Fbxo40 complex induces 
IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. Dev. Cell 21, 835–847. 
Shibatani, T., Carlson, E.J., Larabee, F., McCormack, A.L., Früh, K., and Skach, W.R. (2006). 
Global organization and function of mammalian cytosolic proteasome pools: Implications for 
PA28 and 19S regulatory complexes. Mol. Biol. Cell 17, 4962–4971. 
Smith, C.D., Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Stadtman, E.R., Floyd, R.A., and 
Markesbery, W.R. (1991). Excess brain protein oxidation and enzyme dysfunction in normal 
aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.a. 88, 10540–10543. 
Smith, D.M., Chang, S.-C., Park, S., Finley, D., Cheng, Y., and Goldberg, A.L. (2007). Docking 
of the Proteasomal ATPases“ Carboxyl Termini in the 20S Proteasome”s α Ring Opens the Gate 
for Substrate Entry. Mol. Cell 27, 731–744. 
Smith, S., Giriat, I., Schmitt, A., and de Lange, T. (1998). Tankyrase, a poly(ADP-ribose) 
polymerase at human telomeres. Science 282, 1484–1487. 
Smyth, K.A., and Belote, J.M. (1999). The dominant temperature-sensitive lethal DTS7 of 
Drosophila melanogaster encodes an altered 20S proteasome beta-type subunit. Genetics 151, 
211–220. 
Speese, S.D., Trotta, N., Rodesch, C.K., Aravamudan, B., and Broadie, K. (2003). The ubiquitin 
proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy. Curr. 
Biol. 13, 899–910. 
Stadtmueller, B.M., and Hill, C.P. (2011). Proteasome activators. Mol. Cell 41, 8–19. 
Steffan, J.S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.Z., Gohler, H., 
 176 
Wanker, E.E., Bates, G.P., Housman, D.E., and Thompson, L.M. (2000). The Huntington's 
disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. 
Natl. Acad. Sci. U.S.a. 97, 6763–6768. 
Steffen, J., Seeger, M., Koch, A., and Krüger, E. (2010). Proteasomal degradation is 
transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol. Cell 40, 147–
158. 
Stitt, T.N., Drujan, D., Clarke, B.A., Panaro, F., Timofeyva, Y., Kline, W.O., Gonzalez, M., 
Yancopoulos, G.D., and Glass, D.J. (2004). The IGF-1/PI3K/Akt pathway prevents expression of 
muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 
395–403. 
Strehl, B., Seifert, U., Krüger, E., Heink, S., Kuckelkorn, U., and Kloetzel, P.-M. (2005). 
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I 
antigen processing. Immunological Reviews 207, 19–30. 
Sun, H., Gong, Y., Qiu, J., Chen, Y., Ding, F., and Zhao, Q. (2014). TRAF6 inhibition rescues 
dexamethasone-induced muscle atrophy. Int J Mol Sci 15, 11126–11141. 
Sundaram, P., Pang, Z., Miao, M., Yu, L., and Wing, S.S. (2009). USP19-deubiquitinating 
enzyme regulates levels of major myofibrillar proteins in L6 muscle cells. Am. J. Physiol. 
Endocrinol. Metab. 297, E1283–E1290. 
Suzuki, R., Moriishi, K., Fukuda, K., Shirakura, M., Ishii, K., Shoji, I., Wakita, T., Miyamura, T., 
Matsuura, Y., and Suzuki, T. (2009). Proteasomal turnover of hepatitis C virus core protein is 
regulated by two distinct mechanisms: a ubiquitin-dependent mechanism and a ubiquitin-
independent but PA28gamma-dependent mechanism. J. Virol. 83, 2389–2392. 
Szlanka, T., Haracska, L., Kiss, I., Deák, P., Kurucz, E., Andó, I., Virágh, E., and Udvardy, A. 
(2003). Deletion of proteasomal subunit S5a/Rpn10/p54 causes lethality, multiple mitotic defects 
and overexpression of proteasomal genes in Drosophila melanogaster. J. Cell. Sci. 116, 1023–
1033. 
Tanahashi, N., Murakami, Y., Minami, Y., Shimbara, N., Hendil, K.B., and Tanaka, K. (2000). 
Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent 
proteolysis. Journal of Biological Chemistry 275, 14336–14345. 
Tanaka, K., and Kasahara, M. (1998). The MHC class I ligand-generating system: roles of 
immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. 
Immunological Reviews 163, 161–176. 
Tanaka, K., Yoshimura, T., Tamura, T., Fujiwara, T., Kumatori, A., and Ichihara, A. (1990). 
Possible mechanism of nuclear translocation of proteasomes. FEBS Letters 271, 41–46. 
Tang, A.H., and Rando, T.A. (2014). Induction of autophagy supports the bioenergetic demands 
of quiescent muscle stem cell activation. The EMBO Journal 33, 2782–2797. 
Tawa, N.E., Odessey, R., and Goldberg, A.L. (1997). Inhibitors of the proteasome reduce the 
accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100, 197–203. 
Taylor, J.P., Hardy, J., and Fischbeck, K.H. (2002). Toxic proteins in neurodegenerative disease. 
 177 
Science 296, 1991–1995. 
Thrower, J.S., Hoffman, L., Rechsteiner, M., and Pickart, C.M. (2000). Recognition of the 
polyubiquitin proteolytic signal. The EMBO Journal 19, 94–102. 
Tian, G., Park, S., Lee, M.J., Huck, B., McAllister, F., Hill, C.P., Gygi, S.P., and Finley, D. 
(2011). An asymmetric interface between the regulatory and core particles of the proteasome. 
Nature Structural & Molecular Biology 18, 1259–1267. 
Tiao, G., Fagan, J.M., Samuels, N., James, J.H., Hudson, K., Lieberman, M., Fischer, J.E., and 
Hasselgren, P.O. (1994). Sepsis stimulates nonlysosomal, energy-dependent proteolysis and 
increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 94, 2255–2264. 
Tintignac, L.A., Lagirand, J., Batonnet, S., Sirri, V., Leibovitch, M.P., and Leibovitch, S.A. 
(2005). Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J. Biol. Chem. 
280, 2847–2856. 
Tsvetkov, P., Mendillo, M.L., Zhao, J., Carette, J.E., Merrill, P.H., Cikes, D., Varadarajan, M., 
van Diemen, F.R., Penninger, J.M., Goldberg, A.L., et al. (2015). Compromising the 19S 
proteasome complex protects cells from reduced flux through the proteasome. Elife 4, 109. 
Tsvetkov, P., Sokol, E., Jin, D., Brune, Z., Thiru, P., Ghandi, M., Garraway, L.A., Gupta, P.B., 
Santagata, S., Whitesell, L., et al. (2017). Suppression of 19S proteasome subunits marks 
emergence of an altered cell state in diverse cancers. Proc. Natl. Acad. Sci. U.S.a. 114, 382–387. 
Turrens, J.F., and Boveris, A. (1980). Generation of superoxide anion by the NADH 
dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421–427. 
Ugrankar, R., Berglund, E., Akdemir, F., Tran, C., Kim, M.S., Noh, J., Schneider, R., Ebert, B., 
and Graff, J.M. (2015). Drosophila glucome screening identifies Ck1alpha as a regulator of 
mammalian glucose metabolism. Nat Commun 6, 7102. 
Unno, M., Mizushima, T., Morimoto, Y., Tomisugi, Y., Tanaka, K., Yasuoka, N., and Tsukihara, 
T. (2002). The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure 10, 
609–618. 
Ustrell, V., Hoffman, L., Pratt, G., and Rechsteiner, M. (2002). PA200, a nuclear proteasome 
activator involved in DNA repair. The EMBO Journal 21, 3516–3525. 
Velichutina, I., Connerly, P.L., Arendt, C.S., Li, X., and Hochstrasser, M. (2004). Plasticity in 
eucaryotic 20S proteasome ring assembly revealed by a subunit deletion in yeast. The EMBO 
Journal 23, 500–510. 
Voisin, L., Breuillé, D., Combaret, L., Pouyet, C., Taillandier, D., Aurousseau, E., Obled, C., and 
Attaix, D. (1996). Muscle wasting in a rat model of long-lasting sepsis results from the activation 
of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. J. Clin. Invest. 97, 
1610–1617. 
Wang, X.H., Zhang, L., Mitch, W.E., LeDoux, J.M., Hu, J., and Du, J. (2010a). Caspase-3 
cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity. J. 
Biol. Chem. 285, 21249–21257. 
178 
Wang, X., Yen, J., Kaiser, P., and Huang, L. (2010b). Regulation of the 26S proteasome complex 
during oxidative stress. Sci Signal 3, ra88–ra88. 
Wang, X., Blagden, C., Fan, J., Nowak, S.J., Taniuchi, I., Littman, D.R., and Burden, S.J. (2005). 
Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes 
Dev. 19, 1715–1722. 
Watanabe, Y., Suzuki, O., Haruyama, T., and Akaike, T. (2003). Interferon-gamma induces 
reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J. Cell. 
Biochem. 89, 244–253. 
Wendler, P., Lehmann, A., Janek, K., Baumgart, S., and Enenkel, C. (2004). The bipartite nuclear 
localization sequence of Rpn2 is required for nuclear import of proteasomal base complexes via 
karyopherin alphabeta and proteasome functions. Journal of Biological Chemistry 279, 37751–
37762. 
Wesley, C.S., and Saez, L. (2000). Analysis of notch lacking the carboxyl terminus identified in 
Drosophila embryos. The Journal of Cell Biology 149, 683–696. 
Whitby, F.G., Masters, E.I., Kramer, L., Knowlton, J.R., Yao, Y., Wang, C.C., and Hill, C.P. 
(2000). Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 408, 
115–120. 
Wiles, B., Miao, M., Coyne, E., Larose, L., Cybulsky, A.V., and Wing, S.S. (2015). USP19 
deubiquitinating enzyme inhibits muscle cell differentiation by suppressing unfolded-protein 
response signaling. Mol. Biol. Cell 26, 913–923. 
Wilkinson, C.R., Wallace, M., Morphew, M., Perry, P., Allshire, R., Javerzat, J.P., McIntosh, 
J.R., and Gordon, C. (1998). Localization of the 26S proteasome during mitosis and meiosis in 
fission yeast. The EMBO Journal 17, 6465–6476. 
Wing, S.S., and Goldberg, A.L. (1993). Glucocorticoids activate the ATP-ubiquitin-dependent 
proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264, E668–E676. 
Witt, E., Zantopf, D., Schmidt, M., Kraft, R., Kloetzel, P.-M., and Krüger, E. (2000). 
Characterisation of the newly identified human Ump1 homologue POMP and analysis of 
LMP7(β5i) incorporation into 20 S proteasomes. Journal of Molecular Biology 301, 1–9. 
Wójcik, C., and DeMartino, G.N. (2002). Analysis of Drosophila 26 S proteasome using RNA 
interference. Journal of Biological Chemistry 277, 6188–6197. 
Xie, Y., and Varshavsky, A. (2001). RPN4 is a ligand, substrate, and transcriptional regulator of 
the 26S proteasome: A negative feedback circuit. Proc. Natl. Acad. Sci. U.S.a. 98, 3056–3061. 
Xie, Y., and Varshavsky, A. (2002). UFD4 lacking the proteasome-binding region catalyses 
ubiquitination but is impaired in proteolysis. Nat. Cell Biol. 4, 1003–1007. 
YAO, Y., TOTH, C.R., Huang, L., WONG, M.-L., DIAS, P., BURLINGAME, A.L., COFFINO, 
P., and WANG, C.C. (1999). α5 subunit in Trypanosoma brucei proteasome can self-assemble to 
form a cylinder of four stacked heptamer rings. Biochem. J. 344, 349–358. 
Yashiroda, H., Toda, Y., Otsu, S., Takagi, K., Mizushima, T., and Murata, S. (2015). N-terminal 
179 
α7 deletion of the proteasome 20S core particle substitutes for yeast PI31 function. Mol. Cell. 
Biol. 35, 141–152. 
Yu, Y., Smith, D.M., Kim, H.M., Rodriguez, V., Goldberg, A.L., and Cheng, Y. (2010). 
Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the 
eukaryotic proteasome-ATPase interactions. The EMBO Journal 29, 692–702. 
Zhang, Y., Nicholatos, J., Dreier, J.R., Ricoult, S.J.H., Widenmaier, S.B., Hotamisligil, G.S., 
Kwiatkowski, D.J., and Manning, B.D. (2014). Coordinated regulation of protein synthesis and 
degradation by mTORC1. Nature 513, 440–443. 
Zhao, J., Brault, J.J., Schild, A., and Goldberg, A.L. (2014). Coordinate activation of autophagy 
and the proteasome pathway by FoxO transcription factor. Autophagy 4, 378–380. 
Zhao, J., Brault, J.J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S.H., and Goldberg, 
A.L. (2007). FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and 
proteasomal pathways in atrophying muscle cells. Cell Metabolism 6, 472–483. 
Zhao, J., Zhai, B., Gygi, S.P., and Goldberg, A.L. (2015). mTOR inhibition activates overall 
protein degradation by the ubiquitin proteasome system as well as by autophagy. Proc. Natl. 
Acad. Sci. U.S.a. 112, 15790–15797. 
Zhong, L., and Belote, J.M. (2007). The testis-specific proteasome subunit Pros 6T of D. 
melanogaster is required for individualization and nuclear maturation during spermatogenesis. 
Development 134, 3517–3525. 
Zirin, J., Nieuwenhuis, J., Samsonova, A., Tao, R., and Perrimon, N. (2015). Regulators of 
autophagosome formation in Drosophila muscles. PLoS Genet. 11, e1005006. 
Zwickl, P., Kleinz, J., and Baumeister, W. (1994). Critical elements in proteasome assembly. Nat. 
Struct. Biol. 1, 765–770. 
